Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3002173	ab-hb	g/l (g/l)	24376	233648	0.00%
3002173	ab-thb	g/l (g/l)	10227	48546	0.00%
3002173	ab-hb	— (—)	1925	9082	100.00%	Distribution not available
3002173	ab-chb	g/l (g/l)	536	1200	0.00%
3002173	ab-hemoglobiini	g/l (—)	480	2002	100.00%	Distribution not available
3002173	ab-hb-vt	g/l (g/l)	138	213	0.00%
3002173	hemoglobiini(totaali),valtimoveri	g/l (—)	117	203	100.00%	Distribution not available
3002173	ab-chb	— (—)	25	28	100.00%	Distribution not available
3002173	ab-hblask	g/l (g/l)	7	27	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Alcohol use disorder, ICD-based

3233

16097

2.18

323.31

10.5

8.6

122.29

123.56

g/l

2.53

3169

15645

Peripheral arterial reconstruction

1743

6802

3.04

321.64

10.8

7.2

113.20

120.59

g/l

43.22

1699

6617

Colorectal cancer

2009

8109

2.74

320.99

8.1

7.7

115.21

122.26

g/l

49.28

1964

7891

Pacemaker

2896

13378

2.32

320.60

10.8

7.0

118.47

120.28

g/l

4.75

2799

13001

Nausea and vomiting

2094

8578

2.62

318.63

9.6

7.1

118.39

120.46

g/l

4.34

2052

8323

Symptoms and signs involving the digestive system and abdomen

6731

20197

1.74

316.21

8.7

8.2

122.12

122.43

g/l

0.51

6561

19589

Suicide or other Intentional self-harm

1830

7229

2.80

316.19

9.0

8.5

124.79

123.08

g/l

2.84

1782

7035

Spinal stenosis

3951

15894

2.04

314.21

6.9

8.3

120.68

120.63

g/l

0.05

3841

15491

GI-bleeding

2731

12973

2.33

312.85

10.1

7.5

113.72

121.94

g/l

69.28

2687

12599

Other diseases of the digestive system

2724

12947

2.33

311.84

10.1

7.5

113.65

121.95

g/l

70.55

2680

12576

Sequelae with surgical and medical care as external cause

1829

7370

2.85

311.34

10.9

7.7

115.02

121.22

g/l

30.67

1786

7170

Other nutritional deficiencies

4314

22417

1.92

308.08

9.9

8.2

124.42

121.60

g/l

14.28

4230

21789

Other diseases of the respiratory system

2010

7713

3.03

307.65

14.3

7.2

125.72

120.07

g/l

22.86

1962

7498

GASTRO-related operations

5441

10886

2.66

307.65

9.6

6.2

120.64

126.17

g/l

55.58

5294

10559

Asthma (only as main-diagnosis), excluding more controls

4946

11213

2.71

307.65

8.0

6.5

124.63

122.22

g/l

10.80

4809

10891

L04AD Calcineurin inhibitors

1111

3194

4.28

307.65

21.4

8.8

108.09

124.33

g/l

109.34

1092

3113

Any reimbursement code in KELA

3410

5554

3.26

307.65

9.5

7.3

123.64

125.55

g/l

4.59

3322

5386

Viral Sepsis

2157

6461

4.00

307.65

12.9

6.3

119.60

122.29

g/l

6.35

2096

6277

Nephropathy related operations

1452

4188

4.45

307.65

21.2

7.9

105.45

123.21

g/l

179.26

1428

4078

Venous thromboembolism

4295

21543

2.09

307.65

9.0

7.5

120.99

120.91

g/l

0.08

4181

20971

3195

14604

2.34

307.65

8.6

8.0

124.49

121.13

g/l

15.66

3115

14202

Low back pain

5145

20227

1.93

307.65

7.4

8.6

122.83

121.51

g/l

4.46

5020

19687

Covid-19 confirmed case

4047

13631

3.52

307.65

11.9

7.3

120.46

121.06

g/l

0.98

3999

13207

Other neurological diseases

5379

23953

1.88

307.65

8.0

7.9

121.44

121.08

g/l

0.63

5236

23327

Pulmonary heart disease

2683

11380

2.67

307.65

9.9

7.6

121.65

120.39

g/l

2.27

2619

11059

COPD

4020

15164

2.42

307.65

9.5

7.8

124.57

120.11

g/l

30.10

3931

14756

Heart failure and coronary heart disease

4473

10707

3.49

307.65

11.5

7.1

118.84

121.10

g/l

8.45

4384

10417

Dorsalgia

6515

20597

1.77

307.65

7.2

8.6

123.34

121.59

g/l

8.37

6348

20047

Other heart diseases

4066

5550

5.39

307.65

12.7

6.5

121.56

125.61

g/l

19.16

3968

5360

Bacterial pneumonia (organism specified)

4348

15525

2.87

307.65

11.4

7.1

119.25

121.45

g/l

8.98

4184

15114

Other intervertebral disc disorders

5807

19691

1.87

307.65

7.7

8.6

123.24

121.44

g/l

7.89

5605

19162

Type 2 diabetes, wide definition

6396

19951

2.22

307.65

9.6

7.4

120.37

121.91

g/l

6.15

6235

19401

Type 2 diabetes, definitions combined

6382

21737

1.81

307.65

9.3

7.4

122.78

122.02

g/l

1.89

6234

21125

Other soft tissue disorders, not elsewhere classified

6358

21167

1.85

307.65

8.0

8.4

121.72

121.82

g/l

0.13

6200

20604

Non-invasive ventilation

4966

3329

20.77

307.65

9.7

5.8

120.77

122.36

g/l

3.30

4601

3266

Cerebrovascular diseases (FINNGEN)

2944

3995

6.06

307.65

11.6

6.3

121.92

125.13

g/l

10.01

2874

3873

COPD/asthma/ILD related infections

7196

18599

2.05

307.65

9.5

7.0

120.92

121.92

g/l

3.26

6998

18086

Septicaemia

4580

14616

3.43

307.65

12.9

6.9

113.41

122.80

g/l

152.93

4474

14212

Cardiovascular diseases (excluding rheumatic etc)

4341

6659

4.06

307.65

10.3

6.4

123.07

125.46

g/l

8.11

4243

6435

Renal tubulo-interstitial diseases

7823

24297

2.64

307.65

11.6

7.1

115.12

123.33

g/l

199.63

7664

23622

Asthma-related infections

4839

21094

2.45

307.65

9.0

7.8

123.49

120.82

g/l

14.86

4705

20519

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2001

6875

3.18

307.65

8.8

8.1

124.68

122.54

g/l

4.43

1941

6682

Solid cancers, helper endpoint

6326

17880

2.24

307.65

8.2

8.5

119.78

124.00

g/l

46.35

6157

17410

Coronary revascularization (ANGIO or CABG)

7251

16945

2.93

307.65

10.6

7.5

121.15

122.28

g/l

3.77

7070

16491

Codes for special purposes

4727

19239

2.74

307.65

11.3

7.4

121.00

121.48

g/l

0.84

4671

18657

Influenza and pneumonia

9529

23325

2.86

307.65

11.3

7.0

120.52

122.83

g/l

18.59

9252

22711

All influenza

2081

7895

2.95

307.65

8.8

7.1

122.03

122.72

g/l

0.74

2001

7696

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5413

23050

2.57

307.65

10.7

7.3

116.63

122.11

g/l

68.99

5262

22439

Acute tubulo-interstitial nephritis

4839

19844

2.28

307.65

8.7

6.8

116.65

122.52

g/l

71.81

4738

19275

Implicit viral Sepsis

2873

9658

3.46

307.65

12.3

6.2

119.74

122.37

g/l

8.33

2807

9370

Other septicaemia

4107

13367

3.47

307.65

13.2

6.9

113.11

122.67

g/l

142.78

4016

12990

Other diseases of pleura

4130

16698

2.42

307.65

11.7

7.3

122.05

120.76

g/l

3.25

4041

16236

Symptoms and signs involving the circulatory and respiratory systems

6830

17213

2.09

307.65

8.2

8.3

124.11

120.90

g/l

25.35

6656

16715

Antihypertensive medication - note that there are other indications

3402

6826

2.79

307.65

9.7

6.8

123.79

124.40

g/l

0.76

3313

6599

Bleeding

7080

23920

2.30

307.65

10.5

7.6

118.24

122.58

g/l

50.00

6921

23264

COPD, hospital admissions

3828

16327

2.18

307.65

9.4

7.7

124.51

120.33

g/l

26.05

3746

15881

Hypothyroidism, drug reimbursement

693

717

7.34

307.65

9.6

5.1

123.99

127.13

g/l

2.33

667

692

Chronic lower respiratory diseases

8378

25733

1.82

307.65

8.5

8.1

124.43

121.13

g/l

34.37

8152

25037

Other pulmonary diagnosis

5372

12875

2.21

307.65

9.4

6.8

122.29

121.81

g/l

0.81

5218

12527

Hypo-osmolality and hyponatraemia

1668

5802

3.34

307.65

11.5

6.8

116.75

120.35

g/l

9.97

1634

5627

Care involving use of rehabilitation procedures

5125

21630

2.37

307.65

9.6

7.6

121.23

122.94

g/l

6.85

4900

21084

Bacterial Sepsis

5371

14827

3.67

307.65

13.6

6.4

116.14

122.55

g/l

79.08

5246

14407

Condition for Implicit Sepsis (Organ dysfunction codes)

8155

21463

2.90

307.65

12.2

6.6

120.26

123.40

g/l

27.95

7963

20852

Pain in limb

5738

20755

1.96

307.65

8.0

8.4

121.10

121.67

g/l

1.19

5607

20208

Implicit bacterial Sepsis

5173

14383

3.70

307.65

13.7

6.4

116.63

122.41

g/l

61.81

5056

13978

4693

21279

2.09

307.65

10.6

8.3

121.99

123.17

g/l

2.99

4598

20677

Hypertension

5805

13623

2.59

307.65

10.1

7.7

122.11

123.53

g/l

4.67

5678

13222

Other diseases of intestines

7061

23017

1.83

307.65

9.0

8.1

120.60

123.14

g/l

18.08

6890

22352

Provisional assignment of new diseases of uncertain etiology

4721

19217

2.73

307.65

11.3

7.4

120.99

121.49

g/l

0.86

4665

18635

Cardiovascular diseases

3687

5803

3.65

307.65

10.0

6.5

123.64

125.37

g/l

3.99

3597

5607

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8325

18594

3.00

307.65

11.4

7.0

120.03

121.92

g/l

11.17

8089

18081

Hypothyroidism, levothyroxine purchases

1233

1160

6.39

307.65

10.3

5.7

125.47

128.11

g/l

2.58

1202

1118

Asthma, hospital admission 2, infections

4839

21094

2.45

307.65

9.0

7.8

123.49

120.82

g/l

14.86

4705

20519

Explicit Sepsis

4681

14554

3.50

307.65

13.0

6.3

113.44

122.45

g/l

144.74

4577

14128

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6720

22074

1.94

307.65

9.6

7.5

121.30

122.20

g/l

2.60

6558

21445

Anaemias

1835

1090

12.48

307.65

12.5

5.5

112.12

127.96

g/l

79.09

1801

1054

Heart failure, not strict

8059

18070

3.53

307.65

11.9

7.2

118.89

123.03

g/l

45.76

7895

17568

Major coronary heart disease event

7514

18278

2.75

307.65

10.6

7.4

121.24

122.19

g/l

2.92

7327

17788

Hard cardiovascular diseases

7428

16491

2.99

307.65

11.1

7.2

121.40

122.60

g/l

4.25

7242

16038

Acute renal failure

2516

8301

3.72

307.65

18.5

6.9

111.76

122.28

g/l

100.90

2471

8055

Codeine

6637

17404

2.20

307.65

8.0

7.9

121.98

123.31

g/l

4.95

6459

16885

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3516

17405

2.19

307.65

10.5

8.6

122.23

123.55

g/l

2.91

3445

16925

Oral corticosteroids

7922

25306

1.97

307.65

8.6

8.0

122.19

121.92

g/l

0.51

7725

24604

Type 2 diabetes, definitions combined, including avohilmo

6296

21648

1.77

307.65

9.2

7.5

122.95

121.94

g/l

2.98

6150

21035

Cardiac arrhythmias

4184

8661

3.41

307.65

10.4

6.5

123.33

123.12

g/l

0.21

4062

8385

Dental caries

2279

8381

2.94

307.65

12.7

8.4

115.10

123.03

g/l

53.70

2226

8143

Implicit bacterial Sepsis

4842

13532

3.81

307.65

14.0

6.3

116.14

122.32

g/l

66.64

4732

13143

Later onset COPD, excluding more controls

1888

5424

3.09

307.65

8.3

6.0

122.89

119.50

g/l

8.80

1851

5269

Diseases of the digestive system

3626

18384

2.13

307.65

10.0

7.5

114.79

121.91

g/l

71.24

3559

17853

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1320

4249

3.52

307.65

9.2

8.8

125.48

123.48

g/l

2.77

1289

4135

Heart failure, strict

6137

16605

3.02

307.65

11.1

7.3

119.11

121.52

g/l

13.14

6025

16135

Non-ischemic cardiomyopathy

2759

7956

3.20

307.65

10.6

7.0

119.46

121.32

g/l

4.05

2711

7729

Erysipelas

4659

19043

2.37

307.65

9.4

7.1

119.46

123.73

g/l

33.93

4564

18520

Pulmonary embolism

2683

11301

2.69

307.65

9.9

7.6

121.65

120.30

g/l

2.55

2619

10981

Calcific aortic valvular stenosis, operated

2759

12071

2.52

307.65

8.7

7.1

114.59

120.72

g/l

46.65

2693

11709

Mental and behavioural disorders due to psychoactive substance use

4625

21595

2.14

307.65

10.2

8.4

122.70

123.06

g/l

0.49

4534

20987

Asthma, excluding more controls

5575

11213

2.79

307.65

8.4

6.5

124.66

122.22

g/l

11.84

5426

10891

Metabolic disorders

8040

21194

2.52

307.65

10.0

7.6

120.54

122.74

g/l

14.74

7846

20581

Paralytic ileus and intestinal obstruction

2393

9422

2.88

307.65

10.2

7.5

117.26

121.61

g/l

19.89

2334

9149

Complications of procedures, not elsewhere classified

7069

25348

2.53

307.65

10.3

7.4

117.18

122.97

g/l

95.06

6904

24646

All pneumoniae

9330

23796

2.90

307.65

11.5

7.0

120.22

122.88

g/l

24.27

9067

23159

Alcohol use disorder, Swedish definition

4342

20186

2.13

307.65

10.8

8.3

121.75

123.32

g/l

4.63

4256

19616

Peripheral artery disease

3774

14679

2.26

307.65

9.6

7.1

115.71

121.61

g/l

55.07

3688

14260

Other CVD (FINNGEN)

1021

1500

6.25

307.65

9.0

6.3

117.93

123.22

g/l

9.89

1002

1447

Endocrine, nutritional and metabolic diseases

5056

12511

2.15

307.65

9.9

7.1

123.18

123.08

g/l

0.12

4940

12116

Other bacterial diseases

9060

23601

2.87

307.65

10.8

7.3

116.97

123.91

g/l

154.68

8830

22938

Chronic kidney disease

2779

12029

2.56

307.65

12.4

6.7

109.21

122.19

g/l

195.43

2711

11686

Diseases of arteries, arterioles and capillaries

5929

20656

2.34

307.65

10.6

7.4

116.85

122.21

g/l

67.55

5795

20092

Atrial fibrillation and flutter

2766

3785

5.42

307.65

12.4

6.4

122.40

125.45

g/l

7.81

2695

3665

Dyspnoea

8396

25209

2.73

307.65

8.3

8.0

123.77

120.87

g/l

26.98

8230

24483

Insulin, intermediate and long-acting

4441

21927

2.14

307.65

10.2

7.8

119.17

122.36

g/l

18.36

4341

21315

Heart failure and bmi 25plus

3379

9054

2.91

307.65

10.7

7.2

119.86

123.22

g/l

13.49

3313

8747

Bacterial pneumoniae

4151

12706

3.31

307.65

11.5

6.7

119.41

122.13

g/l

12.48

3991

12374

Transplanted organ and tissue status

1074

2803

4.83

307.65

23.3

7.8

107.45

124.98

g/l

118.81

1058

2722

Asthma, unspecified (mode), excluding more controls

4192

10598

3.25

307.65

8.4

6.4

123.70

121.84

g/l

5.99

4083

10300

Hernia of abdominal wall, postoperative

1637

4628

4.08

307.65

10.9

6.4

119.56

125.89

g/l

24.59

1607

4482

Pneumonias (Asthma/COPD co-morbidities)

9288

23797

2.90

307.65

11.5

7.0

120.21

122.91

g/l

24.91

9035

23150

Substance abuse

4531

21252

2.16

307.65

10.2

8.4

122.70

123.11

g/l

0.58

4442

20650

COPD, early/later onset

3870

16431

2.19

307.65

9.4

7.7

124.48

120.33

g/l

26.01

3789

15978

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7361

24100

2.12

307.65

11.4

7.3

117.75

123.22

g/l

85.33

7172

23457

Malignant neoplasm

6527

18043

2.30

307.65

8.3

8.5

119.39

124.04

g/l

56.39

6356

17565

Implicit viral Sepsis

2156

6448

4.01

307.65

12.9

6.3

119.60

122.27

g/l

6.29

2095

6264

Depression medications

1487

1229

6.46

307.65

9.4

5.4

125.99

128.64

g/l

2.86

1452

1184

Emergency coronary revascularization (for ACS)

7872

19206

2.77

307.65

10.2

7.4

120.95

122.00

g/l

3.66

7668

18693

Intestinal stricture

2809

12009

2.65

307.65

10.5

7.5

116.71

121.24

g/l

25.74

2749

11671

Certain infectious and parasitic diseases

6655

17727

1.98

307.65

9.6

7.2

120.06

123.76

g/l

33.80

6480

17202

Lower back pain or/and sciatica

7157

28385

1.72

307.65

7.2

8.4

122.85

121.57

g/l

5.61

6982

27598

Opioids

6882

17562

2.15

307.65

8.7

7.8

121.12

123.34

g/l

12.92

6714

17038

Cerebrovascular diseases

6096

22053

2.11

307.65

9.6

7.8

120.72

121.43

g/l

1.77

5947

21471

Asthma-related pneumonia or sepsis

3543

13393

3.01

307.65

9.9

7.4

122.12

120.00

g/l

7.08

3443

13009

Asthma (mode)

5414

12885

2.40

307.65

8.1

6.9

124.12

121.80

g/l

11.10

5261

12537

Examination and observation for other reasons

4539

12231

2.30

307.65

8.9

8.0

119.85

122.74

g/l

14.79

4502

11862

Asthma-related pneumonia

3536

13373

3.01

307.65

9.9

7.4

122.10

120.01

g/l

6.89

3436

12991

Substance abuse, excluding more controls

4531

17530

2.39

307.65

10.2

8.4

122.70

122.53

g/l

0.20

4442

17019

Malignant neoplasm, wide definition for exclusion

6672

18355

2.29

307.65

8.4

8.5

119.72

124.11

g/l

50.85

6489

17867

Diabetes, insulin treatment (Kela reimbursement)

7136

24662

1.84

307.65

9.5

7.8

121.19

122.14

g/l

3.03

6961

23970

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

9035

24033

2.83

307.65

11.1

7.3

120.03

122.87

g/l

27.06

8784

23388

Parasetamol

5141

10888

2.54

307.65

8.8

8.6

122.84

123.68

g/l

1.66

5011

10555

Excluding asthma or asthma-COPD overlap

5350

12875

2.20

307.65

9.4

6.8

122.24

121.81

g/l

0.70

5200

12527

Hypertensive diseases (excluding secondary)

3849

5468

4.51

307.65

10.9

6.5

122.81

125.52

g/l

8.82

3770

5286

Other heart diseases, wide

7231

17679

2.71

307.65

10.8

7.4

121.62

123.42

g/l

8.65

7044

17155

Bacterial infection, other or unspecified

5078

17456

2.85

307.65

10.9

7.0

114.05

123.02

g/l

166.60

4939

16976

Tramadol

6722

16641

2.71

307.65

9.0

7.9

121.02

123.18

g/l

12.27

6604

16145

General symptoms and signs

8035

19309

2.22

307.65

8.8

7.9

121.67

123.01

g/l

5.62

7834

18745

Hypertension, essential

5865

13448

2.67

307.65

9.5

7.7

122.21

123.50

g/l

3.97

5735

13052

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2001

8068

2.70

307.65

8.8

8.4

124.68

122.89

g/l

3.36

1941

7848

Diseases of oesophagus, stomach and duodenum

7235

25991

1.74

307.65

9.5

7.9

120.04

122.59

g/l

18.90

7051

25272

Ischaemic heart disease, wide definition

6466

18203

2.42

307.65

9.7

7.9

121.26

121.88

g/l

1.37

6312

17734

Other chronic obstructive pulmonary disease, including avohilmo

4456

19032

2.12

307.65

9.3

7.8

124.37

120.52

g/l

26.08

4359

18517

Presence of cardiac and vascular implants and grafts

4288

14351

2.50

307.65

11.1

7.2

117.68

122.20

g/l

34.95

4161

13977

Codeine or tramadol medication

7993

25029

1.84

307.65

8.0

8.2

121.93

121.89

g/l

0.05

7781

24338

Any event in cancer register

6841

19471

2.21

307.65

8.3

8.4

119.84

123.76

g/l

42.88

6659

18953

Oxycodone

3639

12463

3.00

307.65

8.7

7.6

115.63

122.37

g/l

65.62

3546

12105

Asthma, hospital admissions 3, pneumonia

3543

13393

3.01

307.65

9.9

7.4

122.12

120.00

g/l

7.08

3443

13009

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5215

24369

2.07

307.65

9.0

7.7

121.84

120.98

g/l

2.12

5081

23737

Any death

5466

18945

2.30

307.65

12.0

7.3

115.38

122.90

g/l

112.90

5320

18449

Concussion

3165

12165

2.25

307.65

7.6

7.8

123.27

120.71

g/l

8.88

3099

11823

Complications of medical and surgical care

6760

25887

2.67

307.65

10.4

7.4

117.14

122.30

g/l

75.03

6576

25202

Caries of dentine

2044

7449

3.02

307.65

13.0

8.4

115.16

122.98

g/l

46.74

1993

7241

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2671

5088

3.56

307.65

9.8

6.3

121.53

124.82

g/l

10.36

2599

4919

Calcific aortic valvular stenosis, diagnosis (helper)

2755

12064

2.51

307.65

8.7

7.0

114.60

120.71

g/l

46.46

2689

11702

Viral pneumonia

1286

3722

4.13

307.65

15.5

6.8

121.87

122.70

g/l

0.64

1238

3632

Implicit Sepsis

7717

20702

3.20

307.65

12.6

6.6

119.15

123.14

g/l

42.92

7543

20127

Abnormalities of breathing

7367

17176

2.70

307.65

8.4

8.3

124.71

120.87

g/l

37.43

7200

16679

Valvular operations

1591

4144

4.75

307.65

14.6

7.0

111.09

123.01

g/l

89.37

1551

4018

ILD differential diagnosis

5292

12885

2.17

307.65

9.4

6.9

122.32

121.80

g/l

0.86

5143

12537

DVT of lower extremities and pulmonary embolism

3504

16880

2.28

307.65

9.2

7.5

121.26

120.66

g/l

0.90

3414

16412

Convulsions, not elsewhere classified

1843

6650

3.02

307.65

9.2

8.2

122.20

123.43

g/l

1.58

1806

6442

Bacterial pneumonia, not elsewhere classified

3985

12059

3.35

307.65

11.6

6.7

119.42

122.06

g/l

11.38

3832

11743

Asthma (only as main-diagnosis)

5127

12773

2.48

307.65

7.9

6.8

124.32

121.80

g/l

12.42

4987

12428

Heart failure,strict

5720

13486

3.53

307.65

11.4

7.2

119.25

122.53

g/l

21.09

5618

13108

Percutaneous Coronary Intervention

7265

16942

2.94

307.65

10.5

7.5

121.18

122.28

g/l

3.63

7082

16488

Asthma

5813

12773

2.56

307.65

8.3

6.8

124.52

121.80

g/l

15.47

5654

12428

Condition for Implicit Sepsis (Organ dysfunction codes)

8139

21460

2.99

307.65

12.4

6.5

119.96

123.19

g/l

29.47

7953

20851

Early onset COPD, excluding more controls

1835

6009

3.51

307.65

10.9

7.0

126.46

122.18

g/l

12.54

1796

5848

Other respiratory disorders and diseases

2010

7713

3.03

307.65

14.3

7.2

125.72

120.07

g/l

22.86

1962

7498

Pneumonia, organism unspecified

8229

22396

2.85

307.65

10.7

7.0

119.88

122.76

g/l

25.54

8030

21808

Abnormal findings on diagnostic imaging of lung

3891

19465

2.09

307.65

9.2

7.7

122.21

120.73

g/l

4.28

3786

18956

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1045

1713

5.07

307.65

12.2

7.8

123.58

120.26

g/l

4.00

1015

1663

ILD medications: prednisolone, methylprednisolone, prednisone

7926

24137

1.94

307.65

9.3

7.7

121.12

122.41

g/l

5.56

7738

23446

All chronic kidney diseases

4791

16762

2.59

307.65

11.0

7.0

112.52

123.42

g/l

222.53

4688

16293

Other medical care

4263

15794

2.73

307.65

7.8

7.2

116.28

121.85

g/l

54.49

4144

15388

Symptoms and signs involving cognition, perception, emotional state and behaviour

6874

26582

1.86

307.65

7.7

8.3

122.41

121.68

g/l

2.07

6709

25856

Heart failure and antihypertensive medication

2864

3552

6.47

307.65

13.8

7.0

119.87

123.53

g/l

10.74

2815

3441

Complications of surgical and medical care, not elsewhere classified

8816

26046

2.54

307.65

10.1

7.5

117.29

123.12

g/l

115.39

8608

25317

Myocardial infarction, strict

3887

11687

2.64

307.65

9.8

7.4

120.11

121.89

g/l

5.35

3789

11385

Valvular heart disease excluding rheumatic fever

4259

11046

3.14

307.65

10.9

7.1

115.36

122.63

g/l

83.92

4170

10717

COPD related to multimorbidity

3435

14203

2.27

307.65

9.6

7.4

123.91

120.18

g/l

18.80

3360

13807

Diabetes, varying definitions

7123

22776

1.93

307.65

10.1

7.5

121.77

122.21

g/l

0.87

6958

22127

COPD/asthma related infections

7196

18599

2.05

307.65

9.5

7.0

120.92

121.92

g/l

3.26

6998

18086

Diabetes mellitus

7158

22772

1.94

307.65

10.1

7.5

121.78

122.20

g/l

0.84

6992

22126

All kidney diseases

8294

24881

2.48

307.65

11.2

7.2

116.63

123.79

g/l

156.78

8115

24173

Other arrhythmias

4026

15174

2.12

307.65

7.9

7.2

123.17

122.85

g/l

0.41

3904

14727

Erysipelas

5935

20853

2.36

307.65

9.2

7.2

119.79

123.86

g/l

38.25

5810

20269

Insulin, combination of fast acting with intermediate-acting or long-acting

4828

23260

2.04

307.65

10.3

7.7

119.03

122.25

g/l

20.16

4715

22613

Operations 2 for CAVS

2755

12064

2.51

307.65

8.7

7.0

114.60

120.71

g/l

46.46

2689

11702

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1676

6183

3.16

307.65

7.8

8.0

115.38

122.69

g/l

40.66

1627

6019

8325

18594

3.00

307.65

11.4

7.0

120.03

121.92

g/l

11.17

8089

18081

COPD differential diagnosis

5295

12889

2.17

307.65

9.4

6.9

122.29

121.81

g/l

0.78

5146

12541

Asthma/COPD (KELA code 203)

6529

25692

1.83

307.65

7.8

8.1

124.55

121.11

g/l

31.25

6344

24997

Major coronary heart disease event excluding revascularizations

5200

14742

2.61

307.65

9.8

7.3

121.26

121.84

g/l

1.05

5074

14353

Type 2 diabetes

6886

22202

1.91

307.65

9.8

7.5

121.93

122.12

g/l

0.29

6723

21572

Mental and behavioural disorders due to alcohol

3959

19299

2.13

307.65

10.2

8.4

122.42

123.28

g/l

1.56

3877

18748

First line medication for Crohn's disease

8081

22791

2.03

307.65

9.1

7.8

120.85

122.82

g/l

12.00

7874

22145

Implicit Sepsis

8035

21465

3.08

307.65

12.5

6.6

119.70

123.13

g/l

33.16

7856

20857

Asthma, unspecified (mode)

4346

12061

2.97

307.65

8.3

6.8

123.45

121.44

g/l

7.24

4231

11744

Respiratory insufficiency

941

2216

5.33

307.65

13.5

6.2

131.24

119.93

g/l

38.61

922

2159

Sequelae of external causes of morbidity and mortality

2304

9374

2.80

307.65

10.9

7.7

115.70

121.36

g/l

31.08

2246

9118

Infections, IBD-co-morbidities

1334

2259

4.76

307.65

12.4

7.8

115.54

121.09

g/l

13.53

1296

2197

All-cause Heart Failure

6023

16356

3.01

307.65

10.9

7.3

119.03

121.47

g/l

13.31

5912

15889

COPD (mode)

3025

8042

3.41

307.65

9.8

6.7

124.40

120.99

g/l

12.83

2960

7836

Headache

4092

16974

2.03

307.65

7.5

7.8

124.24

122.70

g/l

5.03

4000

16479

Diabetes medication

7115

24233

1.83

307.65

9.5

7.7

121.52

122.14

g/l

1.48

6946

23547

Other chronic obstructive pulmonary disease

3847

14694

2.40

307.65

9.5

7.7

124.48

120.02

g/l

28.95

3766

14302

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7890

26366

2.22

307.65

9.9

7.7

113.74

124.18

g/l

315.20

7694

25643

Calcific aortic valvular stenosis, including rheumatic fever

2756

12099

2.50

307.65

8.7

7.1

114.61

120.72

g/l

46.35

2690

11732

Coronary atherosclerosis

5633

14613

2.72

307.65

9.7

7.4

120.11

121.97

g/l

7.71

5501

14232

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2151

3848

2.95

307.65

9.0

8.1

124.19

123.42

g/l

0.75

2096

3720

Pain in throat and chest

6354

16900

2.42

307.65

7.6

8.3

124.43

120.87

g/l

29.94

6169

16412

Stroke, including SAH

4915

19605

1.96

307.65

9.7

7.7

120.67

121.08

g/l

0.67

4793

19078

Calcific aortic valvular stenosis

2759

12071

2.52

307.65

8.7

7.1

114.59

120.72

g/l

46.65

2693

11709

Hypertensive Heart Disease

1982

5945

2.93

307.65

8.9

6.9

119.86

121.53

g/l

2.55

1957

5782

Type 2 diabetes, strict (exclude DM1)

6405

21910

1.80

307.65

9.3

7.5

122.74

121.95

g/l

2.04

6256

21295

Inflammatory bowel disease treatment related agents

8003

25711

1.83

307.65

8.6

8.0

122.04

122.02

g/l

0.03

7804

24995

Unstable angina pectoris

2997

10410

2.52

307.65

8.1

7.1

122.21

121.24

g/l

1.60

2901

10123

Bacterial infection, other or unspecified

5458

18227

2.85

307.65

10.8

7.0

114.37

123.15

g/l

169.87

5312

17725

ILD medications

7941

24352

1.86

307.65

9.4

7.7

121.06

122.47

g/l

6.42

7743

23656

Myocardial infarction, without ST-elevation

3519

15932

2.23

307.65

9.4

7.5

119.02

121.07

g/l

6.84

3427

15491

Haemorrhage from respiratory passages

2711

10875

2.46

307.65

9.8

7.9

119.88

119.92

g/l

0.03

2645

10560

Hypothyroidism (congenital or acquired)

1251

1166

6.45

307.65

10.4

5.7

125.19

128.12

g/l

3.10

1221

1124

Hypertensive diseases

5814

13630

2.60

307.65

10.1

7.7

122.11

123.53

g/l

4.67

5687

13228

Malaise and fatigue

4405

14287

2.73

307.65

8.4

7.7

119.51

121.83

g/l

10.13

4326

13886

Angina pectoris

4674

13572

2.53

307.65

8.7

7.4

121.55

121.71

g/l

0.19

4528

13213

Hypothyroidism and >3 levothyroxin purchases

1233

1160

6.39

307.65

10.3

5.7

125.47

128.11

g/l

2.58

1202

1118

Asthma (diagnoses ohter than nonallergic)

6354

28383

1.97

307.65

8.2

8.1

123.76

121.14

g/l

18.59

6190

27615

Hypertensive heart and/or renal disease

2230

6283

2.97

307.65

8.8

7.0

118.93

121.76

g/l

6.95

2199

6114

Insulin medication

4819

19704

2.23

307.65

10.4

7.7

119.04

122.20

g/l

19.03

4707

19163

Disorders of lipoprotein metabolism and other lipidaemias

6533

19627

2.22

307.65

8.9

7.5

121.10

122.61

g/l

6.40

6384

19071

Fever of other and unknown origin

4742

16715

2.77

307.65

9.7

7.8

116.53

122.51

g/l

66.78

4642

16242

Poisoning by medicine

1759

5909

3.36

307.65

9.0

8.7

125.27

123.10

g/l

4.06

1721

5741

Malignant neoplasm of digestive organs

3392

11380

2.64

307.65

9.0

8.0

115.13

122.66

g/l

85.36

3310

11083

Coronary artery bypass grafting

2420

6887

3.00

307.65

11.9

7.1

114.66

121.60

g/l

45.53

2355

6697

Persons encountering health services for specific procedures and health care

8949

23832

2.43

307.65

10.0

7.6

119.27

123.30

g/l

53.35

8673

23221

STROKE

4619

10813

3.23

307.65

10.6

6.7

121.24

123.21

g/l

7.14

4504

10521

COPD, hospital admission 2, with asthma infections

2838

11407

2.38

307.65

9.9

7.4

124.55

120.35

g/l

19.46

2774

11080

Paroxysmal tachycardia

1454

3206

4.17

307.65

10.8

6.3

123.48

124.50

g/l

0.92

1427

3100

Non-rheumatic valve diseases

4225

11009

3.13

307.65

10.6

7.1

115.43

122.60

g/l

81.44

4136

10682

Other disorders of fluid, electrolyte and acid-base balance

3159

10501

3.34

307.65

11.3

6.9

116.88

121.06

g/l

22.53

3094

10192

Ischemic heart diseases

7196

17354

2.76

307.65

10.6

7.5

121.39

122.35

g/l

2.92

7023

16889

Spondylopathies

5604

18891

1.87

307.65

7.0

8.6

121.80

121.32

g/l

0.91

5453

18392

Atherosclerosis, excluding cerebral and coronary sclerosis

3512

13827

2.22

307.65

9.5

7.0

115.62

121.50

g/l

51.73

3427

13429

Diseases of arteries, arterioles and capillaries (FINNGEN)

2500

3074

6.74

307.65

12.2

6.4

116.48

125.33

g/l

56.25

2444

2980

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4899

22346

2.41

307.65

10.7

7.4

116.63

121.84

g/l

57.66

4760

21744

Neoplasms

4659

12454

2.08

307.65

8.4

9.0

122.66

125.23

g/l

11.74

4533

12112

Poisoning by drugs, medicaments and biological substances

1917

6644

3.24

307.65

8.8

8.6

125.26

123.15

g/l

4.19

1875

6462

Other bacterial diseases

9153

23215

2.75

307.65

10.8

7.3

117.62

124.03

g/l

132.39

8921

22551

Any gastric operation

5441

10886

2.66

307.65

9.6

6.2

120.64

126.17

g/l

55.58

5294

10559

Renal failure

4706

16858

2.84

307.65

14.4

6.9

111.39

122.42

g/l

217.40

4604

16386

Pulmonary heart disease, diseases of pulmonary circulation

2973

12466

2.71

307.65

10.0

7.5

121.94

120.40

g/l

3.42

2905

12111

Cardiac arrest

653

950

7.13

307.65

16.8

6.9

119.12

124.21

g/l

6.08

641

914

4525

20911

2.11

307.65

10.6

8.3

121.88

123.23

g/l

3.67

4433

20319

Dialysis, with operation codes

1471

4275

4.36

307.65

21.3

7.4

105.49

123.98

g/l

192.34

1448

4159

Aplastic and other anaemias

3719

17876

2.11

307.65

9.5

7.3

107.84

122.20

g/l

307.65

3642

17375

Myocardial infarction

4244

12260

2.72

307.65

10.1

7.4

120.26

121.90

g/l

4.89

4139

11941

Atrial fibrillation and flutter with reimbursement

2405

3080

5.80

307.65

11.9

6.5

123.63

124.82

g/l

1.41

2357

2985

Fall on same level

7521

25126

1.70

307.65

8.8

8.2

120.60

122.93

g/l

16.34

7326

24433

Pure hypercholesterolaemia

6071

18734

2.30

307.65

8.5

7.4

121.07

122.46

g/l

5.23

5925

18224

Intracranial trauma

3997

12273

2.44

307.65

8.7

7.8

122.28

120.71

g/l

4.35

3913

11928

Injuries to the head

7329

28150

1.67

306.66

8.5

8.1

121.55

121.99

g/l

0.97

7182

27341

Oedema, not elsewhere classified

2394

10672

2.41

305.23

9.1

7.5

119.12

121.42

g/l

6.04

2340

10361

Neurological diseases, wide definition

1736

3034

3.03

304.77

9.6

8.1

125.20

121.46

g/l

8.38

1692

2936

Asthma, including avohilmo

7781

27615

1.65

304.63

8.0

8.2

124.20

121.24

g/l

27.40

7575

26864

Syncope and collapse

3206

13713

2.14

304.59

7.7

121.96

121.94

g/l

0.02

3125

13327

Conduction disorders

2167

7487

2.57

303.96

9.3

6.7

120.43

122.16

g/l

3.29

2116

7250

Polyarthropathies

4628

16757

1.90

303.83

9.1

8.7

118.99

122.06

g/l

17.46

4516

16307

AV-block

1499

4732

3.13

303.60

9.6

6.5

119.35

121.95

g/l

4.79

1458

4578

Abdominal and pelvic pain

6647

20193

1.72

301.06

8.6

8.2

122.82

122.42

g/l

0.74

6487

19585

Insulin, fast-acting

2745

13197

2.27

301.06

10.7

7.8

117.80

122.67

g/l

26.07

2671

12819

Other and unspecified anaemias

3400

16842

2.09

300.24

9.3

7.3

107.67

122.09

g/l

302.64

3336

16359

COPD-related respiratory insufficiency

1263

4320

3.57

300.12

12.8

7.3

126.16

119.93

g/l

17.56

1237

4197

Other anaemias

3422

16955

2.09

299.51

9.3

7.3

107.69

122.09

g/l

304.53

3358

16468

Other or unspecified ileus, impaction or obstruction

1669

6525

2.91

299.50

9.6

7.5

116.98

121.68

g/l

16.35

1630

6325

Epilepsy

2364

10717

2.40

297.31

8.7

8.0

122.76

120.57

g/l

5.73

2308

10413

Any mental disorder

7231

22463

1.68

296.96

8.5

8.1

122.55

121.58

g/l

3.15

7054

21825

Other (not insulin) diabetes medications

6450

23318

1.72

296.84

8.9

7.7

122.20

121.97

g/l

0.36

6294

22661

COPD, hospital admissions 3, with asthma pneumonia sepsis

2433

9617

2.43

292.36

9.9

7.4

123.92

119.97

g/l

15.27

2375

9329

Disorders of gallbladder, biliary tract and pancreas

6693

26175

1.69

291.88

9.2

7.9

120.29

121.90

g/l

7.77

6546

25452

Hernia

6230

25506

1.71

291.38

8.7

8.1

120.95

121.99

g/l

3.35

6104

24758

Asthma, hospital admissions , main diagnosis only

5397

28373

1.76

290.73

7.7

8.1

124.08

121.25

g/l

18.77

5248

27605

Statin medication

3996

11866

1.98

290.52

9.5

7.7

123.02

122.79

g/l

0.26

3896

11498

Diarrhoea and gastroenteritis of presumed infectious origin

4712

24404

1.83

289.98

9.3

7.8

121.06

122.28

g/l

3.46

4606

23706

Personality disorders, excluding more controls

1623

6272

2.80

288.65

8.2

8.4

124.70

123.15

g/l

2.21

1591

6093

Dipeptidyl peptidase 4 (DPP-4) inhibitors

4195

18720

1.93

288.64

8.9

7.6

119.69

121.22

g/l

4.48

4081

18220

Stroke, excluding SAH

4554

18920

1.88

286.76

9.4

7.7

120.47

120.99

g/l

0.89

4440

18413

Intestinal infectious diseases

6217

29102

1.69

285.37

9.3

7.9

120.63

122.08

g/l

5.93

6078

28284

Obesity related asthma

2519

11976

2.29

284.75

8.9

8.2

126.03

121.24

g/l

22.66

2465

11645

Obesity

4049

21689

1.90

284.74

9.9

8.2

124.77

121.60

g/l

16.98

3972

21070

Obesity and other hyperalimentation

4064

21784

1.90

283.74

9.9

8.2

124.76

121.58

g/l

17.08

3987

21163

Non-allergic asthma (mode), excluding more controls

1320

4597

3.12

282.49

8.2

6.0

125.14

121.39

g/l

8.12

1288

4454

Cardiomyopathy

1400

5142

3.08

282.00

13.8

7.0

123.51

123.44

g/l

0.04

1382

4987

Colorectal adenocarcinoma

1704

6950

2.79

279.83

8.0

7.6

115.53

122.45

g/l

40.36

1668

6765

Nerve, nerve root and plexus disorders

7069

27456

1.64

279.03

7.7

8.3

122.51

121.59

g/l

3.00

6849

26738

Other antidepressants

6893

22043

1.67

278.19

8.3

8.1

122.79

121.73

g/l

3.57

6729

21415

Colectomy operation

1586

6323

2.92

278.13

10.9

7.7

113.96

121.00

g/l

37.19

1559

6139

Sciatica+with lumbago

3479

17085

1.99

275.85

6.9

8.7

123.50

121.32

g/l

7.79

3397

16640

Other dorsopathies, not elsewhere classified

6410

20631

1.69

274.53

7.6

8.6

123.43

121.60

g/l

9.05

6220

20080

Pain, not elsewhere classified

1895

8168

2.51

268.42

8.4

7.6

121.40

122.15

g/l

0.84

1862

7915

Insulin, fast-acting or short human

2758

13869

2.15

267.57

10.8

8.0

117.78

122.47

g/l

24.65

2684

13477

Other special examinations and investigations of persons without complaint or reported diagnosis

4391

12359

1.88

266.65

8.3

7.9

122.40

122.68

g/l

0.34

4248

11982

7304

24157

1.62

265.34

8.4

7.7

122.34

121.05

g/l

5.40

7121

23490

Diseases of the respiratory system

3972

10735

1.94

263.22

8.7

6.9

121.79

120.94

g/l

1.54

3864

10455

Osteopathies and chondropathies

3867

20241

1.89

262.22

8.5

7.8

117.92

121.41

g/l

21.62

3764

19701

Episodal and paroxysmal disorders

6911

22276

1.64

260.92

8.2

8.0

124.18

120.59

g/l

34.44

6725

21637

Diverticular disease of intestine

4982

18862

1.78

260.21

8.0

7.9

120.06

122.44

g/l

12.32

4896

18343

Secondary hypertension

570

1184

5.44

260.05

12.1

6.6

111.75

125.12

g/l

35.06

554

1143

Abnormal findings on examination of blood, without diagnosis

3573

18120

1.95

259.41

8.4

8.3

120.14

122.24

g/l

7.19

3461

17666

Mood disorders, excluding more controls

5913

21769

1.69

258.64

8.6

8.1

122.94

121.68

g/l

4.37

5780

21151

Nutritional anaemias

3570

19013

1.94

258.46

9.7

7.2

111.58

121.44

g/l

151.13

3493

18486

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1018

3347

3.68

257.16

7.4

7.7

119.99

122.64

g/l

3.97

1002

3260

Vocal cord dysfunction

853

2142

3.90

256.77

10.9

5.9

121.70

122.50

g/l

0.49

818

2072

Neurological diseases

5161

15262

1.76

256.45

8.5

8.1

123.79

120.65

g/l

19.52

5025

14842

Care involving dialysis

834

2436

4.25

255.70

16.9

7.7

103.26

123.89

g/l

148.28

819

2376

Iron deficiency anaemia

3093

16189

2.03

254.92

10.0

7.2

111.03

121.40

g/l

143.91

3029

15722

ILD medications: immunosuppressive drugs

4039

21450

1.84

254.85

11.7

8.0

116.50

122.59

g/l

62.97

3955

20850

Biguanides

6262

24024

1.66

254.85

8.8

7.9

122.23

121.66

g/l

1.22

6100

23356

Other disorders of skin and subcutaneous tissue

4748

25253

1.76

254.66

8.8

7.7

117.45

121.59

g/l

36.05

4639

24565

Alcohol abuse, main dg, excluding more controls

1213

4373

3.13

252.80

9.2

8.7

124.96

123.76

g/l

1.04

1193

4255

Dizziness and giddiness

4993

23924

1.74

251.61

7.3

8.1

122.10

121.15

g/l

2.56

4868

23282

Use of hypnotics and sedatives

6945

25737

1.61

250.30

8.3

121.34

122.25

g/l

2.87

6764

25029

Other disorders of urethra and urinary system

4564

19371

1.78

249.80

7.9

7.6

119.37

121.15

g/l

7.26

4460

18802

Ulcer of lower limb, not elsewhere classified

1381

5435

2.98

249.45

11.6

7.8

111.58

121.19

g/l

53.48

1366

5284

Malignant neoplasm of urinary organs

968

3156

3.72

248.17

7.6

119.32

122.61

g/l

5.52

949

3074

Early onset COPD

1835

8191

2.52

247.07

10.9

8.5

126.46

121.38

g/l

18.10

1796

7958

Misadventures to patients during surgical and medical care

1225

4524

3.11

246.86

11.8

7.3

115.59

122.12

g/l

23.39

1196

4396

Symptoms and signs involving the urinary system

5235

24546

1.71

245.42

8.3

8.0

120.11

121.78

g/l

7.04

5115

23890

Infections of the skin and subcutaneous tissue

3837

21749

1.85

244.93

10.1

8.3

120.29

122.95

g/l

11.48

3763

21129

General examination and investigation of persons without complaint and reported diagnosis

4183

12326

1.85

243.45

8.8

7.9

123.04

122.69

g/l

0.44

4109

11951

ILD, hospital admission 2, with pulmonary infections

939

3034

3.69

242.57

12.7

6.5

122.05

120.77

g/l

1.00

912

2951

Lumbar disc prolapse

4186

18678

1.81

241.26

8.0

8.8

123.54

121.56

g/l

7.31

4048

18182

Benign neoplasm of colon, rectum, anus and anal canal

4577

23949

1.76

241.11

7.8

8.0

119.23

121.30

g/l

9.55

4488

23305

Other postsurgical states

690

1849

4.68

239.84

8.0

7.5

119.49

123.15

g/l

4.27

683

1792

Gastrointestinal diseases

3333

8749

1.98

238.98

8.9

7.2

122.11

124.93

g/l

10.13

3237

8481

Other functional intestinal disorders

3070

15333

1.97

237.65

7.6

7.4

120.18

121.71

g/l

3.94

2978

14895

Kidney transplant status

605

1495

5.32

237.64

14.3

10.0

105.07

124.64

g/l

90.39

598

1458

COPD, hospital admissions 1, only main diagnosis

2802

12595

2.08

237.63

9.5

7.4

125.91

120.30

g/l

33.99

2750

12235

Non-allergic asthma (mode)

1321

5048

2.83

237.06

8.2

6.5

125.12

120.71

g/l

11.10

1289

4903

Certain infectious and parasitic diseases

4641

13616

1.77

234.93

8.7

7.3

120.93

123.69

g/l

13.99

4520

13191

Lung cancer and mesothelioma

1497

5250

2.71

233.94

8.3

6.5

120.81

120.45

g/l

0.28

1455

5111

Volume depletion

899

2886

3.67

233.38

10.2

6.6

116.54

120.78

g/l

6.67

885

2804

Autoimmune diseases excluding thyroid diseases

6736

23876

1.60

232.60

9.2

8.0

119.94

122.85

g/l

22.69

6566

23212

L04AA Selective immunosuppressants

1650

7202

2.53

231.06

15.5

8.4

112.22

122.58

g/l

74.25

1625

6995

malignant neoplasm of female genital organs

1138

4153

3.10

230.08

5.6

6.4

115.75

119.15

g/l

8.16

1108

4027

Bronchitis

6813

28203

1.58

229.84

8.7

7.9

123.07

121.35

g/l

8.92

6661

27405

Malignant neoplasm of kidney, except renal pelvis

886

2893

3.72

226.89

7.4

7.7

120.06

122.67

g/l

3.43

870

2819

Other acute lower respiratory infections

3571

19479

1.85

226.72

9.0

7.8

123.21

121.44

g/l

5.33

3496

18915

Schizophrenia or delusion, excluding more controls

1917

8813

2.30

225.89

7.7

8.3

124.14

122.63

g/l

2.38

1863

8553

Malignant neoplasm of colon, including Hilmo

1534

6584

2.62

225.24

8.1

7.5

114.58

122.23

g/l

43.24

1503

6400

Hypokalaemia

1026

3619

3.27

224.94

11.5

6.9

118.79

120.96

g/l

2.41

1002

3516

Focal epilepsy

1645

7293

2.50

222.53

8.7

8.0

123.28

121.68

g/l

2.55

1605

7084

Autoimmune diseases excluding thyroid diseases, strict definition

6497

23169

1.59

221.90

9.1

8.0

119.93

122.84

g/l

21.85

6335

22525

Substance use, excluding alcohol

1381

5664

2.67

220.14

10.1

8.8

124.94

123.95

g/l

0.93

1359

5508

Obesity due to excess calories

2937

16034

1.94

219.98

9.8

8.2

124.70

121.73

g/l

11.26

2881

15581

Falls/tendency to fall

6629

21645

1.59

219.70

8.7

8.1

120.97

122.90

g/l

10.11

6450

21054

Pain (limb, back, neck, head abdominally)

4576

13690

1.74

216.16

8.4

8.5

122.67

121.90

g/l

1.45

4453

13268

Ischaemic Stroke, excluding all haemorrhages

4099

18264

1.78

216.07

8.7

7.7

120.21

120.87

g/l

1.17

3996

17780

Psychiatric diseases

6251

20267

1.60

214.52

8.4

8.2

122.54

121.58

g/l

2.73

6091

19677

ILD, hospital admissions 3, with pneumonia sepsis

830

2690

3.72

214.48

12.8

6.6

121.79

120.47

g/l

0.96

806

2625

Implicit fungal Sepsis

665

1874

4.36

214.00

15.7

6.5

116.00

121.52

g/l

8.10

649

1812

Gout

2227

9884

2.17

212.32

9.9

8.2

117.84

121.71

g/l

13.26

2180

9628

Liquid cancers, helper endpoint

2578

11864

2.03

211.94

8.7

8.0

114.24

123.05

g/l

76.41

2505

11554

Alcohol dependence

2033

10007

2.22

210.89

10.0

8.7

122.71

123.35

g/l

0.63

2002

9738

Other symptoms and signs involving cognitive functions and awareness

3277

17044

1.87

210.68

7.1

7.8

121.54

120.69

g/l

1.53

3194

16576

Abnormalities of heart beat

2198

10821

2.11

209.65

7.7

123.01

119.55

g/l

11.67

2145

10493

Intracranial injury

3832

21710

1.75

205.75

8.5

7.9

121.61

121.79

g/l

0.21

3753

21085

Aneurysms, operations, SAH

1330

5584

2.68

205.61

10.3

7.6

122.19

120.48

g/l

2.42

1293

5415

Focal epilepsy, strict definition

1530

6815

2.49

205.18

8.7

8.1

123.36

121.59

g/l

2.77

1495

6623

Anxiety disorders, excluding more controls

4850

19727

1.66

203.94

8.6

8.1

123.32

121.69

g/l

6.10

4741

19156

Dorsopathies

6220

20681

1.58

203.72

7.7

8.6

123.22

121.60

g/l

6.91

6042

20130

Other and unspecified iron deficiency

2368

12408

2.05

203.71

9.7

7.1

111.24

121.31

g/l

110.68

2329

12043

Benzodiazepine use

6331

29115

1.55

201.60

8.2

8.1

122.05

121.78

g/l

0.47

6200

28289

Artificial opening status

603

1684

4.59

199.61

15.7

7.6

113.54

122.59

g/l

23.31

593

1630

Type 1 diabetes

1645

7559

2.34

199.55

11.0

7.6

116.57

123.25

g/l

28.24

1598

7329

Focal epilepsy, mode (most common among epilepsy diagnosis)

1450

6392

2.52

199.22

8.7

8.0

123.61

121.59

g/l

3.39

1417

6215

Peripheral artery operations in Hilmo

1138

4522

2.88

198.82

12.1

7.0

111.39

121.37

g/l

49.28

1118

4396

Constipation

5717

26016

1.58

197.59

8.3

8.0

119.67

121.73

g/l

11.45

5570

25330

Intestinal infectious diseases

7181

28044

1.51

196.51

8.9

7.9

121.02

122.04

g/l

3.60

7028

27246

Personality disorders

1623

7511

2.31

193.48

8.2

8.7

124.70

123.45

g/l

1.61

1591

7303

Malignant neoplasm of rectum, including Hilmo

1050

4082

2.96

192.36

8.3

8.1

117.47

122.88

g/l

16.53

1028

3974

External causes of morbidity and mortality

3823

11243

1.77

191.44

8.6

7.4

121.30

123.38

g/l

6.99

3723

10937

Viral hepatitis, IBD co-morbidity

397

798

5.64

191.23

11.9

7.7

121.08

123.93

g/l

1.50

390

769

Benign neoplasm: Colon

3835

22505

1.73

190.46

8.0

7.9

119.09

121.09

g/l

7.68

3760

21895

Disorders of adult personality and behaviour

1675

7916

2.26

188.98

8.1

8.8

124.93

123.48

g/l

2.13

1640

7693

Alcohol abuse, main dg

1213

5079

2.67

187.55

9.2

124.96

123.81

g/l

1.00

1193

4947

Injuries to the abdomen, lower back, lumbar spine and pelvis

2700

14969

1.90

186.86

8.9

7.6

118.24

121.51

g/l

13.36

2637

14534

Type 1 diabetes, wide definition, subgroup 1

1331

5757

2.50

186.76

10.7

7.6

116.49

123.79

g/l

27.04

1293

5572

Problems related to lifestyle

840

2933

3.24

185.93

9.5

8.2

124.59

125.05

g/l

0.23

819

2838

Unspecified mental disorder

2492

13634

1.93

185.00

7.6

8.5

124.22

122.61

g/l

3.39

2425

13255

Other respiratory diseases principally affecting the interstitium

1502

6995

2.41

183.56

12.3

7.5

122.19

120.13

g/l

3.06

1462

6804

Chronic pancreatitis

1073

4353

2.84

180.74

13.1

8.3

115.97

122.91

g/l

21.19

1051

4227

Injuries to the hip and thigh

3296

17807

1.77

180.56

8.2

7.4

116.06

121.54

g/l

43.49

3221

17308

Mood disorders

6209

27268

1.52

180.45

8.6

8.1

123.15

121.76

g/l

5.54

6067

26505

Mood [affective] disorders

6191

27234

1.52

179.95

8.6

8.1

123.14

121.77

g/l

5.42

6050

26471

Other diseases of urinary system

6160

23401

1.53

178.00

8.2

8.1

120.20

122.18

g/l

10.89

6014

22749

Soft tissue disorders

6152

21329

1.53

176.60

7.8

8.4

122.34

121.88

g/l

0.87

5976

20762

Cutaneous abscess, furuncle and carbuncle

1735

8577

2.18

176.01

11.2

8.4

118.35

123.14

g/l

15.95

1700

8337

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1708

8327

2.22

175.97

6.6

8.1

114.60

122.82

g/l

52.25

1663

8108

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

880

3287

3.14

175.71

11.0

8.4

116.50

121.67

g/l

9.86

854

3200

Clear cell adenocarcinoma of kidney

511

1398

4.80

175.68

7.3

8.1

120.47

123.18

g/l

2.24

501

1365

Benign neoplasms

5916

21878

1.54

175.67

7.9

8.5

122.35

122.61

g/l

0.39

5765

21262

Cardiomyopathies, Primary/intrinsic

922

3489

2.97

175.63

15.9

7.3

123.44

123.40

g/l

0.02

908

3385

Finngen Rheumatological endpoints

5708

21689

1.55

174.15

8.2

8.4

121.67

122.66

g/l

2.81

5529

21104

Explicit bacterial Sepsis

864

3184

3.09

174.09

12.5

6.6

114.87

122.78

g/l

22.65

843

3093

Other reaction to severe stress, and adjustment disorders

2006

10404

2.03

174.09

9.0

8.3

122.65

122.37

g/l

0.23

1970

10086

Depression

5658

25782

1.54

173.53

8.7

8.3

123.25

121.86

g/l

5.18

5526

25054

Injuries to the thorax

3111

18547

1.78

173.40

9.4

8.0

121.11

121.97

g/l

1.44

3034

18032

Acute alcohol intoxication

1830

9291

2.13

173.18

8.9

8.4

124.16

123.02

g/l

1.36

1797

9038

Obesity, other/unspecified

2026

10594

2.03

173.18

10.0

8.0

124.45

121.58

g/l

7.50

1994

10290

Glomerular diseases

1396

6449

2.41

172.50

12.1

8.3

109.92

122.63

g/l

90.33

1372

6270

Deforming dorsopathies

1804

9098

2.12

172.26

7.0

8.2

120.02

120.60

g/l

0.62

1753

8856

Specific personality disorders

1392

6351

2.35

171.99

8.1

8.8

124.61

123.25

g/l

1.63

1365

6174

Complications of internal orthopaedic prosthetic devices, implants and grafts

1659

8185

2.22

171.92

8.0

6.7

115.69

121.26

g/l

24.25

1618

7939

Cardiomyopathy (excluding other)

948

3686

2.89

171.09

15.7

7.1

123.49

123.67

g/l

0.08

934

3573

Osteoporosis

1881

9049

2.12

170.79

7.9

6.6

116.86

119.09

g/l

5.22

1829

8801

Exposure to unspecified factor

6053

29891

1.51

169.76

9.6

7.9

119.87

122.28

g/l

15.69

5903

29070

Hernia of abdominal wall

3099

18590

1.77

169.55

9.6

8.2

121.93

122.01

g/l

0.07

3034

18089

Diaphragmatic hernia

2456

13822

1.90

169.31

8.2

7.4

118.82

120.71

g/l

4.82

2411

13406

Kela-code for severe mental illness

2256

12315

1.94

169.24

7.3

8.6

124.26

122.71

g/l

2.92

2192

11978

Factors influencing health status and contact with health services

1898

4620

2.16

168.94

9.2

7.3

123.35

126.01

g/l

5.15

1854

4473

Transient ischemic attack

3604

18087

1.71

167.83

7.6

120.87

120.63

g/l

0.29

3508

17595

Shoulder lesions

4866

19288

1.59

167.58

7.1

8.4

122.85

121.63

g/l

3.53

4725

18789

Gastroduodenal ulcer

1979

10429

2.05

167.55

10.0

7.2

114.62

121.36

g/l

35.48

1934

10141

Malignant neoplasm of colon

1165

5073

2.58

165.99

8.0

7.5

113.71

122.15

g/l

39.83

1141

4937

Streptococcal septicaemia

771

2759

3.25

165.88

12.1

7.1

114.41

123.44

g/l

25.95

751

2679

Ventral hernia

1728

8749

2.15

165.86

10.6

7.6

120.26

121.31

g/l

1.28

1694

8487

Fungal Sepsis

436

1100

5.09

165.71

18.6

6.9

113.31

121.97

g/l

12.00

426

1060

Disorders of thyroid, IBD co-morbidities

934

2423

2.86

165.12

9.5

7.3

122.91

120.44

g/l

2.61

904

2352

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

728

2531

3.31

163.76

8.8

7.3

121.19

122.78

g/l

1.19

711

2455

Acute alcohol intoxication, ICD10

1441

6852

2.30

163.53

9.2

9.1

124.67

123.76

g/l

0.82

1416

6680

Any operation in hilmo

190

25.51

162.38

10.1

16.8

125.42

141.87

g/l

3.86

182

Type 1 diabetes, wide definition

1368

6361

2.30

161.10

10.6

7.6

116.65

123.43

g/l

24.32

1329

6165

Spondylosis

3451

17382

1.70

161.07

6.7

8.6

122.26

121.10

g/l

2.66

3382

16940

Persons encountering health services for specific procedures, not carried out

656

2169

3.45

160.10

11.4

7.4

118.92

124.37

g/l

8.59

656

2108

Amputation

907

3602

2.92

160.07

12.6

7.7

109.96

121.20

g/l

49.15

892

3504

Fracture of femur

2005

9766

2.01

158.77

8.2

6.8

112.41

120.43

g/l

59.82

1964

9479

Acute bronchitis

2617

14908

1.82

158.67

8.6

7.5

123.38

120.89

g/l

7.67

2563

14490

Diseases of the skin and subcutaneous tissue

6124

21107

1.50

158.27

8.9

7.8

121.00

122.70

g/l

7.45

5972

20491

Aortic aneurysm

1774

9051

2.10

158.12

12.2

7.4

118.44

122.62

g/l

13.45

1734

8799

Diseases of liver

2331

13199

1.89

157.30

12.0

8.0

116.52

122.30

g/l

29.24

2274

12839

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

555

1681

3.84

157.26

7.9

8.9

125.78

123.06

g/l

2.36

548

1635

Unspecified kidney failure

901

3598

2.89

157.01

11.8

6.6

109.98

121.52

g/l

52.91

886

3496

Unspecified acute lower respiratory infection

1131

4964

2.52

156.90

10.9

8.2

122.34

122.57

g/l

0.13

1104

4839

Implicit fungal Sepsis

405

1013

5.16

155.96

18.6

7.0

113.44

121.85

g/l

10.46

395

977

Intestinal adhesions without obstruction

753

2754

3.19

155.93

11.0

7.3

118.91

121.53

g/l

2.70

740

2667

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

518

1500

3.93

155.75

9.7

9.5

125.84

126.36

g/l

0.20

511

1465

Extracorporeal dialysis

610

2008

3.75

155.69

18.6

8.9

103.37

123.18

g/l

105.13

596

1953

Other headache syndromes

2394

13597

1.84

155.60

7.7

7.9

124.24

119.79

g/l

21.81

2337

13205

Used for control exclusion in common control thyroid runs

6353

22314

1.48

154.80

8.8

8.0

121.51

122.81

g/l

4.77

6190

21686

Glomerular disorders in diseases classified elsewhere

970

4033

2.75

154.79

13.6

8.4

106.85

122.74

g/l

102.39

955

3921

Schizophrenia or delusion

1917

10225

1.99

154.67

7.7

8.7

124.14

122.90

g/l

1.75

1863

9959

Allergic asthma (mode), excluding more controls

1140

4851

2.42

154.62

7.9

6.3

124.55

122.31

g/l

2.98

1106

4702

Status post-ami

1788

7023

2.09

154.54

8.1

7.0

120.75

121.50

g/l

0.76

1747

6826

Emotionally unstable personality disorder

731

2592

3.08

154.41

7.2

8.5

124.40

123.67

g/l

0.42

716

2520

Invasive ventilation

666

2303

3.44

153.97

20.0

8.3

114.72

121.92

g/l

14.05

645

2232

Other CVD

1554

7824

2.19

153.45

8.4

7.1

117.59

119.99

g/l

4.75

1517

7613

Gout, FINNGEN

2227

12559

1.92

153.23

9.9

7.8

117.84

121.90

g/l

15.07

2180

12211

Schizophrenia, schizotypal and delusional disorders

1922

10296

1.98

153.02

7.6

8.7

124.18

122.89

g/l

1.86

1867

10027

Hyperkalaemia

544

1679

3.90

152.02

12.1

6.8

111.67

121.09

g/l

20.21

538

1629

Other complications of surgical and medical care, not elsewhere classified

739

2697

3.10

151.21

11.8

7.3

119.61

122.91

g/l

4.27

730

2607

Unspecified haematuria

2957

14867

1.75

151.01

8.8

8.1

118.98

122.06

g/l

12.83

2883

14467

Viral pneumonia (unknown virus, not influenza)

605

1994

3.56

150.62

21.8

8.4

122.46

123.35

g/l

0.42

595

1944

Malignant neoplasm of ovary, including Hilmo

513

1531

3.95

149.59

6.6

7.0

113.20

120.02

g/l

14.74

499

1475

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

819

3192

2.96

149.59

8.2

7.9

117.22

122.58

g/l

13.06

797

3104

Disorders of lens

4330

17736

1.59

149.28

9.1

8.5

119.31

122.36

g/l

16.79

4214

17274

Traumatic subdural haemorrhage

1041

4310

2.57

149.26

9.6

7.0

118.78

119.42

g/l

0.44

1019

4171

ILD, hospital admissions

1238

5808

2.40

149.19

11.1

7.6

123.62

120.12

g/l

6.62

1206

5647

Unspecified fall

3189

19555

1.69

148.95

9.4

7.8

120.06

121.48

g/l

3.40

3114

19013

Other interstitial pulmonary diseases

1252

5911

2.38

148.34

11.1

7.5

123.63

120.13

g/l

6.69

1220

5746

Retention of urine

2504

11987

1.83

148.28

8.1

8.0

119.48

121.83

g/l

6.74

2455

11645

Interstitial lung disease endpoints

1252

5919

2.38

147.84

11.1

7.5

123.63

120.11

g/l

6.75

1220

5753

Interstitial lung disease

1252

5919

2.38

147.84

11.1

7.5

123.63

120.11

g/l

6.75

1220

5753

Other external causes of accidental injury

4773

15826

1.56

147.44

8.6

7.8

121.03

122.62

g/l

5.36

4645

15379

Endovascular or surgical operations to intracerebral aneurysms

577

1885

3.68

147.32

9.3

8.4

123.13

121.48

g/l

1.19

568

1823

Sequelae of cerebrovascular disease

2522

12794

1.81

146.03

8.7

7.2

120.19

120.52

g/l

0.33

2462

12419

Cough

2287

12335

1.84

145.87

7.7

8.0

122.34

119.84

g/l

7.09

2243

11980

Hyperlipidaemia, other/unspecified

2542

13830

1.79

144.94

8.1

7.2

120.55

121.68

g/l

1.90

2492

13451

Autoimmune diseases

6637

23957

1.45

144.77

8.9

8.0

120.91

122.85

g/l

10.40

6474

23286

Anxiety (asthma-related co-morbidities)

3090

14677

1.69

143.52

8.9

8.3

123.85

122.60

g/l

2.63

3024

14258

Colon adenocarcinoma

936

3954

2.68

143.47

7.9

7.2

113.76

121.90

g/l

29.77

918

3845

Other and unspecified drugs and medicaments

700

2570

3.15

143.35

8.8

8.3

121.27

121.71

g/l

0.21

684

2495

Persons encountering health services for examination and investigation

3874

12359

1.62

142.61

8.8

7.9

122.35

122.68

g/l

0.38

3769

11982

Injury, poisoning and certain other consequences of external causes

2991

8925

1.74

142.24

8.5

7.4

121.82

123.15

g/l

2.60

2919

8658

Diarrhoea and gastroenteritis of presumed infectious origin

6007

27959

1.46

142.18

9.0

7.9

121.44

122.02

g/l

1.29

5881

27160

Vascular disorders of the intestines

647

2308

3.32

141.26

13.0

7.0

112.02

120.95

g/l

21.42

627

2234

Accidents

4735

15826

1.54

140.88

8.6

7.8

121.05

122.62

g/l

5.19

4606

15379

Adenocarcinoma and papilloma adenocarcinoma of rectum

781

3065

2.93

140.65

8.1

7.9

117.59

122.49

g/l

10.55

762

2980

Enterocolitis due to Clostridium difficile

881

3657

2.73

140.38

11.6

7.5

113.26

120.53

g/l

20.37

858

3555

Nontraumatic intracranial haemmorrhage

1476

7513

2.14

139.91

11.7

7.2

121.24

120.11

g/l

1.29

1445

7293

Other/unspecified dorsalgia

2228

12718

1.82

138.96

7.9

8.3

121.52

120.73

g/l

1.02

2175

12383

Other bacterial intestinal infections

1287

6241

2.25

138.95

10.8

7.5

115.75

120.99

g/l

15.45

1252

6052

Missing teeth due to accident, extraction or parodontitis

3838

23875

1.59

138.76

7.9

8.0

120.89

121.25

g/l

0.50

3723

23274

Pain in joint

3274

13015

1.66

138.49

7.9

8.7

122.25

121.98

g/l

0.31

3198

12610

Medical observation and evaluation for suspected diseases and conditions

3786

12356

1.62

138.25

8.8

7.9

122.25

122.68

g/l

0.55

3710

11979

Gastric ulcer

1360

6762

2.20

138.14

10.1

7.2

114.44

121.02

g/l

23.92

1334

6574

Cholelithiasis, broad definition with cholecystitis

5222

24364

1.49

137.94

8.0

7.7

121.09

121.42

g/l

0.53

5102

23690

Postprocedural musculoskeletal disorders, not elsewhere classified

651

2372

3.28

137.66

8.3

8.0

116.40

120.95

g/l

6.67

622

2304

Undetermined asthma, excluding more controls

764

2957

2.80

136.09

8.2

6.0

123.33

121.63

g/l

1.38

747

2862

Cerebral aneurysm, nonruptured

706

2676

3.04

136.05

8.5

8.1

123.03

121.25

g/l

1.55

686

2594

Anxiety disorders

5038

24242

1.49

135.65

8.6

8.3

123.37

121.93

g/l

5.18

4924

23539

ILD-related respiratory insufficiency

402

1126

4.86

135.56

15.5

8.2

123.59

120.49

g/l

1.83

385

1097

Congenital malformations, deformations and chromosomal abnormalities

3152

18962

1.64

135.43

9.4

8.3

121.55

122.69

g/l

2.31

3066

18433

Ascites

646

2350

3.20

135.22

11.6

7.6

109.59

121.26

g/l

38.41

632

2285

ILD, hospital admissions 1, main diag only

1111

5199

2.42

135.08

11.0

7.5

124.03

120.24

g/l

6.91

1084

5055

Neurotic, stress-related and somatoform disorders

4969

23970

1.49

134.90

8.6

8.3

123.40

121.98

g/l

4.92

4856

23274

Emphysema

657

2422

3.18

134.60

9.5

7.6

128.41

120.21

g/l

16.02

637

2357

Gout, idiopatic and unspecified

1890

10606

1.94

134.44

10.0

7.9

118.45

121.80

g/l

8.90

1855

10309

Symptoms and signs involving the nervous and musculoskeletal systems

3538

23096

1.60

134.32

8.1

7.9

123.19

121.03

g/l

8.24

3449

22473

883

3704

2.60

134.11

12.8

7.6

118.16

122.66

g/l

8.93

863

3588

Genitourinary diseases

3504

11092

1.64

133.54

10.2

8.2

122.76

125.64

g/l

10.82

3409

10787

Mycoses

1739

9486

1.97

132.69

10.0

8.0

119.72

121.57

g/l

3.01

1699

9219

Allergic asthma (mode)

1140

5174

2.26

132.59

7.9

6.6

124.55

122.00

g/l

3.74

1106

5026

Malignant neoplasm of brain, including Hilmo

444

1317

4.02

131.36

8.9

8.4

127.36

123.74

g/l

3.23

430

1283

Extreme obesity with alveolar hypoventilation

424

1238

4.33

131.34

11.3

8.9

132.35

121.49

g/l

17.06

419

1200

Other diseases of pericardium

404

1130

4.31

130.86

13.5

7.8

114.77

122.85

g/l

10.70

396

1099

Abnormal serum enzyme levels

2202

12650

1.83

130.53

7.8

8.8

121.54

122.77

g/l

1.93

2116

12340

Malignant neoplasm of brain

340

850

4.98

129.69

9.0

8.5

128.34

124.26

g/l

2.98

328

828

Myocarditis

306

685

5.03

129.69

15.3

7.4

125.76

127.08

g/l

0.42

296

663

Rotator cuff syndrome

3846

18305

1.57

128.89

7.1

8.4

122.99

121.53

g/l

4.11

3742

17839

Cardiodefibrillation

2553

15689

1.74

128.43

10.8

7.7

122.81

121.07

g/l

3.76

2500

15252

Persons encountering health services in other circumstances, wide

7005

26403

1.40

127.81

9.4

7.7

120.67

122.44

g/l

9.57

6889

25592

Delirium, not induced by alcohol and other psychoactive substances

974

4399

2.48

127.59

12.3

7.1

117.75

120.02

g/l

2.80

964

4270

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1149

5557

2.31

127.56

12.9

8.6

112.63

122.58

g/l

40.29

1129

5409

Malignant neoplasm of rectum

761

3089

2.81

127.50

8.0

7.8

117.20

122.48

g/l

12.01

741

3002

Fracture of rib(s), sternum and thoracic spine

2074

12108

1.83

126.37

9.6

8.0

120.85

121.79

g/l

1.24

2028

11778

Other bacterial intestinal infections

1499

7922

2.03

125.84

10.5

7.6

116.45

121.18

g/l

15.06

1461

7697

Visual disturbances

2909

18463

1.65

125.61

8.4

7.9

122.03

121.04

g/l

1.90

2819

17967

Fracture of lumbar spine and pelvis

1541

8287

2.01

123.29

8.5

7.1

115.71

120.62

g/l

17.95

1507

8047

Senile cataract

3957

16264

1.55

122.94

9.0

8.5

119.39

121.96

g/l

11.46

3846

15830

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5784

26673

1.43

122.41

8.5

8.1

120.65

122.02

g/l

5.17

5638

25953

Other and unspecified nonorganic psychotic disorders

1092

5190

2.24

121.83

8.6

9.0

124.25

124.05

g/l

0.11

1056

5048

Disorders of other endocrine glands

2528

15349

1.69

121.54

8.6

7.6

121.17

120.94

g/l

0.21

2467

14917

Endocarditis

339

889

4.68

120.87

20.8

7.8

110.04

123.07

g/l

20.96

334

863

Hypotension

1306

6733

2.13

120.73

8.1

7.1

118.12

119.79

g/l

2.25

1280

6544

Visual disturbances and blindness

3104

20183

1.61

120.12

8.4

7.8

121.77

120.96

g/l

1.47

3010

19641

Non-small cell lung cancer, including Hilmo

1108

5067

2.26

118.65

8.4

7.4

120.83

122.58

g/l

2.22

1077

4938

Acute pancreatitis

1359

7128

2.06

117.82

12.2

8.1

119.04

122.26

g/l

6.10

1334

6919

Other diseases of intestine

1032

4926

2.30

116.91

13.8

8.0

115.70

121.91

g/l

17.79

1014

4776

Depression or dysthymia

3959

14700

1.53

116.52

8.3

8.4

123.21

121.56

g/l

4.81

3867

14263

Cervicobrachial syndrome

1324

6871

2.05

116.43

5.7

8.6

125.32

120.89

g/l

12.33

1296

6687

Other disorders of the musculoskeletal system and connective tissue

1060

5132

2.28

116.23

7.9

8.0

119.26

121.32

g/l

2.57

1024

4990

Amiodarone users

849

3800

2.57

116.20

16.2

7.9

122.47

121.18

g/l

0.96

834

3699

Undetermined asthma

764

3191

2.58

116.13

8.2

6.2

123.33

121.22

g/l

1.94

747

3098

Bacterial intestinal infections, IBD co-morbidities

1269

6536

2.10

116.09

10.8

7.6

115.38

120.89

g/l

17.16

1234

6356

Chronic periodontitis, including avohilmo

5740

27963

1.42

116.05

9.2

8.0

121.22

121.99

g/l

1.92

5588

27196

Periodontitis

5751

27969

1.42

115.88

9.2

8.0

121.21

121.99

g/l

2.01

5598

27201

Cholelithiasis

4908

23965

1.46

115.76

7.8

7.7

121.22

121.33

g/l

0.14

4795

23300

Malignant neoplasm of eye, brain and central nervous system

382

1118

4.08

115.53

8.5

8.3

127.85

124.11

g/l

3.02

370

1087

Diabetic nephropathy, excluding more controls

1135

4609

2.26

115.50

12.1

9.2

110.32

123.97

g/l

80.52

1110

4482

Injuries to the shoulder and upper arm

5025

28948

1.44

115.27

7.9

8.2

121.12

122.03

g/l

2.33

4899

28161

Open wound of head

3315

21258

1.56

114.56

8.7

8.1

120.72

122.34

g/l

4.40

3247

20637

Malignant neoplasm of corpus uteri, including Hilmo

649

2560

2.86

114.45

4.5

6.4

118.80

119.20

g/l

0.21

637

2476

Other arthrosis

3269

14866

1.59

114.32

7.7

8.8

122.17

121.93

g/l

0.28

3179

14484

Other anxiety disorders

2275

11937

1.71

113.98

9.1

8.3

123.63

122.62

g/l

1.47

2231

11585

Gonarthrosis [arthrosis of knee](FG)

4625

18805

1.48

113.76

6.9

8.4

122.48

122.21

g/l

0.37

4477

18311

All anxiety disorders

3128

16103

1.58

113.70

8.9

8.5

123.85

122.62

g/l

2.59

3062

15645

Malignant neoplasm of bronchus and lung, including Hilmo

1463

6592

2.00

113.62

8.2

7.6

120.83

122.42

g/l

2.32

1420

6419

Brain meningioma

405

1249

3.84

112.70

6.7

7.8

121.70

121.07

g/l

0.29

400

1210

Diagnoses used for exclusion with ILD

1717

9819

1.87

112.38

11.8

7.7

121.12

121.14

g/l

0.01

1653

9555

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1006

4644

2.27

112.21

12.9

8.7

116.83

123.32

g/l

18.27

984

4515

Sub-endpoint used in defining T1D endpoints

1772

10006

1.83

112.14

10.7

8.0

116.51

122.45

g/l

25.08

1720

9720

Brain meningioma, including Hilmo

415

1303

3.76

112.13

6.7

7.7

121.97

121.12

g/l

0.42

410

1263

Congenital malformations, deformations and chromosomal abnormalities

3373

20775

1.54

111.69

9.4

8.3

121.50

122.63

g/l

2.44

3282

20197

Acute upper respiratory infections of multiple and unspecified sites

4200

21607

1.48

111.24

8.8

8.1

123.63

121.60

g/l

7.91

4113

20986

Later onset COPD

2058

9834

1.79

111.00

8.0

6.7

122.73

119.32

g/l

10.52

2014

9543

Mental and behavioural disorders due to opioids

298

749

4.66

110.65

12.4

10.0

122.96

125.82

g/l

1.30

292

730

Other specific joint derangements/joint disorders

3963

17520

1.50

110.30

7.7

8.8

122.67

122.39

g/l

0.36

3860

17040

Injuries to the knee and lower leg

6850

28451

1.37

110.20

8.6

8.0

121.75

121.83

g/l

0.11

6682

27666

Superficial injury of head

1472

8072

1.94

109.56

7.8

7.5

121.15

121.61

g/l

0.36

1448

7822

Cellulitis

1405

7630

1.97

108.63

9.7

8.2

118.97

122.69

g/l

8.55

1379

7420

Coxarthrosis

3203

13982

1.58

107.85

7.2

8.5

119.96

121.46

g/l

3.80

3113

13625

Pleural effusion

1132

5778

2.15

107.49

10.2

7.1

116.35

120.11

g/l

8.11

1111

5613

Gout, strict definition

1380

7548

2.01

107.46

10.1

8.0

117.29

121.56

g/l

10.61

1362

7327

Spondylolisthesis/Spondylolysis

1166

5982

2.10

107.14

6.5

8.5

120.69

120.51

g/l

0.11

1134

5820

Decubitus ulcer and pressure area

547

2073

3.09

106.70

13.3

7.7

112.27

120.90

g/l

17.18

539

2013

All influenza (not pneumonia)

892

4145

2.31

106.06

10.1

7.3

122.19

123.68

g/l

1.25

861

4045

Gonarthrosis

3937

15409

1.51

105.86

6.9

8.6

122.81

121.84

g/l

2.07

3807

15008

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1046

5020

2.17

105.58

12.8

8.6

116.95

123.21

g/l

17.84

1022

4879

Other cataract

2765

13544

1.62

105.56

8.1

8.3

119.00

121.59

g/l

8.56

2713

13163

Idiopathic pulmonary fibrosis

667

2809

2.75

104.90

11.2

7.4

126.40

120.08

g/l

11.07

651

2730

Other gastritis (incl. Duodenitis)

1498

8400

1.91

104.82

8.9

7.5

118.56

121.53

g/l

6.29

1468

8173

Adjustment and management of implanted device

1309

7061

2.01

104.78

12.4

6.9

120.22

121.47

g/l

1.40

1293

6874

Coxarthrosis [arthrosis of hip](FG)

3448

16435

1.54

104.51

7.1

8.2

119.84

121.67

g/l

5.80

3354

16011

Gout, unspecified

1516

8595

1.92

104.41

10.1

7.9

118.39

121.76

g/l

7.67

1490

8354

Viral and other specified intestinal infections

1370

7160

1.93

103.11

8.3

8.1

122.72

123.11

g/l

0.27

1335

6950

Candidiasis

1618

9295

1.84

102.72

10.0

7.6

119.52

120.83

g/l

1.81

1581

9040

Bipolar affective disorders

996

4893

2.16

101.49

7.7

8.5

123.95

122.73

g/l

1.04

974

4748

Glucagon-like peptide-1 (GLP-1) analogues

1711

10039

1.80

101.47

8.8

8.6

127.31

122.64

g/l

15.66

1680

9760

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1711

10039

1.80

101.47

8.8

8.6

127.31

122.64

g/l

15.66

1680

9760

Viral and other specified intestinal infections

1061

5186

2.09

101.32

8.7

8.1

122.53

123.48

g/l

0.71

1034

5039

Diseases of the musculoskeletal system and connective tissue

2855

9189

1.60

100.70

8.0

9.2

123.24

122.54

g/l

0.91

2773

8938

ILD medications: azathioprine

875

4120

2.28

100.67

12.7

8.0

116.95

123.11

g/l

15.48

860

3993

Symptoms and signs concerning food and fluid intake

697

2994

2.55

100.63

8.5

7.5

118.81

121.77

g/l

3.21

676

2907

Acute peritonitis

535

2069

3.00

99.84

15.8

8.5

109.07

121.91

g/l

34.70

527

2009

Abdominal aortic aneurysm (AAA)

786

3561

2.42

99.65

11.9

6.4

118.01

121.43

g/l

4.57

765

3467

Disorders of choroid and retina

4912

25448

1.42

99.14

8.6

8.0

118.76

121.87

g/l

21.21

4799

24763

Acute pancreatitis (for exclusion)

1359

7541

1.94

99.07

12.2

8.2

119.04

122.07

g/l

5.51

1334

7333

Autoimmune diseases related-to ILD

4755

29586

1.41

98.77

8.7

8.0

120.49

122.00

g/l

5.58

4641

28772

Vascular diseases of the intestine

373

1200

3.77

98.24

15.7

7.4

114.54

120.63

g/l

6.48

362

1166

Chronic ulcer of skin, not elsewhere classified

573

2314

2.85

97.86

9.4

8.1

113.86

121.49

g/l

15.35

561

2246

Malignant neoplasm of respiratory system and intrathoracic organs

1386

6396

1.93

97.80

8.8

7.8

120.27

122.56

g/l

4.10

1349

6226

Diabetic maculopathy, excluding more controls

741

3327

2.45

97.39

10.9

7.3

113.02

122.50

g/l

25.88

721

3232

Dermatitis

3530

24481

1.49

97.30

8.4

7.9

120.39

121.36

g/l

1.98

3443

23812

Nonischemic cardiomyopathy

681

2957

2.55

97.06

14.2

7.7

122.51

122.18

g/l

0.13

668

2875

Arthrosis

4185

16197

1.46

96.72

7.4

8.7

122.74

122.12

g/l

1.06

4042

15765

Diseases of the eye and adnexa

4310

15221

1.45

96.65

8.9

8.5

123.30

123.47

g/l

0.18

4196

14799

Fracture of lower leg, including ankle

3166

21395

1.52

96.52

9.5

8.0

120.14

121.71

g/l

3.98

3083

20799

Left ventricular outflow tract obstruction (LVOTO), broad definition

720

3222

2.49

96.40

15.4

9.7

115.63

124.55

g/l

23.31

708

3141

Cholecystectomy

4099

25244

1.45

96.13

8.4

7.7

121.32

120.66

g/l

1.28

4004

24556

Unspecified misadventure during surgical and medical care

469

1734

3.18

96.05

12.9

8.7

115.75

121.71

g/l

8.17

458

1684

Azathioprine

875

4208

2.23

95.38

12.7

8.3

116.95

122.65

g/l

13.41

860

4088

Iron deficiency anaemia secondary to blood loss (chronic)

1103

5797

2.06

95.36

11.2

7.1

108.90

121.26

g/l

65.82

1071

5634

Diseases of peritoneum

739

3368

2.44

94.75

13.1

7.9

112.43

121.68

g/l

26.11

720

3270

Dysphagia

1518

8794

1.83

94.17

8.8

7.5

120.30

121.03

g/l

0.71

1482

8534

Malignant neoplasm of corpus uteri

553

2223

2.80

93.98

4.3

6.3

118.88

119.17

g/l

0.14

543

2151

Selective serotonin reuptake inhibitors

5686

22085

1.38

93.77

8.0

8.1

122.95

121.72

g/l

4.04

5537

21456

Subarachnoid haemorrhage

752

3466

2.41

93.68

12.3

7.3

121.54

121.02

g/l

0.29

733

3363

Congenital malformations of the circulatory system

860

4015

2.24

93.64

14.5

8.7

119.47

123.35

g/l

6.11

844

3906

Other retinal disorders

3936

21817

1.46

93.64

8.5

7.8

117.77

121.42

g/l

23.65

3848

21206

Other symptoms and signs involving the circulatory and respiratory systems

467

1721

3.03

93.56

7.3

7.9

125.24

120.88

g/l

4.12

449

1669

Exclusions for E4_PCOS_BROAD

1011

5180

2.09

92.72

9.4

8.5

123.89

122.36

g/l

1.48

984

5036

Transport accidents

2443

13620

1.59

92.48

8.4

8.0

122.27

123.02

g/l

0.94

2357

13232

Symptoms and signs involving the skin and subcutaneous tissue

3957

27740

1.44

92.30

7.9

8.0

121.88

121.36

g/l

0.83

3857

26990

Assault

752

3451

2.34

92.15

10.2

9.5

124.30

126.03

g/l

1.33

737

3360

Mental and behavioural disorders due to sedatives or hypnotics

475

1788

2.98

91.62

10.2

9.3

125.49

124.26

g/l

0.62

464

1743

Amputation of toe

603

2585

2.69

91.12

11.3

8.2

111.02

121.47

g/l

27.54

593

2516

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

576

2402

2.71

90.99

11.3

7.7

115.12

121.33

g/l

11.01

564

2329

severe traumatic brain injury, does not include concussion

1513

8878

1.82

90.94

10.5

7.7

118.99

121.20

g/l

3.84

1479

8624

Enlarged lymph nodes

907

4496

2.15

90.85

8.4

8.1

120.42

122.53

g/l

2.18

876

4358

Elevated blood glucose level

609

2603

2.62

90.78

10.2

8.4

121.43

122.77

g/l

0.77

601

2532

Aortic valve malfunction, age under 60 years

677

3037

2.49

90.40

14.8

9.6

115.65

124.68

g/l

22.59

665

2959

Other and unspecified nerve root and plexus disorders, also in other diseases

1203

6593

1.95

90.27

7.0

8.7

125.11

122.11

g/l

5.57

1135

6421

Non-selective monoamine reuptake inhibitors

2193

13550

1.63

90.08

7.5

7.7

120.90

120.45

g/l

0.49

2140

13163

Pain in thoracic spine

897

4448

2.16

90.04

6.8

8.5

125.35

121.04

g/l

7.41

874

4325

Other pulmonary heart/vessel disease

409

1460

3.33

89.75

14.9

8.1

125.49

119.62

g/l

5.36

403

1417

Disorders of eyelid, lacrimal system and orbit

4886

27480

1.39

89.51

7.2

8.1

121.39

121.27

g/l

0.15

4744

26758

Acidosis

227

566

5.24

88.42

14.5

8.1

115.43

122.01

g/l

4.15

221

549

Cystitis

4652

20214

1.40

88.37

7.9

7.7

119.42

121.31

g/l

8.30

4556

19625

Total colectomy

354

1172

3.57

88.13

13.6

9.1

115.73

122.65

g/l

7.47

347

1141

Total colectomy operation

354

1172

3.57

88.13

13.6

9.1

115.73

122.65

g/l

7.47

347

1141

Lung diseases due to external agents

995

5196

2.08

88.11

12.8

7.3

119.91

120.79

g/l

0.63

959

5054

Sleep apnoea

5386

26227

1.36

86.85

8.6

8.2

126.33

121.03

g/l

59.76

5268

25492

Secondary right heart disease

377

1313

3.44

86.73

14.5

7.9

125.80

119.72

g/l

5.14

371

1272

Migraine

2241

11680

1.60

86.62

7.2

8.0

124.65

120.08

g/l

22.73

2192

11348

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6311

26279

1.33

85.90

9.9

7.7

119.58

122.47

g/l

22.49

6221

25477

Suppurative and necrotic conditions of lower respiratory tract

475

1873

2.96

85.83

14.3

8.7

115.40

122.85

g/l

11.70

463

1815

Other pleural conditions

761

3656

2.31

85.75

9.8

7.0

116.22

120.14

g/l

5.82

747

3553

Nonorganic sleeping disorders, excluding more controls

952

4886

2.05

85.57

8.4

7.9

123.47

122.07

g/l

1.27

933

4735

Acute upper respiratory infections

5882

27598

1.34

85.52

8.5

7.9

122.56

121.13

g/l

5.63

5743

26833

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

248

672

4.60

85.19

6.5

5.8

111.62

119.41

g/l

10.02

243

652

Disorders of mineral metabolism

565

2396

2.61

85.07

9.3

7.2

115.40

121.79

g/l

9.26

554

2329

Candidiasis

834

4130

2.18

84.96

12.6

8.0

116.95

121.29

g/l

7.66

813

4010

Carpal tunnel syndrome

3406

21224

1.46

84.79

7.0

8.2

122.52

121.07

g/l

3.93

3301

20679

Post-traumatic stress disorder

401

1419

3.02

84.52

7.9

125.44

122.32

g/l

2.31

388

1378

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1792

11149

1.68

84.32

8.4

8.1

121.23

122.16

g/l

1.08

1737

10844

Chronic viral hepatitis

355

1192

3.35

84.30

11.4

10.5

122.16

125.74

g/l

2.18

348

1163

Abnormal findings on diagnostic imaging of other body structures

884

4496

2.13

84.15

7.7

7.6

120.20

120.82

g/l

0.37

865

4370

Panic disorder

710

3290

2.28

83.93

10.9

7.9

124.71

123.14

g/l

1.18

689

3193

Fibrosis and cirrhosis of liver

594

2614

2.58

83.90

12.1

8.1

111.70

121.92

g/l

22.67

580

2549

Schizophrenia

939

4861

2.06

83.71

7.6

9.4

123.88

123.77

g/l

0.05

914

4736

Other degenerative diseases of the nervous system

1591

7095

1.75

83.36

6.2

7.0

121.01

119.25

g/l

2.79

1554

6894

Benign neoplasm of other and ill-defined parts of digestive system

1165

6512

1.93

83.27

8.9

7.7

118.52

120.56

g/l

2.86

1140

6334

Other metabolic disorders

713

3356

2.27

81.99

9.4

7.1

120.30

121.53

g/l

0.82

692

3259

Arthropathies

4830

18097

1.38

81.97

7.6

8.8

122.53

122.37

g/l

0.20

4686

17607

Noninfective enteritis and colitis

2537

17106

1.53

81.87

9.0

8.1

119.75

122.14

g/l

7.23

2476

16619

Acute sinusitis

2636

16544

1.52

81.67

8.3

8.2

123.56

122.03

g/l

3.15

2560

16068

Sequelae of other external causes

425

1613

3.00

81.58

11.4

8.9

116.38

121.79

g/l

5.41

414

1561

Viral pneumonia (known virus, not influenza)

259

749

4.33

81.34

12.2

9.3

121.01

120.85

g/l

0.04

251

736

Toxic effects of substances chiefly nonmedicinal as to source

712

3383

2.28

80.99

8.7

8.5

126.64

123.36

g/l

3.97

701

3296

Organic, including symptomatic, mental disorders

3235

16230

1.48

80.98

7.8

7.5

120.04

120.25

g/l

0.23

3156

15793

Insulin, fast-acting (human)

802

3970

2.15

80.73

11.3

7.9

114.87

124.15

g/l

26.03

779

3852

Congenital malformations of heart and great arteries

751

3524

2.23

80.54

14.1

8.9

118.13

123.62

g/l

9.89

735

3427

Exposure to other specified factors

4050

27290

1.40

80.40

8.9

8.3

121.06

122.49

g/l

4.27

3973

26520

Fracture of shoulder and upper arm

2094

13643

1.60

80.36

8.6

7.8

117.74

121.18

g/l

12.23

2050

13267

Diabetic retinopathy, excluding more controls

1688

5762

1.75

80.07

11.5

9.1

115.86

123.90

g/l

40.63

1653

5611

Migraine with aura

1089

5956

1.90

80.02

7.6

7.5

124.51

120.03

g/l

11.40

1067

5777

Serous carcinoma of ovary, including Hilmo

269

799

4.02

79.82

6.5

6.2

111.90

119.23

g/l

9.64

264

775

Malignant neoplasm of ovary

334

1125

3.41

79.71

7.7

7.1

112.45

119.57

g/l

10.97

323

1089

Haemorrhage, not elsewhere classified

327

1099

3.49

79.15

13.6

8.1

115.22

120.60

g/l

3.99

319

1062

Schizoaffective disorder

485

1978

2.70

79.09

6.8

9.2

125.76

124.21

g/l

0.87

474

1929

Other joint disorders

4629

18070

1.38

78.80

7.2

8.8

123.24

122.36

g/l

1.93

4491

17581

Other diseases of biliary tract

629

2898

2.41

78.73

11.1

7.3

114.36

120.87

g/l

11.82

618

2810

Phobic anxiety disorders

614

2748

2.35

78.62

9.5

8.2

124.99

124.16

g/l

0.42

597

2672

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

927

4907

2.03

78.20

7.5

8.3

115.74

123.20

g/l

22.13

901

4771

Alcohol-induced chronic pancreatitis

510

2176

2.68

77.57

14.6

9.1

119.37

124.48

g/l

5.43

500

2123

Mycoses

4661

30538

1.36

77.43

8.7

8.1

121.73

121.99

g/l

0.36

4564

29686

Other disorders of kidney and ureter

893

4707

2.07

77.41

11.4

8.0

115.19

121.40

g/l

15.21

870

4573

Other noninfective gastroenteritis and colitis

1398

8357

1.76

76.83

9.4

7.7

118.43

121.40

g/l

6.19

1362

8126

Arterial embolism and thrombosis

448

1801

2.81

76.48

12.7

6.8

114.64

121.54

g/l

9.70

432

1753

Malignant neoplasm of bronchus and lung

1186

5610

1.87

76.46

8.2

7.4

120.69

122.40

g/l

2.26

1156

5467

Other diseases of anus and rectum

1733

10933

1.65

76.23

8.1

7.4

118.08

121.68

g/l

10.91

1690

10621

Fentanyl

679

3245

2.26

75.73

9.6

6.6

114.07

121.40

g/l

16.81

653

3149

Chronic apical periodontitis

6249

27732

1.31

75.65

9.0

7.9

121.43

122.02

g/l

1.34

6102

26955

Thoracic aortic aneurysm

963

5244

2.00

75.62

13.2

7.8

118.52

123.31

g/l

9.98

943

5091

Postprocedural endocrine and metabolic disorders, not elsewhere classified

653

3066

2.28

75.62

8.8

7.0

120.09

121.32

g/l

0.78

635

2978

Disorders of calcium metabolism

439

1756

2.80

75.33

9.0

6.8

113.97

121.22

g/l

9.40

431

1705

Postprocedural disorders of digestive system, not elsewhere classified

297

980

3.66

75.08

10.9

8.9

115.22

121.00

g/l

4.76

292

957

Gastro-oesophageal reflux disease

3748

23698

1.40

74.93

8.4

7.8

121.56

122.32

g/l

1.43

3647

23058

Other viral hepatitis

399

1520

2.91

74.85

12.0

10.1

120.73

125.68

g/l

4.21

392

1484

Other disorders of glucose regulation and pancreatic internal secretion

566

2544

2.45

74.51

11.2

8.3

117.11

122.24

g/l

7.08

558

2468

Neuromuscular dysfunction of bladder

629

2963

2.34

74.15

8.6

8.1

121.20

122.22

g/l

0.60

608

2869

Pneumonitis due to solids and liquids

613

2864

2.37

74.12

16.0

7.5

117.11

121.30

g/l

5.19

590

2779

Status epilepticus

304

1018

3.49

73.94

15.7

7.9

120.88

121.28

g/l

0.12

289

986

Other and unspecified dermatitis

2837

19965

1.47

73.85

8.4

7.8

120.24

121.27

g/l

1.83

2773

19419

Use of disulfiram, acamprosate or naltrexone

591

2722

2.39

73.60

9.8

10.0

126.18

125.07

g/l

0.60

585

2654

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1804

11605

1.62

73.58

8.8

7.8

123.26

120.84

g/l

5.16

1749

11298

Other and unspecified effects of external causes

1392

8397

1.73

73.44

8.9

8.4

123.84

122.03

g/l

2.54

1365

8150

Polyneuropathies and other disorders of the peripheral nervous system

1411

8618

1.75

73.27

9.8

8.1

118.61

121.37

g/l

5.43

1390

8372

Cirrhosis of liver, NAS

448

1860

2.81

73.11

12.4

8.5

110.98

122.23

g/l

20.56

443

1804

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

474

2002

2.66

72.89

9.4

6.9

116.62

122.15

g/l

6.66

461

1953

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1215

6972

1.79

72.88

8.5

8.0

123.57

122.44

g/l

1.06

1187

6770

Hydronephrosis

738

3713

2.15

72.39

8.6

6.9

112.25

122.94

g/l

39.27

719

3610

Sleep apnoea, including avohilmo

5532

26564

1.32

71.02

8.3

8.2

126.29

120.95

g/l

62.74

5413

25815

Short Achilles tendon (acquired)

233

679

4.07

70.95

6.7

8.5

125.04

121.83

g/l

1.60

218

660

Other diseases of pancreas

589

2763

2.38

70.88

11.3

8.0

116.24

122.19

g/l

9.69

575

2684

Other and unspecified injuries of head

485

2091

2.58

70.74

7.8

8.5

122.42

122.02

g/l

0.15

478

2017

Other aneurysm

427

1752

2.78

70.42

11.4

7.7

118.00

122.19

g/l

3.70

417

1706

Gonarthrosis,primary

5274

25090

1.33

70.41

7.0

8.3

121.96

121.30

g/l

1.46

5112

24454

Abnormalities of gait and mobility

825

4390

2.05

69.66

8.8

7.6

119.95

120.58

g/l

0.39

805

4267

Right hemicolectomy

465

2000

2.66

69.60

12.6

7.3

112.07

120.53

g/l

15.40

453

1942

Certain disorders involving the immune mechanism

1113

6449

1.83

69.58

11.9

8.2

120.06

122.06

g/l

2.33

1068

6268

Intracerebral haemorrhage

859

4619

2.01

69.51

12.1

7.0

121.29

120.07

g/l

0.93

841

4487

Malignant neoplasm of bladder, including Hilmo

811

4259

2.05

69.20

8.5

7.3

117.07

123.16

g/l

14.67

793

4147

Sleep disorders (combined)

6269

25908

1.29

68.73

8.0

124.37

120.74

g/l

32.98

6128

25162

Soft tissue disorders related to use, overuse and pressure

1549

9793

1.66

68.43

8.0

8.3

121.87

121.24

g/l

0.58

1513

9538

Other embolism and thrombosis

826

4408

2.02

68.22

10.3

8.1

117.82

121.28

g/l

5.07

806

4289

Pyothorax

367

1432

3.01

68.07

15.7

8.9

114.57

122.69

g/l

10.83

358

1387

Other and unspecified polyneuropathies, also in other diseases

1243

7504

1.77

67.76

9.3

8.1

118.50

121.13

g/l

4.50

1227

7289

Diseases of the myoneural junction and muscle

803

4268

2.04

67.60

10.8

8.0

121.79

121.54

g/l

0.13

784

4145

Dilated cardiomyopathy

840

4555

2.02

67.32

15.6

8.2

124.11

121.90

g/l

2.11

826

4431

Other disorders of adrenal gland

324

1184

3.12

66.85

11.0

8.4

122.69

121.14

g/l

0.66

319

1159

Cholecystitis

907

5018

1.94

66.71

9.3

7.4

118.75

120.65

g/l

1.89

893

4872

Oesophageal varices

352

1362

3.04

66.47

12.7

8.4

107.90

122.41

g/l

24.70

347

1324

Other specified and unspecified personality disorders

512

2304

2.40

66.38

9.2

8.9

123.68

124.09

g/l

0.17

507

2243

Other diseases of blood and blood-forming organs, wide

1287

7857

1.73

66.25

10.3

7.9

116.70

121.57

g/l

11.39

1254

7642

Other systemic involvement of connective tissue (FG)

1391

8518

1.68

66.00

7.5

118.34

120.17

g/l

3.06

1355

8289

Pneumonia due to other infectious organisms, not elsewhere classified

259

844

3.58

65.89

11.3

8.1

115.60

121.72

g/l

4.04

251

823

Hypoglycaemia, other or unspecified

459

1991

2.55

65.86

11.5

8.7

116.34

122.59

g/l

8.37

452

1932

Alcoholic liver disease

709

3658

2.13

65.86

13.2

8.9

112.59

123.15

g/l

27.75

696

3573

Disorder of lipoprotein metabolism, unspecified

841

4572

1.98

65.60

9.8

7.3

118.95

121.17

g/l

2.29

831

4433

Systemic connective tissue disorders

1931

12935

1.55

65.59

8.4

7.3

117.79

120.10

g/l

5.93

1882

12566

Exclusions for E4_PCOS_CONSORTIUM

3376

15422

1.40

65.42

7.7

120.58

120.61

g/l

0.03

3285

14987

Benign neoplasm of meninges

669

3384

2.16

65.32

7.2

7.6

121.14

119.51

g/l

1.55

656

3277

Sequelae of injuries, of poisoning and of other consequences of external causes

1310

8054

1.71

65.01

11.2

8.5

120.40

123.04

g/l

4.43

1260

7839

Benign neoplasm of other and unspecified endocrine glands

820

4447

1.99

64.64

7.9

8.1

123.90

121.51

g/l

2.69

799

4316

Coagulation defects, purpura and other haemorrhagic conditions

1105

6518

1.79

64.55

11.1

7.8

116.40

121.54

g/l

12.51

1080

6347

Other arthritis (FG)

1661

10803

1.60

64.38

8.9

8.3

120.16

121.80

g/l

2.56

1621

10528

Disturbances of skin sensation

1400

8751

1.67

64.33

7.6

8.3

124.77

121.84

g/l

6.18

1368

8515

Alcohol withdrawal state with delirium

518

2406

2.42

64.31

11.7

9.3

120.68

123.94

g/l

2.63

510

2345

Rheumatoid arthritis

1770

10445

1.58

64.08

7.9

8.2

118.09

120.77

g/l

6.66

1722

10172

Abnormal spermatozoa

157

5348

0.27

64.03

5.7

9.1

121.59

122.37

g/l

0.18

150

5198

Type of accident

1591

10304

1.61

63.15

8.1

120.80

122.07

g/l

1.60

1542

10022

Myocardial infarction, with ST-elevation

1181

7166

1.76

63.11

9.5

7.8

120.68

121.01

g/l

0.21

1154

6959

Unspecified privation

676

3469

2.11

62.81

12.4

8.1

117.48

122.61

g/l

8.17

669

3372

Osteomyelitis

471

2121

2.49

62.77

11.3

8.7

111.51

122.50

g/l

22.69

458

2062

Other disorders of ear

5124

26218

1.31

62.55

7.5

8.3

121.81

121.61

g/l

0.28

4972

25558

Cervical disc disorders

1985

13492

1.53

62.48

7.7

8.7

124.51

121.25

g/l

9.95

1935

13152

Ulcer of oesophagus

522

2469

2.37

61.84

8.5

7.8

118.17

122.16

g/l

4.10

509

2405

Attention to artificial openings

319

1212

3.04

61.73

10.3

7.6

115.50

122.55

g/l

7.50

312

1184

Combinations of oral blood glucose lowering drugs

1692

11204

1.59

61.65

9.3

8.2

122.54

122.12

g/l

0.34

1661

10905

Other mental disorders due to brain damage and dysfunction and to physical disease

786

4288

1.99

61.41

7.2

121.14

120.25

g/l

0.61

773

4168

Pneumonia due to Streptococcus pneumoniae

297

1082

3.10

61.37

10.0

8.0

120.61

123.00

g/l

1.02

284

1057

Pneumothorax

491

2267

2.40

61.19

12.7

8.0

122.68

121.70

g/l

0.46

479

2202

Cytomegalovirus infection, IBD co-morbidity

205

615

4.09

60.74

15.8

10.4

107.70

122.42

g/l

18.48

195

601

Abnormal involuntary movements

807

4434

1.95

60.71

7.2

8.1

123.51

121.20

g/l

2.38

794

4315

Asthma and allergy, excluding more controls

487

2177

2.29

60.15

7.4

6.1

125.95

123.13

g/l

2.37

475

2113

Idiopathic gout

681

3593

2.10

59.80

9.6

8.2

118.72

121.98

g/l

3.21

669

3497

Other and unspecified local infections of skin and subcutaneous tissue

601

3011

2.16

59.79

11.3

8.2

119.32

122.84

g/l

3.62

589

2925

Diseases of pulp and periapical tissues, including avohilmo

5803

23850

1.28

59.62

8.4

7.9

121.82

121.49

g/l

0.54

5646

23192

Recurrent or chronic depression

1859

8717

1.54

59.60

8.8

123.97

122.16

g/l

3.16

1823

8472

Chronic periodontitis, complicated

3098

22772

1.39

59.40

9.8

8.2

120.99

122.03

g/l

1.95

3027

22190

Diabetic nephropathy

1144

6953

1.76

59.20

12.1

9.2

110.43

122.25

g/l

65.76

1119

6769

Fracture of skull and facial bones

1174

7191

1.71

58.98

10.8

8.4

121.81

123.24

g/l

1.51

1154

6979

Second line medication for Crohn's disease

2972

21886

1.39

58.84

9.7

8.1

118.68

122.02

g/l

15.74

2903

21293

Other viral diseases

1378

8729

1.63

58.71

10.8

8.6

120.05

123.24

g/l

6.37

1342

8501

Cytomegaloviral disease

205

628

3.96

58.58

15.8

10.5

107.70

122.25

g/l

18.32

195

614

L04AX Other immunosuppressants

2905

21337

1.40

58.53

9.8

8.1

118.62

121.96

g/l

15.58

2838

20758

Malignant neoplasm of stomach, including Hilmo

419

1846

2.52

58.31

10.7

7.1

113.32

122.17

g/l

15.77

408

1799

Disorders of synovium and tendon

2739

17413

1.41

58.14

7.4

8.5

122.32

121.58

g/l

1.10

2662

16949

Benign neoplasm: Cerebral meninges

606

3088

2.15

58.08

7.3

7.7

120.96

119.53

g/l

1.19

594

2993

Appendectomy

3238

23107

1.37

58.05

8.6

8.3

122.13

122.34

g/l

0.23

3157

22470

Cerebral palsy and other paralytic syndromes

670

3519

2.04

57.85

9.9

8.2

122.40

121.99

g/l

0.20

651

3422

Malignant neoplasm of pancreas, including Hilmo

554

2734

2.21

57.82

8.5

6.9

114.66

121.80

g/l

15.02

542

2660

Left ventricular outflow tract obstruction, narrow definition

340

1371

2.79

57.76

18.0

9.6

113.52

125.13

g/l

19.98

335

1338

Speech and linguistic disorders, excluding more controls

340

1257

2.68

57.61

9.2

8.7

124.03

122.43

g/l

0.65

329

1218

Cervicalgia

1105

6715

1.72

57.20

6.6

8.2

123.91

120.43

g/l

6.74

1082

6538

Viral infections characterized by skin and mucous membrane lesions

2212

15589

1.46

57.07

8.9

8.2

120.15

122.20

g/l

4.79

2162

15153

Tobacco use

360

1498

2.69

57.07

9.2

9.5

123.23

g/l

0.00

349

1459

Disorders of parathyroid gland

1209

7450

1.69

57.04

7.6

6.9

117.45

119.31

g/l

2.49

1180

7231

Diseases of oral cavity, salivary glands and jaws

3525

13552

1.37

56.85

8.0

7.8

120.79

121.53

g/l

1.22

3431

13180

Carcinoma in situ of other and unspecified digestive organs

297

1149

3.10

56.82

10.2

8.7

116.52

121.05

g/l

3.59

291

1115

Osteoporosis with pathological fracture (FG)

467

2176

2.37

56.80

7.7

6.2

114.46

118.26

g/l

4.19

447

2111

Umbilical hernia

1538

10142

1.58

56.67

8.8

8.5

123.69

123.30

g/l

0.29

1510

9846

Malignant neoplasm of bladder

483

2280

2.33

56.66

9.8

7.1

114.59

122.16

g/l

14.79

477

2229

Viral hepatitis

428

1917

2.43

56.52

11.8

9.7

120.91

125.12

g/l

3.55

420

1873

Cholangitis (primary sclerosing, PSC)

424

1907

2.46

56.26

12.0

7.8

113.12

122.01

g/l

14.63

417

1846

Injuries to unspecified part of trunk, limb or body region

627

3258

2.08

56.18

10.2

8.2

117.52

121.94

g/l

6.11

620

3165

Other local infections of skin and subcutaneous tissue

624

3238

2.08

56.10

11.2

8.3

119.47

122.60

g/l

3.11

612

3149

Inguinal hernia

3381

16962

1.37

56.07

8.2

8.5

122.61

123.43

g/l

1.36

3297

16472

Paracetamol or NSAID medication

839

2274

1.91

55.98

8.4

9.6

122.48

122.06

g/l

0.20

816

2201

Open wound of lower leg

860

4928

1.85

55.82

10.4

8.0

118.18

121.76

g/l

5.40

843

4798

Other/unspecified cytomegaloviral diseases

178

516

4.28

55.75

16.4

11.3

106.90

122.08

g/l

17.26

170

505

Noninfectious colitis NAS

775

4317

1.91

55.37

8.9

7.8

118.23

121.55

g/l

4.63

759

4197

DVT of lower extremities

1134

7028

1.70

55.15

8.3

8.0

120.27

121.01

g/l

0.56

1101

6835

Procreative management

1502

8181

1.58

54.98

9.8

9.4

123.40

123.82

g/l

0.31

1437

7965

Hydrocephalus

516

2536

2.24

54.82

8.7

7.5

123.68

120.11

g/l

3.72

506

2455

Pneumocystosis

195

616

4.08

54.52

13.3

8.9

113.77

121.19

g/l

4.52

189

600

Gingivitis and periodontal diseases

5737

23716

1.27

54.43

8.5

7.9

121.32

121.87

g/l

1.14

5571

23082

Asthma and allergy

487

2269

2.20

54.30

7.4

6.4

125.95

122.83

g/l

2.81

475

2206

Assault by bodily force

411

1833

2.41

54.29

10.1

9.6

125.13

126.35

g/l

0.52

404

1789

Psychotic depression

346

1432

2.61

54.26

9.1

7.7

123.76

121.43

g/l

1.18

336

1391

Glomerulonephritis

620

3255

2.06

54.17

10.7

8.4

114.22

122.61

g/l

17.69

605

3165

Stomatitis and related lesions

1023

6191

1.73

54.04

8.8

8.0

120.05

121.75

g/l

1.81

991

6020

Conductive and sensorineural hearing loss

4525

23979

1.30

53.80

7.1

8.2

121.65

121.29

g/l

0.54

4383

23395

Mixed and other personality disorders

424

1925

2.37

53.78

7.3

9.3

125.23

124.89

g/l

0.12

414

1877

Disorders of continuity of bone

551

2773

2.13

53.76

8.2

8.5

117.60

122.76

g/l

7.44

534

2701

Benign neoplasm: Sigmoid colon

1177

7438

1.68

53.47

7.8

8.1

119.91

120.73

g/l

0.71

1159

7220

Seropositive rheumatoid arthritis

1347

8695

1.61

53.40

7.8

117.24

120.41

g/l

7.30

1313

8462

Dental operations

3664

14293

1.35

53.12

8.1

7.9

120.78

121.83

g/l

2.19

3551

13945

Polyarthrosis

1134

6556

1.69

53.10

5.4

7.8

119.94

119.49

g/l

0.32

1115

6385

Benign neoplasm: Colon, unspecified

1535

10297

1.57

52.98

8.4

7.9

118.79

120.93

g/l

3.93

1495

10007

Injury of intra-abdominal organs

196

619

3.69

52.60

16.5

9.3

116.80

123.94

g/l

4.20

189

602

Other viral diseases, not elsewhere classified

921

5439

1.77

52.46

10.5

8.6

121.11

123.01

g/l

1.89

903

5296

Somatoform disorder

815

4681

1.83

51.94

7.4

7.9

123.66

121.54

g/l

2.31

796

4536

Migraine without aura

751

4185

1.85

51.88

7.7

7.6

125.70

120.52

g/l

10.65

739

4059

Cerebral cysts

347

1481

2.57

51.44

13.7

8.9

122.50

123.28

g/l

0.27

337

1435

Other and unspecified myopathies

576

3019

2.08

50.99

11.3

7.9

120.56

121.17

g/l

0.28

561

2933

Myalgia

1146

7221

1.65

50.88

8.3

8.2

123.49

121.23

g/l

3.28

1113

7025

Vascular syndromes of brain in cerebrovascular disorders

348

1515

2.62

50.82

7.1

7.7

119.97

119.74

g/l

0.07

338

1465

Alzheimer’s disease (Atypical or mixed), excluding more controls

556

2252

2.12

50.77

4.2

6.4

120.03

116.98

g/l

2.77

541

2184

Shock, not elsewhere classified

110

241

6.07

50.60

41.5

7.1

110.21

119.67

g/l

3.90

104

234

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2522

12478

1.41

50.59

6.9

7.9

119.69

122.65

g/l

10.52

2448

12141

Injuries to the neck

1145

7236

1.65

50.50

8.6

8.3

122.09

122.54

g/l

0.30

1121

7031

Artrosis, including avohilmo

4545

19593

1.29

50.41

7.2

8.9

123.12

121.85

g/l

3.59

4404

19055

Congenital malformations of aortic and mitral valves

291

1165

2.82

50.38

18.3

9.8

113.48

124.92

g/l

17.26

286

1136

Acute and transient psychotic disorders

617

3294

1.99

50.31

7.5

9.1

123.75

123.51

g/l

0.09

597

3210

Other blood glucose lowering drugs, excl. Insulins

973

5951

1.73

50.21

8.5

7.4

121.43

120.70

g/l

0.49

946

5764

Non-small cell lung cancer

631

3383

1.99

50.14

7.8

7.0

120.17

122.10

g/l

1.66

612

3296

Other specified/unspecified arthritis

1397

9275

1.56

49.35

9.1

8.5

120.29

121.59

g/l

1.52

1363

9038

Scoliosis

429

2026

2.25

49.09

7.9

7.7

117.02

120.66

g/l

3.42

415

1974

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

343

1499

2.56

49.03

9.4

7.0

116.24

121.78

g/l

4.95

332

1465

Other symptoms and signs involving the nervous and musculoskeletal systems

2135

15378

1.43

48.80

7.9

124.66

121.19

g/l

12.47

2072

14957

Acute posthaemorrhagic anaemia

265

1034

2.92

48.56

10.2

8.3

106.08

121.98

g/l

26.72

256

1003

Reimbursement for rheumatic diseases

2936

22133

1.35

48.52

8.6

7.8

118.98

121.27

g/l

8.03

2860

21545

Malignant neoplasm of skin

2562

12929

1.40

48.47

7.1

7.9

119.80

122.78

g/l

10.79

2494

12583

Alzheimer disease, excluding more controls

1025

4139

1.71

48.31

5.2

6.7

120.48

118.42

g/l

2.47

999

4018

Superficial injury of lower leg

1233

8012

1.60

48.05

7.8

121.38

121.63

g/l

0.16

1210

7791

Amputation of foot

235

882

3.22

47.91

11.7

9.4

108.48

121.28

g/l

19.30

229

851

Focal brain injury

395

1833

2.33

47.79

11.8

7.6

119.13

120.39

g/l

0.56

388

1774

Benign neoplasm: Transverse colon

703

4012

1.90

47.76

7.7

8.1

120.50

120.85

g/l

0.16

690

3900

Nonorganic sleeping disorders

952

5828

1.70

47.67

8.4

123.47

122.65

g/l

0.60

933

5663

Diplopia

764

4443

1.83

47.57

9.2

7.9

122.13

121.34

g/l

0.51

743

4319

Superficial injury of thorax

839

4996

1.77

47.55

8.9

8.1

122.00

122.16

g/l

0.08

818

4860

Coxarthrosis, primary

3462

22746

1.33

47.45

6.9

7.9

119.50

120.73

g/l

3.07

3369

22143

Dermatophytosis

781

4581

1.82

47.36

7.1

8.3

122.38

121.99

g/l

0.18

762

4464

Other disorders of lacrimal gland

1787

12574

1.47

47.05

7.1

7.8

121.48

120.25

g/l

1.87

1733

12225

Phlebitis and thrombophlebitis (not including DVT)

1232

8079

1.59

46.68

8.4

8.0

121.59

121.33

g/l

0.17

1197

7855

Sensorineural hearing loss

4304

23221

1.29

46.59

6.9

8.1

121.49

121.20

g/l

0.42

4172

22655

Disorders of lacrimal system

2186

15899

1.41

46.56

6.9

7.8

121.15

120.20

g/l

1.45

2116

15458

Other diseases of liver

961

5959

1.69

46.44

10.6

8.2

118.57

122.03

g/l

5.14

941

5796

Hypertensive Renal Disease

246

942

2.92

46.21

8.5

7.3

111.47

119.89

g/l

7.28

238

915

Laparoscopic left hemicolectomy

172

556

3.92

46.16

10.2

8.8

117.09

120.26

g/l

1.32

172

543

Traumatic subarachnoid haemorrhage

257

1009

2.86

46.11

14.2

7.7

118.18

119.51

g/l

0.43

250

975

Fall on and from stairs and steps

1377

9270

1.55

45.91

8.5

7.9

119.50

121.56

g/l

3.31

1340

9023

Benign neoplasm: Rectum, anus and anal canal

1214

7994

1.60

45.91

7.5

8.0

119.28

120.71

g/l

1.73

1188

7766

Chronic gastritis

1553

10717

1.51

45.86

8.7

7.0

117.13

120.55

g/l

8.93

1521

10417

Hyperparathyroidism

1044

6555

1.66

45.82

7.5

6.9

117.48

119.31

g/l

2.10

1019

6356

Malignant neoplasm of stomach

346

1558

2.45

45.82

11.1

7.3

113.61

122.22

g/l

12.66

337

1522

Subjective visual disturbances

1293

8596

1.56

45.72

8.2

7.7

121.83

121.02

g/l

0.75

1260

8355

Familial hypercholesterolemia

882

5384

1.73

45.70

8.1

7.1

119.58

121.09

g/l

1.33

877

5215

Dissociative [conversion] disorders

207

723

3.13

45.51

6.5

7.8

126.18

121.49

g/l

2.71

201

702

Dermatitis and eczema

5882

29962

1.24

45.43

8.5

8.1

121.28

122.00

g/l

1.79

5740

29134

Benign neoplasm: Rectum

1096

7082

1.64

45.34

7.6

8.0

119.56

120.76

g/l

1.21

1072

6875

Functional dyspepsia

1354

9096

1.54

45.30

8.8

7.3

123.24

121.32

g/l

2.83

1316

8844

Extrapyramidal and movement disorders

2105

15377

1.42

44.89

6.2

7.7

122.39

120.53

g/l

4.08

2043

14961

Follow-up examination after treatment for conditions other than malignant neoplasms

2098

9986

1.42

44.86

8.8

7.8

119.22

122.00

g/l

8.30

2069

9684

Familial hypercholesterolemia, with ischemic heart disease

576

3149

1.98

44.66

9.0

7.0

119.51

120.57

g/l

0.60

571

3062

Arterial embolism and thrombosis of lower extremity artery

266

1084

2.78

44.59

12.4

6.8

113.88

121.34

g/l

7.06

256

1053

Follow-up examination after treatment for malignant neoplasms

614

3418

1.91

44.29

8.1

7.1

118.61

120.06

g/l

1.06

592

3313

Other viral diseases

1635

11322

1.47

44.21

10.5

8.5

120.63

123.21

g/l

5.26

1595

11012

Fall on same level involving ice and snow

2939

22558

1.33

44.11

8.3

8.0

121.40

121.36

g/l

0.03

2861

21937

Disorders of skin appendages

2261

16683

1.39

43.91

8.7

8.2

121.53

122.15

g/l

0.72

2201

16209

Strabismus

1271

8462

1.55

43.76

9.9

8.1

122.38

121.80

g/l

0.44

1238

8220

Type 1 diabetes, definitions combined

404

1937

2.18

43.64

10.1

8.0

121.12

126.08

g/l

4.53

391

1880

Persistent mood disorders

959

6020

1.66

43.59

8.1

7.8

121.40

121.32

g/l

0.04

942

5838

Primary_lymphoid and hematopoietic malignant neoplasms

1397

9561

1.53

43.49

9.8

7.8

111.99

121.47

g/l

51.98

1361

9291

Type 1 diabetes, strict (exclude DM2)

401

1923

2.18

43.31

10.2

8.9

121.08

126.06

g/l

4.51

388

1868

Disorders of ocular muscles, binocular movement, accommodation and refraction

2189

15986

1.39

43.19

9.4

8.1

122.78

121.93

g/l

1.14

2137

15542

Lesion of ulnar nerve

771

4614

1.76

42.99

9.7

9.0

124.18

122.35

g/l

1.57

752

4495

Other symptoms and signs involving general sensations and perceptions

274

1149

2.66

42.87

7.7

8.3

121.78

120.58

g/l

0.45

268

1111

Parkinson's disease, excluding more controls

748

4183

1.77

42.43

5.4

6.9

122.24

118.94

g/l

4.23

722

4063

Agranulocytosis

631

3598

1.87

42.23

9.8

8.2

111.88

121.56

g/l

26.80

615

3496

Dental caries, including avohilmo

4250

17340

1.28

42.14

8.1

7.8

120.97

121.39

g/l

0.63

4133

16848

Family history of malignant neoplasm

503

2657

1.99

42.09

7.4

6.8

121.14

122.73

g/l

1.11

479

2574

Recurrent aphthous stomatitis , including avohilmo

742

4417

1.77

42.07

8.3

7.9

119.43

121.60

g/l

2.11

716

4288

Pneumonia derived septicemia

237

938

2.84

42.01

12.0

9.1

116.39

121.73

g/l

3.39

227

913

Injuries to the elbow and forearm

3526

24445

1.29

41.79

8.2

8.0

119.83

121.67

g/l

6.27

3432

23785

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

433

2195

2.14

41.78

7.6

7.3

119.41

119.70

g/l

0.10

420

2130

Malignant neoplasm of rectosigmoid junction, including Hilmo

221

855

2.98

41.58

9.0

7.4

116.00

121.75

g/l

4.45

214

838

Other diseases of arteries and capillaries

519

2802

1.99

41.52

10.3

7.4

115.36

122.07

g/l

9.95

504

2726

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2328

11874

1.38

41.42

6.8

7.8

119.69

122.47

g/l

8.73

2265

11557

Fall involving bed

252

1043

2.78

41.41

8.7

6.8

115.35

118.90

g/l

2.05

239

1012

Injury of other and unspecified intrathoracic organs

417

2102

2.17

41.37

13.3

8.7

116.94

122.86

g/l

6.88

407

2037

Failure and rejection of transplanted organs and tissues

121

330

4.52

41.37

17.1

9.4

104.64

124.85

g/l

21.15

115

321

Hyperkinetic disorders, excluding more controls

326

1396

2.30

41.18

7.8

8.7

129.49

124.56

g/l

4.12

321

1356

Volvulus

210

794

3.04

41.15

9.6

7.3

115.12

121.44

g/l

3.96

205

766

Other symptoms and signs involving the digestive system and abdomen

803

4893

1.71

41.11

7.5

7.2

117.09

120.43

g/l

5.08

790

4751

Malignant neoplasm of breast, HER2-negative, including Hilmo

1687

7679

1.46

41.00

6.0

7.2

118.25

120.94

g/l

7.70

1649

7445

Malignant neoplasm of breast, including Hilmo

1687

7679

1.46

40.98

6.0

7.2

118.25

120.94

g/l

7.70

1649

7445

Duodenal ulcer

681

4010

1.81

40.76

10.5

7.4

114.55

121.60

g/l

13.38

665

3906

Caries of dentine, including avohilmo

4461

18347

1.26

40.75

8.0

7.9

121.05

121.36

g/l

0.44

4336

17839

Neuralgia and neuritis, unspecified

315

1431

2.41

40.66

8.8

9.2

122.34

122.37

g/l

0.01

305

1394

Radiculopathy

881

5529

1.67

40.53

6.3

8.1

122.71

120.10

g/l

3.36

865

5386

Other or ill-defined heart diseases

293

1285

2.45

40.49

12.1

7.8

122.88

124.41

g/l

0.57

285

1250

Benign neoplasm: Adrenal gland

489

2630

2.03

40.31

7.9

8.1

122.61

121.29

g/l

0.69

481

2562

Adenocarcinoma and ductal carcinoma of pancreas

240

980

2.78

40.20

8.8

7.4

113.55

121.43

g/l

8.37

233

959

Other systemic involvement of connective tissue

1413

9816

1.49

40.12

7.5

7.3

118.44

120.15

g/l

2.81

1377

9537

Event of undetermined intent

358

1717

2.25

40.01

10.2

9.7

122.43

124.50

g/l

1.03

350

1674

Hepatic failure, not elsewhere classified

269

1161

2.62

39.97

21.6

9.4

111.11

121.32

g/l

10.52

262

1133

Zoster [herpes zoster]

1027

6713

1.60

39.89

8.5

7.4

117.98

120.37

g/l

3.30

1005

6523

Malignant neoplasm of breast

1655

7604

1.45

39.88

6.1

7.3

118.37

120.92

g/l

6.90

1617

7375

Trochanteric bursitis

725

4355

1.75

39.65

6.7

7.7

120.73

119.73

g/l

0.69

710

4233

Diseases of pulp and periapical tissues and dental caries

3812

15491

1.28

39.62

7.8

7.7

121.00

121.23

g/l

0.28

3710

15054

Superficial injury of hip and thigh

814

5040

1.70

39.61

7.2

7.1

117.88

121.85

g/l

6.20

794

4895

Vitreous haemorrhage

612

3533

1.86

39.55

10.8

8.1

114.01

121.83

g/l

15.32

596

3435

Arthropod-borne viral fevers and viral haemorrhagic fevers

960

6189

1.62

39.44

9.0

8.4

122.16

122.02

g/l

0.07

943

6012

Disorders of muscles

549

3057

1.90

39.38

9.8

8.6

122.31

122.12

g/l

0.07

539

2973

Other and unspecified abdominal hernia

281

1242

2.53

39.33

8.6

8.2

120.82

121.10

g/l

0.08

272

1200

Other other unspecified disorders of the circulatory system

261

1121

2.63

39.16

9.9

8.8

114.51

121.39

g/l

6.00

250

1089

Oesophagitis

357

1738

2.25

39.00

11.9

8.0

118.53

122.72

g/l

3.35

346

1693

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

217

849

2.81

38.80

13.6

10.0

112.45

126.34

g/l

15.03

207

825

Type 1 diabetes, strict definition, subgroup 1

274

1176

2.43

38.75

10.2

7.3

123.64

127.96

g/l

2.46

264

1138

Purpura and other haemorrhagic conditions

739

4502

1.73

38.66

10.1

7.8

114.18

121.78

g/l

18.05

722

4383

Diseases of the ear and mastoid process

6036

25268

1.22

38.57

7.7

8.5

122.83

121.89

g/l

2.81

5862

24622

Viral infections characterized by skin and mucous membrane lesions

4388

30582

1.25

38.55

8.0

8.2

121.06

121.92

g/l

2.00

4287

29742

Malignant neoplasm of head and neck

468

2506

2.01

38.50

11.5

7.7

115.26

122.98

g/l

13.07

454

2441

Protozoal diseases

225

917

2.83

38.26

12.8

9.6

114.88

121.12

g/l

3.95

218

898

Mental and behavioural disorders due to tobacco

493

2700

1.96

37.79

10.2

8.9

124.74

123.14

g/l

0.88

487

2624

Injuries to the ankle and foot

3314

23349

1.28

37.57

8.7

8.5

122.73

122.60

g/l

0.13

3241

22682

Other viral diseases, not elsewhere classified

1151

7715

1.53

37.54

10.1

8.6

121.65

123.02

g/l

1.39

1130

7503

Malignant neoplasm of breast, HER2-negative

1626

7555

1.44

37.50

6.0

7.2

118.23

120.87

g/l

7.17

1588

7326

Smoking dependency

493

2708

1.95

37.45

10.2

9.0

124.74

123.23

g/l

0.82

487

2632

Viral haemorrhagic fevers, not elsewhere classified/unspecified

849

5389

1.65

37.38

9.3

8.3

122.34

122.06

g/l

0.14

833

5238

Malignant neoplasm of small intestine, including Hilmo

215

865

2.83

37.24

6.7

7.4

118.08

122.55

g/l

2.27

206

846

Tubulo-interstitial nephritis, not specified as acute or chronic

383

1933

2.12

37.22

8.1

6.7

117.78

121.60

g/l

3.42

375

1877

Basal cell carcinoma, including avohilmo

2296

11941

1.36

37.09

6.6

7.8

120.17

122.47

g/l

6.17

2231

11621

Acute gastritis

453

2432

2.00

37.03

7.5

7.9

119.48

121.62

g/l

1.31

446

2368

Necrotizing fasciitis

143

7.50

37.03

16.9

13.1

110.86

120.42

g/l

2.48

137

Other disorders of skin and subcutaneous tissue, not elsewhere classified

793

4971

1.68

36.98

9.2

7.6

115.04

121.50

g/l

15.60

774

4823

Parkinson's disease, strict definition, excluding more controls

684

3927

1.74

36.74

5.5

7.0

122.12

118.75

g/l

4.12

660

3812

Heartburn

548

3111

1.85

36.65

8.6

7.7

124.61

122.14

g/l

1.90

535

3021

Toxic effect of other and unspecified substances

101

262

4.56

36.46

13.8

11.4

125.82

124.52

g/l

0.24

101

255

Other arterial embolism and thrombosis

205

813

2.86

36.45

14.0

6.8

116.04

121.12

g/l

2.72

199

791

Primary gonarthrosis, bilateral

2843

19073

1.31

36.38

6.6

8.1

120.82

120.48

g/l

0.40

2757

18580

Social phobias

330

1576

2.19

36.30

9.3

8.3

125.62

124.96

g/l

0.22

318

1535

Benign neoplasm: Stomach

573

3330

1.84

36.28

8.3

7.7

117.62

120.42

g/l

2.79

563

3237

Cardiac murmurs and other cardiac sounds

408

2084

2.03

36.25

8.4

7.7

116.28

120.13

g/l

3.24

394

2021

Basal cell carcinoma

2211

11537

1.36

36.07

6.6

7.7

119.82

122.33

g/l

7.06

2152

11226

Other fall from one level to another

1112

7525

1.53

36.04

9.6

8.5

121.28

122.86

g/l

1.73

1081

7324

Malignant neoplasm of pancreas

408

2140

2.06

35.97

8.5

6.6

114.65

121.65

g/l

10.68

397

2078

Fibromyalgia

396

2035

2.05

35.96

8.1

7.7

122.02

120.81

g/l

0.59

385

1973

Benign neoplasm: Caecum

657

3982

1.77

35.90

8.6

7.7

117.25

120.59

g/l

4.41

648

3872

Oxicams

1399

5531

1.48

35.76

6.4

9.0

122.83

119.79

g/l

5.88

1367

5377

Fracture of neck

392

2043

2.10

35.62

11.6

8.1

118.01

122.40

g/l

4.14

385

1979

Visual field defects

500

2809

1.91

35.47

9.2

8.2

121.53

121.08

g/l

0.19

481

2726

In situ neoplasms

1966

14734

1.37

35.44

7.4

7.2

117.88

119.87

g/l

4.79

1918

14305

Infective dermatitis

628

3760

1.77

35.19

7.8

7.9

121.48

122.08

g/l

0.28

607

3659

Hypopituitarism

378

1938

2.09

35.18

9.3

9.5

127.50

124.86

g/l

1.37

367

1884

Other condition

730

4538

1.69

35.00

9.3

8.3

121.50

122.71

g/l

0.83

717

4410

Artificial joint operation, meniscal resection

5017

27097

1.22

34.98

7.1

8.3

121.90

121.66

g/l

0.35

4878

26381

Migraine with aura and triptan purchases

590

3451

1.77

34.88

6.8

8.1

125.28

121.18

g/l

5.77

579

3352

Adverse effects, not elsewhere classified

880

5704

1.60

34.82

9.0

8.1

123.33

121.80

g/l

1.38

860

5531

Sulfonylureas

1993

11913

1.37

34.67

8.4

7.0

116.89

120.36

g/l

11.19

1946

11579

Open wound of ankle and foot

554

3215

1.82

34.66

10.4

8.5

118.09

123.31

g/l

6.76

548

3120

Hepatocellular carcinoma, including Hilmo

213

885

2.74

34.58

10.4

7.4

117.57

123.05

g/l

3.14

208

864

Pneumococcal septicemia

224

949

2.64

34.50

12.0

9.5

116.68

121.81

g/l

3.03

214

923

Artificial joint re-operation

443

2436

1.98

34.31

7.0

7.3

117.56

120.21

g/l

2.09

430

2363

Disorders of oesophagus in diseases classified elsewhere

170

639

3.12

34.19

11.5

9.0

112.42

121.08

g/l

6.08

165

625

Benign neoplasm: Ascending colon

819

5299

1.64

33.96

7.4

7.9

118.67

120.51

g/l

1.76

808

5156

Alcohol-induced acute pancreatitis

262

1202

2.46

33.95

16.4

9.3

117.49

124.82

g/l

5.49

256

1170

Other congenital malformations of the digestive system

239

1034

2.49

33.87

9.6

9.3

118.18

122.02

g/l

1.92

233

1008

Non-Hodgkin lymphoma, all, including Hilmo

700

4359

1.69

33.61

9.8

8.0

113.93

122.84

g/l

22.80

679

4234

Type 1 diabetes, strict definition

284

1315

2.25

33.55

10.0

7.9

123.32

127.75

g/l

2.67

274

1273

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

307

1499

2.25

33.50

8.6

6.7

114.38

122.14

g/l

9.23

302

1460

Other sleep disorders

577

3415

1.78

33.49

6.9

8.2

125.44

121.17

g/l

4.93

566

3317

Use of biperiden

324

1614

2.19

33.28

6.9

9.1

121.46

123.05

g/l

0.72

318

1573

Other disorders involving the immune mechanism, not elsewhere classified

209

874

2.69

33.20

12.5

10.1

111.93

123.22

g/l

10.53

204

853

Bronchiectasis

461

2586

1.92

32.98

7.8

7.2

121.71

118.95

g/l

2.21

445

2515

Other extrapyramidal and movement disorders in other diseases

1243

8766

1.47

32.89

6.4

7.8

122.13

120.73

g/l

1.66

1207

8533

Disorders of psychological development

435

2186

1.91

32.84

8.5

9.4

125.71

124.25

g/l

0.70

422

2124

Other disorders of eyelid

2408

17854

1.32

32.72

7.2

7.6

120.75

119.97

g/l

1.13

2348

17370

Symptoms and signs involving speech and voice

1671

12377

1.39

32.62

9.1

7.6

122.30

120.60

g/l

3.13

1637

12028

Non-small cell lung cancer, adenocarcinoma

362

1890

2.08

32.50

7.9

6.8

120.22

121.74

g/l

0.77

350

1842

Other disorders of nervous system

398

2147

2.00

32.37

7.7

8.4

121.80

122.39

g/l

0.22

390

2080

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

633

3400

1.70

32.33

9.0

127.25

124.62

g/l

2.44

617

3305

Sulfasalazine

1350

9658

1.44

32.28

8.1

7.8

118.87

121.69

g/l

5.80

1317

9377

Other diseases of oesophagus

552

3273

1.79

32.25

8.7

7.5

119.18

121.86

g/l

2.16

541

3183

Osteonecrosis

373

1978

2.05

32.09

10.7

8.6

114.58

121.88

g/l

10.56

365

1920

Abscess of anal and rectal regions

445

2477

1.90

32.04

9.5

8.5

121.71

125.30

g/l

2.86

435

2407

210

5.09

31.91

6.1

7.1

121.84

120.02

g/l

0.36

201

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2635

20201

1.29

31.83

9.6

8.6

123.91

121.84

g/l

5.67

2539

19665

Cervicocranial syndrome

522

3046

1.80

31.82

6.0

8.0

125.12

120.75

g/l

5.24

511

2954

Malignant neoplasm of endocrine gland

335

1707

2.09

31.63

8.1

8.5

123.58

122.51

g/l

0.40

325

1657

Fracture of foot, except ankle

1109

7693

1.49

31.54

8.6

8.4

121.00

122.36

g/l

1.37

1079

7468

Speech and linguistic disorders

347

1706

2.04

31.44

10.7

9.2

123.91

124.14

g/l

0.07

335

1664

Congenital malformations of cardiac septa

321

1561

2.12

31.34

13.8

9.4

122.96

123.11

g/l

0.04

313

1518

Leisure time condition

908

6087

1.55

31.12

7.2

8.0

120.43

121.78

g/l

1.14

870

5929

Postmenopausal osteoporosis with pathological fracture

382

2065

2.01

31.12

7.2

5.9

113.90

117.36

g/l

3.07

364

2010

Other symptoms and signs involving the urinary system

597

3651

1.73

31.10

7.6

8.3

120.43

122.33

g/l

1.48

586

3546

Ovarian cyst

1493

6206

1.42

31.03

7.0

7.4

119.93

118.14

g/l

3.02

1461

6036

Maltreatment syndromes

235

1050

2.38

31.00

9.1

10.3

125.28

125.22

g/l

0.01

230

1022

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

193

806

2.69

30.78

12.3

10.0

111.22

123.42

g/l

11.46

188

785

Sarcoidosis

700

4456

1.65

30.72

10.6

8.4

122.99

122.12

g/l

0.49

670

4326

Asthma and opportunity respiratory infection

291

1442

2.22

30.63

8.5

7.7

121.96

119.23

g/l

1.46

281

1400

Generalized anxiety disorder

576

3469

1.71

30.52

8.1

7.7

124.01

122.95

g/l

0.61

568

3373

Other infectious diseases

510

3015

1.80

30.18

10.8

7.9

117.79

121.50

g/l

3.39

494

2920

Rheumatoid arthritis, including avohilmo

1902

14520

1.34

30.15

7.7

118.45

120.30

g/l

3.80

1851

14115

Meniscus derangement

2866

15401

1.28

30.06

7.2

8.8

123.50

122.13

g/l

2.95

2793

14996

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1313

9496

1.43

29.95

7.8

7.6

117.22

120.24

g/l

6.62

1280

9231

Other problems related to primary support group, including family circumstances

429

2328

1.86

29.94

10.2

8.6

121.17

123.03

g/l

1.03

420

2267

Other/unspecified seropositive rheumatoid arthritis

1335

9682

1.42

29.93

7.8

7.5

117.26

120.22

g/l

6.49

1301

9413

Gangrene, not elsewhere classified

199

5.01

29.62

8.8

8.0

110.18

119.18

g/l

3.25

190

Other noninfective disorders of lymphatic vessels and lymph nodes

224

1013

2.43

29.56

9.3

8.6

120.76

121.00

g/l

0.06

219

989

Seropositive rheumatoid arthritis, wide

1347

9804

1.42

29.55

7.8

7.5

117.24

120.22

g/l

6.63

1313

9533

Drug-induced neutropenia

401

2231

1.93

29.54

9.3

8.7

111.59

121.56

g/l

18.09

391

2169

Congenital malformations of the urinary system

305

1547

2.12

29.47

9.0

9.2

113.47

122.85

g/l

12.67

298

1503

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

454

2620

1.85

29.47

8.6

7.3

112.63

119.95

g/l

12.96

443

2551

Hypothyroidism, strict autoimmune

3571

19206

1.24

29.44

7.9

7.6

120.77

121.78

g/l

2.22

3482

18663

Gonarthrosis, primary, with knee surgery

3170

20510

1.26

29.34

6.6

8.0

120.35

120.49

g/l

0.16

3080

19980

Disorders of the thyroid gland

4835

26514

1.20

29.28

8.2

8.0

121.41

121.43

g/l

0.02

4702

25805

Toxic effect of ethanol

226

1027

2.39

29.17

10.9

9.9

126.46

124.60

g/l

0.64

219

1001

Other diseases of upper respiratory tract

5903

26284

1.19

29.00

8.3

8.1

123.05

121.14

g/l

9.54

5745

25588

Methotrexate

681

4353

1.63

28.97

9.0

7.5

116.46

120.78

g/l

7.15

668

4226

Other skin changes

982

6803

1.50

28.82

7.7

119.96

120.57

g/l

0.40

948

6612

Inflammatory bowel disease

1474

10906

1.39

28.76

9.1

8.6

121.07

122.72

g/l

2.32

1440

10598

Other and unspecified visual disturbances

525

3165

1.75

28.74

7.6

8.1

120.87

121.48

g/l

0.29

505

3066

Congenital malformations and deformations of the musculoskeletal system

358

1909

1.95

28.67

9.7

9.4

124.65

123.21

g/l

0.66

352

1854

Primary coxarthrosis, bilateral

1577

11846

1.38

28.55

7.0

7.6

120.09

120.06

g/l

0.02

1525

11525

Other inflammatory liver diseases

370

2029

1.95

28.46

10.8

8.5

116.86

122.07

g/l

4.60

359

1974

Childhood asthma (age<16), excluding more controls

346

1417

1.96

28.41

10.5

6.7

124.50

126.33

g/l

0.81

333

1375

Early complications of trauma

263

1287

2.23

28.40

9.1

120.27

123.15

g/l

1.22

255

1249

!Aliquae complicationes praecoces traumatis

263

1287

2.23

28.40

9.1

120.27

123.15

g/l

1.22

255

1249

Superficial injury of abdomen, lower back and pelvis

714

4633

1.60

28.39

8.1

7.8

121.88

122.55

g/l

0.38

692

4509

Exposure to other and unspecified inanimate mechanical forces

384

2128

1.92

28.30

9.9

9.3

120.68

123.85

g/l

1.97

372

2063

Thiazolidinediones

647

4135

1.65

28.29

9.3

7.8

120.02

121.04

g/l

0.63

633

4006

Other strabismus

940

6432

1.50

28.19

10.1

8.1

123.49

122.17

g/l

1.13

915

6243

Congenital malformations of the urinary system

319

1672

2.04

28.03

9.4

9.2

113.72

122.89

g/l

12.66

310

1623

Polycystic ovarian syndrome, consortium definition

2866

13603

1.27

27.94

7.6

6.9

120.63

118.81

g/l

5.53

2778

13235

Benign neoplasm of brain and other parts of central nervous system

368

2031

1.95

27.85

8.6

8.7

124.53

121.53

g/l

2.27

361

1972

Other congenital malformations of the digestive system

257

1241

2.20

27.72

9.3

118.14

121.92

g/l

2.03

251

1207

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

151

593

2.92

27.71

10.4

7.4

116.57

122.01

g/l

2.39

146

581

malignant neoplasm of male genital organs

1631

7446

1.38

27.71

7.4

9.1

121.52

125.41

g/l

10.81

1566

7274

Abnormal findings on antenatal screening of mother

240

1125

2.21

27.61

4.2

7.6

124.59

121.57

g/l

1.48

229

1088

Lesion of lateral popliteal nerve

296

1528

2.10

27.57

11.8

9.3

118.24

122.34

g/l

2.46

287

1482

Other necrotizing vasculopathies

415

2387

1.86

27.43

9.6

7.9

115.72

120.81

g/l

5.53

403

2317

Diseases of salivary glands

1511

11312

1.37

27.43

8.7

7.9

121.09

121.40

g/l

0.23

1478

10996

Other necrotizing vasculopathies (FG)

344

1868

1.98

27.39

9.7

8.2

116.54

120.67

g/l

3.29

335

1820

Zoster [herpes zoster]

2535

19996

1.28

27.22

7.6

7.7

119.83

120.59

g/l

1.11

2478

19453

Hypercalcemia

272

1376

2.18

27.17

7.7

8.0

113.50

120.36

g/l

5.75

266

1340

Other coagulation defects

373

2075

1.90

27.11

12.3

8.5

120.55

121.68

g/l

0.46

365

2017

Ulcerative colitis

1144

8212

1.43

27.02

8.7

8.4

120.99

122.83

g/l

2.27

1113

7982

Haemorrhoids and perianal venous thrombosis

1588

11972

1.36

27.01

6.5

7.4

120.72

121.55

g/l

0.87

1545

11632

Childhood asthma (age<16)

347

1449

1.93

26.97

10.5

7.3

124.43

125.96

g/l

0.63

334

1408

Corns and callosities

376

2111

1.91

26.85

8.1

8.4

119.20

122.23

g/l

1.90

368

2047

Inflammatory diseases of the central nervous system

432

2518

1.82

26.84

12.1

8.6

119.95

122.76

g/l

2.01

422

2446

Periapical abscess

2196

17333

1.29

26.82

8.6

122.97

122.59

g/l

0.36

2136

16868

Malignant neoplasm of small intestine

153

615

2.84

26.78

6.0

7.3

117.01

122.78

g/l

2.60

146

603

Hypothyroidism, other/unspecified

4445

24640

1.20

26.75

8.0

7.9

121.27

121.23

g/l

0.04

4319

23970

Exposure to unspecified smoke, fire and flames

241

4.23

26.74

5.7

10.7

128.06

122.51

g/l

1.28

234

Intestinal malabsorption

260

1294

2.17

26.72

11.6

8.8

114.57

122.46

g/l

8.05

251

1259

Disorders of sclera, cornea, iris and ciliary body

2658

21446

1.26

26.70

8.1

121.23

121.94

g/l

1.02

2597

20840

Coxarthrosis, primary, with hip surgery

2582

19477

1.27

26.49

6.7

7.7

118.84

120.38

g/l

3.68

2517

18953

Ulcerative colitis, NAS

653

4226

1.61

26.37

9.4

8.4

120.73

123.42

g/l

2.57

634

4120

Use of pramipexole

1148

8311

1.43

26.29

7.3

7.6

121.62

120.44

g/l

1.20

1116

8090

Malignant neoplasm of thyroid gland, including Hilmo

334

1811

1.95

26.20

7.9

8.2

124.16

122.62

g/l

0.66

326

1756

Embolic stroke with flimmer

173

739

2.60

26.16

7.1

6.7

117.01

119.34

g/l

0.76

166

717

Embolic stroke

295

1552

2.06

25.96

8.6

7.0

118.73

119.72

g/l

0.35

285

1505

Immunodeficiencies

255

1273

2.16

25.94

15.3

8.9

117.66

121.24

g/l

1.86

243

1241

Multiple myeloma, including Hilmo

266

1354

2.14

25.91

8.2

6.9

106.75

121.95

g/l

27.32

258

1323

Agoraphobia

136

513

2.83

25.85

15.1

8.9

126.64

123.73

g/l

0.79

129

499

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1619

10676

1.34

25.84

6.8

7.7

120.40

119.81

g/l

0.58

1568

10382

Unspecified jaundice

290

1517

2.05

25.83

10.8

7.6

114.32

121.28

g/l

6.80

279

1474

Secondary uncertain malignant neoplasm

649

4225

1.60

25.75

7.3

7.6

115.15

122.67

g/l

16.28

633

4105

Irregular menses

1694

10199

1.33

25.62

7.8

7.3

121.85

119.54

g/l

5.39

1644

9920

Amenorrhoea

234

1123

2.17

25.53

10.2

7.9

119.81

119.99

g/l

0.05

228

1095

Orchitis and epididymitis

537

3365

1.68

25.45

10.7

9.5

123.18

123.57

g/l

0.15

527

3283

Any dementia, excluding more controls

1973

10605

1.32

25.40

5.4

6.9

120.14

119.27

g/l

1.12

1921

10304

Hypothyreosis and Thyroxine purchase for inclusion criteria

4584

25528

1.19

25.40

8.0

7.9

121.26

121.18

g/l

0.08

4457

24836

Brachial plexus disorders

402

2322

1.81

25.39

5.1

9.0

126.51

122.91

g/l

2.73

386

2258

Urticaria and erythema

1566

11902

1.34

25.37

8.1

122.21

121.35

g/l

0.89

1518

11580

5-aminosalicylic acid

921

6432

1.47

25.29

9.3

8.3

121.08

122.72

g/l

1.61

897

6243

Arthropathies in other diseases classified elsewhere

217

1033

2.29

25.25

11.8

10.2

113.69

122.93

g/l

8.01

212

1007

Other diseases of hard tissues of teeth

3171

13422

1.24

25.24

8.3

7.8

120.92

121.58

g/l

0.98

3090

13056

Causalgia

107

367

3.30

25.02

7.3

11.0

126.65

121.71

g/l

1.54

101

361

D07AA Corticosteroids, weak (group I)

647

4216

1.58

24.93

7.7

8.3

121.57

122.73

g/l

0.70

625

4094

Persons with potential health hazards related to communicable diseases

1429

10635

1.36

24.91

11.1

8.4

120.85

123.27

g/l

4.61

1397

10330

Cystic kidney disease

207

975

2.33

24.85

9.1

9.5

110.57

122.08

g/l

13.19

202

950

Diseases of male genital organs

2872

11762

1.26

24.80

8.9

9.8

125.20

124.85

g/l

0.34

2787

11476

Type1 diabetes, definitions combined, early onset

223

1059

2.18

24.78

11.4

10.1

121.78

126.80

g/l

2.54

216

1028

Diabetic retinopathy

2079

10242

1.31

24.68

10.7

9.1

116.11

122.22

g/l

31.90

2035

9987

Budesonide

622

4041

1.59

24.61

8.2

7.9

119.94

122.11

g/l

1.79

609

3923

Other enthesopathies

1353

10123

1.37

24.58

7.2

8.4

123.55

121.44

g/l

3.43

1307

9862

Injury of urinary and pelvic organs

140

561

2.81

24.49

9.9

10.4

118.48

123.57

g/l

1.95

140

542

Pregnancy hypertension

1419

9539

1.36

24.47

6.7

7.7

120.51

120.02

g/l

0.43

1374

9271

Malignant neoplasm of thyroid gland

297

1587

1.98

24.46

7.9

8.6

124.52

122.36

g/l

0.97

289

1543

Sequelae of injuries of neck and trunk

186

845

2.43

24.45

13.3

9.7

119.15

123.20

g/l

1.82

179

822

Other diseases of stomach and duodenum

361

2061

1.87

24.39

10.8

7.6

115.17

121.62

g/l

6.80

351

2003

Benign neoplasm: Small intestine

255

1317

2.13

24.17

8.1

8.2

116.86

120.46

g/l

2.04

247

1283

Car occupant injured in other and unspecified transport accidents

811

5583

1.50

24.16

8.6

8.3

122.62

122.56

g/l

0.03

781

5426

Oter anti-inflammatory and antirheumatic agents, non-steroids

1294

5259

1.40

24.04

7.1

8.8

120.59

119.62

g/l

0.89

1268

5114

Alzheimer’s disease (Atypical or mixed)

585

3764

1.63

24.03

4.1

6.2

119.67

118.08

g/l

1.08

569

3652

Other infectious diseases

425

2552

1.77

23.91

10.7

7.9

117.09

121.37

g/l

3.87

413

2474

Other disorders of optic [2nd] nerve and visual pathways

336

1889

1.90

23.86

9.6

8.5

120.62

121.81

g/l

0.47

323

1832

Retinal vascular occlusion

685

4605

1.56

23.85

7.6

7.2

118.18

120.25

g/l

1.89

671

4479

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

655

4342

1.57

23.81

6.8

6.5

116.94

121.50

g/l

6.62

634

4224

Malignant neoplasm of breast, ER-positive, including Hilmo

1232

6997

1.39

23.78

5.7

6.9

118.12

120.63

g/l

5.32

1197

6786

Adenocarcinoma and papillary adenocarcinoma of stomach

174

777

2.46

23.76

10.4

7.6

113.67

121.69

g/l

5.94

169

759

Anaemia in chronic diseases classified elsewhere

163

716

2.56

23.51

12.1

9.9

102.80

122.45

g/l

28.53

157

698

Retinal vascular disorders

692

4682

1.55

23.32

7.6

7.1

118.06

120.24

g/l

2.06

678

4553

Glaucoma suspect

1872

14787

1.30

23.16

6.4

7.7

121.05

120.14

g/l

1.18

1798

14381

Barrett oesophagus

303

1676

1.96

23.14

10.2

8.6

119.15

123.15

g/l

2.99

296

1632

Examination and encounter for administrative purposes

273

1456

2.01

22.99

8.2

7.7

124.31

121.90

g/l

1.10

266

1414

Hepatocellular carcinoma

150

642

2.64

22.96

10.1

7.2

117.33

123.30

g/l

2.53

145

629

Malignant neoplasm of prostate, including Hilmo

1620

7405

1.34

22.95

7.2

9.0

121.72

125.25

g/l

9.12

1554

7238

Seborrhoeic keratosis

1150

8518

1.40

22.90

6.1

7.5

120.43

120.70

g/l

0.17

1118

8282

Rheumatism, unspecified

608

3998

1.58

22.89

5.9

7.8

120.83

119.59

g/l

0.90

590

3885

Benign neoplasm: Pituitary gland, craniopharyngeal duct

278

1495

1.99

22.84

8.5

9.1

126.55

122.32

g/l

3.14

266

1448

Impingement syndrome of shoulder

1192

8869

1.38

22.83

7.8

8.8

124.61

121.81

g/l

4.68

1145

8631

Early lumbar disc prolapse, operated

368

2131

1.79

22.82

8.3

10.3

129.75

125.11

g/l

3.72

350

2084

Congenital malformations and deformations of the musculoskeletal system

425

2550

1.72

22.74

9.6

8.9

124.54

123.31

g/l

0.59

418

2482

Degeneration of macula and posterior pole

2610

17006

1.25

22.68

6.7

7.3

118.25

120.31

g/l

6.19

2554

16533

Immunodeficiency with predominantly antibody defects

147

622

2.60

22.65

19.3

9.8

116.19

121.51

g/l

2.03

140

609

Olecranon bursitis

363

2127

1.82

22.54

11.7

9.4

122.32

123.20

g/l

0.32

358

2070

Flat foot [pes planus] (acquired)

448

2759

1.70

22.49

7.4

8.5

121.12

120.83

g/l

0.12

434

2684

Malignant neoplasm of prostate

1567

7201

1.34

22.46

7.0

9.0

121.54

125.12

g/l

8.98

1502

7037

Viral warts

448

2760

1.69

22.43

8.1

8.6

120.32

122.98

g/l

1.86

435

2685

Dermatophytosis

2959

24553

1.22

22.40

8.1

8.2

122.76

122.26

g/l

0.64

2898

23874

Chronic sinusitis

1984

15790

1.28

22.38

8.4

8.2

123.65

121.25

g/l

6.03

1929

15366

Collagenous colitis

456

2834

1.69

22.31

9.2

7.8

118.29

121.15

g/l

2.24

444

2751

Sequelae of injuries of lower limb

453

2807

1.69

22.29

9.8

8.6

119.93

123.57

g/l

3.15

442

2731

Other bursopathies

659

4444

1.54

22.22

8.1

8.4

122.20

121.46

g/l

0.42

639

4321

Benign neoplasm: Descending colon

414

2530

1.75

22.18

7.9

8.1

119.28

121.62

g/l

1.50

405

2458

Other diseases of lip and oral mucosa

1874

14860

1.29

22.17

8.6

7.9

121.00

121.24

g/l

0.19

1829

14457

Secondary thrombocytopenia

353

3.31

22.17

14.1

8.4

109.43

121.58

g/l

6.38

345

Trigger finger

673

4556

1.53

22.10

8.1

8.5

121.63

121.29

g/l

0.17

659

4425

Hyperplasia of prostate

2146

9749

1.28

21.98

8.2

9.5

123.78

123.42

g/l

0.32

2082

9540

Spondyloarthritis

830

5846

1.46

21.98

7.8

7.9

118.85

122.07

g/l

4.69

812

5679

Other shoulder lesions

431

2643

1.70

21.93

6.4

8.7

123.83

122.53

g/l

0.61

415

2567

Nonalcoholic fatty liver disease

468

2940

1.67

21.83

11.4

8.8

121.77

123.22

g/l

0.71

461

2866

Migraine without aura and triptan purchases

543

3504

1.59

21.82

7.3

8.0

125.66

121.34

g/l

6.07

535

3404

Acute appendicitis

3299

25911

1.21

21.69

8.4

8.5

123.80

122.39

g/l

3.53

3215

25188

Persons encountering health services in other circumstances

1818

14318

1.29

21.57

7.8

7.6

122.10

122.20

g/l

0.07

1783

13874

Other congenital malformations

353

2059

1.79

21.56

10.6

9.1

120.17

123.00

g/l

1.68

343

2003

Pruritus

504

3228

1.63

21.49

8.4

7.5

119.30

120.52

g/l

0.67

489

3123

Paralytic strabismus

384

2313

1.76

21.48

9.1

8.1

120.08

121.40

g/l

0.61

374

2242

Other intracranial haemorrhages

208

1043

2.20

21.43

9.6

7.4

117.31

120.28

g/l

1.28

203

1007

Fracture of forearm

2568

19333

1.24

21.41

8.2

7.7

118.85

120.95

g/l

6.12

2495

18815

Primary adrenocortical insufficiency

261

3.62

21.37

10.3

9.2

123.16

121.93

g/l

0.21

255

Abnormal findings on examination of urine, without diagnosis

250

1331

2.03

21.36

9.3

8.7

118.41

121.94

g/l

1.75

245

1290

Other and unspecified tonsillitis

1289

8176

1.35

21.33

9.2

9.4

125.99

124.98

g/l

0.91

1254

7947

Presence of other functional implants

2967

17114

1.22

21.29

7.1

7.2

118.25

121.72

g/l

16.43

2890

16659

Irritable bowel syndrome

1115

8279

1.38

21.26

7.1

7.4

123.24

121.67

g/l

1.75

1087

8036

Problems related to social environment

157

703

2.42

21.12

6.8

8.1

123.11

120.68

g/l

0.70

152

687

Polyuria

1151

8639

1.37

21.01

8.0

121.14

121.80

g/l

0.53

1131

8377

Excessive, frequent and irregular menstruation

1517

6376

1.33

20.88

7.8

7.4

120.52

118.12

g/l

4.92

1478

6201

Nephrotic syndrome

182

874

2.28

20.86

11.8

9.8

108.24

122.69

g/l

15.26

177

855

IgA nephropathy (IgA glomerulonephritis)

152

681

2.48

20.86

10.8

10.2

109.93

123.44

g/l

12.71

152

664

Voice disturbances

1238

9392

1.35

20.77

8.9

7.6

122.03

120.66

g/l

1.69

1212

9124

Septal defects

277

1495

1.91

20.66

12.7

9.7

122.46

122.78

g/l

0.09

270

1458

Malignant neoplasm of liver and intrahepatic bile ducts

180

866

2.29

20.64

9.4

7.3

117.01

122.76

g/l

2.91

172

847

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

252

1345

1.95

20.53

8.7

8.0

122.71

122.15

g/l

0.17

246

1307

Appendicitis, broad definition

3510

26944

1.19

20.52

8.5

123.71

122.29

g/l

3.73

3419

26201

Xerosis cutis

117

473

2.86

20.51

6.4

9.0

118.46

121.58

g/l

0.84

112

461

Diseases of appendix

3541

27107

1.19

20.51

8.5

123.67

122.26

g/l

3.68

3449

26361

Varicose veins

3127

19824

1.21

20.48

7.0

7.7

120.36

120.75

g/l

0.50

3033

19276

Cyst of kidney

409

2544

1.71

20.40

10.0

8.2

119.98

121.35

g/l

0.68

396

2477

Open wound of forearm

471

3012

1.63

20.37

7.9

8.2

120.29

123.02

g/l

2.13

462

2926

Alzheimer’s disease (Late onset), excluding more controls

765

3496

1.48

20.32

4.5

6.5

120.43

118.05

g/l

2.63

748

3391

Vitamin B12 deficiency anaemia

557

3704

1.57

20.29

8.2

7.0

114.23

121.05

g/l

13.16

544

3599

Malignant neoplasm of breast, HER-positive

1187

6949

1.36

20.28

5.6

6.9

118.15

120.61

g/l

5.05

1152

6742

Evidence of alcohol involvement determined by level of intoxication

217

3.74

20.19

13.6

12.4

126.99

123.55

g/l

0.72

211

Glaucoma

2971

21443

1.21

20.17

6.4

7.6

120.15

120.36

g/l

0.23

2881

20875

Cardiomyopathy, Hypertrophic obstructive

112

442

2.82

20.15

17.2

7.4

119.50

122.33

g/l

0.68

112

429

Other disorders of bone

859

6184

1.43

20.12

8.0

8.2

123.00

123.05

g/l

0.02

834

6011

Lesion of radial nerve

210

1076

2.11

20.07

10.2

9.4

119.94

121.40

g/l

0.47

203

1042

Gestational [pregnancy-induced] hypertension

793

5602

1.44

20.02

6.3

7.5

121.22

120.40

g/l

0.57

766

5438

Other secondary gonarthrosis

300

1727

1.86

19.95

7.5

8.8

121.03

121.51

g/l

0.15

291

1676

Hallux valgus (acquired)

1522

8521

1.31

19.92

6.5

8.1

120.40

120.08

g/l

0.25

1483

8291

Abnormal results of function studies

413

2577

1.68

19.82

11.2

8.1

121.56

122.54

g/l

0.40

401

2507

Follicular cysts of skin and subcutaneous tissue

868

6295

1.42

19.67

8.3

8.5

121.87

122.14

g/l

0.14

845

6127

Impotence

330

1967

1.80

19.54

9.2

9.8

124.25

123.95

g/l

0.09

316

1920

Disorders of optic nerve and visual pathways

428

2702

1.65

19.51

8.9

8.5

120.71

122.37

g/l

0.91

412

2624

Papillary adenocarcinoma of thyroid gland

226

1194

2.01

19.44

9.1

7.7

123.03

122.49

g/l

0.14

220

1161

Non-allergic asthma

429

2716

1.65

19.39

7.8

8.4

124.40

121.71

g/l

1.78

415

2634

Crohn disease

563

3775

1.54

19.39

9.6

8.4

120.06

123.38

g/l

3.31

549

3676

Sequelae of injuries of head

277

1570

1.88

19.26

15.3

9.4

120.33

124.21

g/l

2.07

263

1527

Inflammatory disease of uterus

486

3155

1.58

19.21

7.0

7.2

121.45

119.65

g/l

1.28

475

3059

Faecal incontinence

422

2672

1.65

19.03

6.7

6.6

118.34

119.31

g/l

0.49

407

2596

Vitamin deficiency, wide

244

1334

1.95

19.03

10.8

8.7

119.95

120.70

g/l

0.20

237

1293

Vitamin deficiency

244

1334

1.95

19.03

10.8

8.7

119.95

120.70

g/l

0.20

237

1293

Carbimazole or st.post thyroidectomy, condition for graves disease

885

6467

1.41

18.99

8.4

7.7

122.54

120.90

g/l

1.58

860

6282

Myocardial infarction, unclassifiable

1240

8503

1.34

18.96

8.1

6.9

119.71

119.92

g/l

0.13

1202

8264

Conjunctivitis (acute, non atopic)

1203

9163

1.34

18.93

7.7

8.2

122.91

122.01

g/l

0.78

1174

8905

Polyarthritis, unspecified

200

1029

2.09

18.88

8.1

8.4

118.60

122.27

g/l

1.75

194

1001

Bulimia nervosa (incl. atypical)

114

461

2.59

18.81

7.4

10.0

124.61

121.25

g/l

1.05

114

446

Mucosal proctocolitis

556

3743

1.54

18.80

8.7

8.8

119.87

123.93

g/l

4.75

543

3646

Thrombocytopenia, unspecified

372

2303

1.71

18.71

11.3

8.5

113.18

121.90

g/l

11.59

363

2234

Acute alcohol intoxication ICD-9

209

1100

2.06

18.67

7.7

8.5

123.26

123.11

g/l

0.03

204

1072

Fracture at wrist and hand level

1567

12390

1.29

18.66

8.7

122.36

123.05

g/l

0.66

1512

12029

Other epidermal thickening

231

1253

1.97

18.59

8.2

9.0

121.31

121.47

g/l

0.04

223

1218

Inflammatory diseases of female pelvic organs

2319

14023

1.23

18.51

7.4

7.1

120.76

118.89

g/l

5.23

2261

13634

Localized swelling, mass and lump of skin and subcutaneous tissue

1487

11736

1.29

18.45

8.0

8.1

121.03

121.28

g/l

0.18

1458

11408

Disorders of speech understanding and production

186

917

2.10

18.37

10.9

8.4

122.12

122.38

g/l

0.05

176

893

Weight loss

501

3334

1.57

18.30

7.9

7.8

119.28

121.06

g/l

1.15

482

3238

Asthma mixed form (mode), excluding more controls

198

1015

2.03

18.29

5.5

6.1

123.72

122.29

g/l

0.40

193

984

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1428

11147

1.30

18.25

8.8

8.6

125.34

122.99

g/l

4.14

1396

10824

2193

16587

1.24

18.20

6.6

7.2

118.99

119.74

g/l

1.02

2125

16150

Arthropod-borne viral fevers and viral haemorrhagic fevers

483

3196

1.58

18.15

7.4

8.8

123.98

123.02

g/l

0.42

469

3100

Complications of other internal prosthetic devices, implants and grafts

212

1127

2.01

18.15

9.6

6.9

117.50

121.59

g/l

2.16

203

1088

Non-small cell lung cancer, adenocarcinoma, helper endpoint

362

2256

1.71

18.02

7.9

7.4

120.22

120.51

g/l

0.11

350

2192

Urticaria

1193

9171

1.33

17.97

8.0

8.1

123.27

121.62

g/l

2.01

1153

8913

Postprocedural disorders of nervous system

271

1546

1.82

17.96

6.0

8.7

125.07

123.30

g/l

0.77

262

1504

Adhesive capsulitis of shoulder

786

5698

1.42

17.89

7.8

8.5

121.65

121.15

g/l

0.27

765

5549

Other specified/unspecified hearing loss

447

2920

1.61

17.85

8.0

7.9

120.23

120.49

g/l

0.11

441

2833

Normal-pressure hydrocephalus

292

1729

1.82

17.83

4.1

7.1

124.84

119.89

g/l

4.06

286

1673

Diffuse large B-cell lymphoma, helper endpoint

241

1345

1.92

17.82

11.5

6.9

110.38

122.79

g/l

14.92

233

1312

Diffuse large B-cell lymphoma

241

1345

1.92

17.82

11.5

6.9

110.38

122.79

g/l

14.92

233

1312

Diffuse large B-cell lymphoma, including Hilmo

241

1345

1.92

17.82

11.5

6.9

110.38

122.79

g/l

14.92

233

1312

Multiple myeloma and malignant plasma cell neoplasms

280

1639

1.84

17.79

8.1

7.6

107.17

121.23

g/l

25.50

272

1588

Acute appendicitis, no complications

2471

20531

1.21

17.76

8.0

8.7

124.33

122.70

g/l

3.52

2405

19944

Dislocation, sprain and strain of joints and ligaments at neck level

592

4080

1.49

17.68

6.7

8.6

125.35

123.29

g/l

1.60

578

3969

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

134

601

2.36

17.67

13.2

10.5

120.49

123.87

g/l

0.92

129

586

Covid-19 suspected case

828

6048

1.40

17.64

8.9

7.7

122.36

122.52

g/l

0.08

815

5860

Dermatitis due to substances taken internally

265

1519

1.84

17.63

9.1

7.9

118.76

121.39

g/l

1.28

258

1473

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

776

3507

1.42

17.63

6.8

7.4

121.16

122.28

g/l

0.82

751

3408

Disorders of vestibular function (Vertigo)

2302

18831

1.22

17.50

6.5

7.7

122.52

120.29

g/l

6.48

2232

18328

Viral haemorrhagic fevers, not elsewhere classified/unspecified

395

2523

1.65

17.44

7.6

9.0

124.84

123.00

g/l

0.89

382

2450

Diabetic retinopathy, strict definition

991

6623

1.38

17.44

12.8

9.3

113.66

123.09

g/l

36.15

967

6455

Benign neoplasm of urinary organs

262

1513

1.86

17.33

6.8

7.8

122.45

120.71

g/l

0.76

253

1468

Other disorders of central nervous system

283

3.16

17.27

7.1

9.6

121.41

122.99

g/l

0.28

275

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1347

10590

1.30

17.27

8.2

8.8

123.21

122.98

g/l

0.14

1316

10298

Monoamine oxidase A inhibitors

534

3640

1.52

17.12

7.8

8.2

121.89

121.16

g/l

0.36

528

3532

Alcoholic gastritis

105

439

2.71

17.09

10.4

8.9

123.17

123.35

g/l

0.02

105

430

Abnormal blood-pressure reading, without diagnosis

203

1082

1.98

17.01

6.5

7.7

121.90

120.40

g/l

0.47

193

1048

Papulosquamous disorders

1860

15196

1.25

17.00

8.4

8.2

122.12

121.73

g/l

0.34

1817

14783

Other/unspecified rheumatoid arthritis

613

4306

1.48

16.98

7.8

7.2

115.66

119.86

g/l

5.99

593

4178

Other follicular disorders

319

1941

1.72

16.94

8.2

8.9

122.96

124.11

g/l

0.45

310

1889

Abnormal findings on diagnostic imaging of central nervous system

224

1237

1.92

16.90

10.2

8.6

123.74

122.42

g/l

0.44

219

1203

Other disorders of eye and adnexa

600

4189

1.48

16.89

8.5

8.0

122.16

121.78

g/l

0.17

588

4075

Suggestive for eosinophilic asthma

444

2930

1.58

16.86

7.3

8.6

124.18

121.65

g/l

1.77

427

2849

Other obstetric conditions, not elsewhere classified

798

3660

1.40

16.84

6.9

7.4

121.14

122.33

g/l

0.92

774

3560

Right bundle-branch block

182

942

2.06

16.81

13.4

7.3

121.83

121.72

g/l

0.02

177

916

Benign neoplasm: Kidney

205

1113

2.00

16.78

6.6

7.9

122.44

120.10

g/l

1.00

199

1086

Generalized epilepsy

182

939

2.04

16.78

8.3

9.2

123.24

123.21

g/l

0.01

176

917

Diseases of inner ear

2690

22021

1.20

16.74

6.8

7.8

122.62

120.66

g/l

5.87

2607

21444

Internal derangement of knee

1693

13639

1.26

16.66

8.2

8.9

123.10

122.33

g/l

0.80

1646

13293

Overexertion and strenuous or repetitive movements

458

3051

1.56

16.55

11.8

8.6

121.94

123.22

g/l

0.67

452

2972

Non-small cell lung cancer, squamous

245

1401

1.85

16.52

7.8

6.8

120.28

121.68

g/l

0.51

239

1372

Enthesopathies of lower limb, excluding foot

934

7032

1.36

16.48

7.6

8.7

123.45

121.44

g/l

2.19

918

6850

Other peripheral vascular diseases

363

2298

1.65

16.47

6.4

7.7

119.90

122.23

g/l

1.30

351

2231

Benign neoplasm of other and unspecified intrathoracic organs

317

3.05

16.42

11.1

7.7

118.77

120.60

g/l

0.37

311

Hypoparathyroidism

195

1047

2.01

16.39

8.4

6.7

117.37

119.32

g/l

0.68

190

1018

Vitamin D deficiency

394

2.69

16.37

8.5

9.8

123.79

121.19

g/l

0.51

382

Iridocyclitis

1031

7892

1.34

16.34

7.6

8.0

120.29

121.81

g/l

1.56

1006

7666

1603

11277

1.27

16.32

6.0

6.6

117.59

119.42

g/l

3.37

1565

10951

Diabetic maculopathy

728

5016

1.43

16.28

10.9

9.4

112.79

122.76

g/l

30.00

708

4883

Primary hyperparathyroidism

530

3657

1.51

16.25

5.8

7.6

122.43

119.38

g/l

2.83

515

3550

Multiple myeloma

157

788

2.18

16.19

7.4

6.3

103.84

121.40

g/l

21.13

150

770

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

157

788

2.18

16.19

7.4

6.3

103.84

121.40

g/l

21.13

150

770

Progressive vascular leukoencephalopathy

225

1273

1.91

16.17

6.7

6.0

117.44

118.22

g/l

0.24

225

1232

Unspecified nephritic syndrome

134

634

2.32

16.15

8.6

9.5

118.18

122.60

g/l

1.53

129

619

Heterophoria

328

2035

1.68

16.07

8.6

8.5

124.66

122.04

g/l

1.45

316

1968

Haemolytic anaemias

191

1028

2.00

15.93

11.8

8.8

107.52

120.84

g/l

13.28

186

1003

Fibroblastic disorders

1141

8886

1.31

15.92

8.7

8.2

120.02

121.25

g/l

1.21

1116

8653

Pre-eclampsia or eclampsia

711

5157

1.41

15.83

6.4

7.5

119.40

119.92

g/l

0.29

682

5006

Urolithiasis

1651

13442

1.26

15.80

7.9

8.3

122.78

121.97

g/l

0.83

1602

13078

Gingival hyperplasia

185

989

2.01

15.72

11.0

9.7

116.59

121.90

g/l

2.66

177

965

Secondary and unspecified malignant neoplasm of lymph nodes

377

2438

1.61

15.68

8.1

7.9

114.21

122.66

g/l

11.00

367

2370

Other hammer toe(s) (acquired)

805

5514

1.39

15.67

7.0

7.7

119.04

119.40

g/l

0.21

781

5365

Ptosis of eyelid

574

4053

1.48

15.63

9.0

8.0

120.53

120.26

g/l

0.12

562

3933

Disturbance of activity and attention

309

1850

1.67

15.62

8.0

9.7

129.60

125.11

g/l

3.51

304

1794

Specific development disorders of speech and language

226

1229

1.84

15.52

9.5

9.2

122.52

123.07

g/l

0.14

216

1197

Pre-eclampsia

646

4630

1.42

15.45

6.3

7.6

119.43

120.18

g/l

0.43

618

4495

Non-follicular lymphoma

508

3519

1.51

15.44

10.2

7.8

112.31

121.17

g/l

17.63

492

3421

Any dementia

2113

12224

1.23

15.43

5.3

6.9

120.05

119.25

g/l

1.03

2058

11882

Calculus of kidney and ureter

1516

12269

1.26

15.38

7.8

8.4

122.93

121.97

g/l

1.02

1469

11935

Non-Hodgkin lymphoma, all

228

1309

1.86

15.35

11.6

7.4

109.35

121.65

g/l

15.17

220

1282

Other specified/unspecified systemic involvement of connective tissue

268

1604

1.76

15.35

9.1

8.2

119.03

120.38

g/l

0.55

259

1561

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1689

16342

0.81

15.34

7.3

8.0

120.06

120.82

g/l

0.91

1634

15877

Other disorders starting during childhood or adolecense, excluding more controls

118

505

2.30

15.34

14.1

9.3

122.88

124.04

g/l

0.21

113

493

Melanocytic naevi

1251

9890

1.29

15.33

7.5

8.1

120.61

121.54

g/l

0.85

1209

9611

Trigeminal neuralgia

273

1642

1.75

15.31

7.3

8.9

123.65

120.20

g/l

2.24

266

1595

Other disorders affecting eyelid function

248

3.25

15.30

6.3

7.4

124.86

121.65

g/l

0.70

243

Metatarsalgia

402

2647

1.57

15.25

7.7

8.4

121.03

121.09

g/l

0.02

389

2571

Convergence insufficiency and excess

255

3.05

15.25

6.2

8.1

123.42

121.47

g/l

0.31

248

Intussusception

118

542

2.37

15.19

7.2

7.9

117.59

119.69

g/l

0.57

109

527

Epidural haemorrhage

198

3.41

15.11

13.6

10.2

125.70

122.24

g/l

0.55

192

Early lumbar disc prolapse operation

381

2480

1.58

15.06

8.3

9.9

129.90

126.02

g/l

2.88

363

2419

Injuries to the wrist and hand

4852

29798

1.14

15.04

8.6

8.2

123.29

121.79

g/l

5.35

4734

28979

Abnormal weight loss

455

3097

1.53

15.03

8.2

7.9

119.66

120.99

g/l

0.69

438

3008

Lyme disease

845

11122

0.74

14.99

7.5

8.2

122.15

121.23

g/l

0.72

839

10798

Pleural plaque

531

3734

1.49

14.94

6.6

7.0

125.45

120.10

g/l

7.62

518

3628

Liposarcoma, including Hilmo

286

3.05

14.92

9.1

7.0

118.77

124.66

g/l

1.80

281

Polymyalgia rheumatica

694

5101

1.41

14.91

7.1

6.8

117.05

119.73

g/l

3.27

679

4960

Hyperkinetic disorders

328

2016

1.63

14.88

7.8

10.1

129.35

125.08

g/l

3.45

323

1955

Nail disorders

374

2446

1.59

14.79

9.6

9.0

118.87

122.97

g/l

3.21

364

2378

IBD patients in KELA-register

948

7269

1.33

14.74

8.7

121.30

123.41

g/l

2.38

922

7072

Speech disturbances, not elsewhere classified

447

3047

1.53

14.65

9.7

7.7

123.43

120.65

g/l

2.42

439

2963

Skin changes due to chronic exposure to nonionizing radiation

2055

15881

1.22

14.62

6.6

7.1

118.86

119.67

g/l

1.10

1988

15455

Dislocation, sprain and strain of joints and ligaments of knee

2581

20267

1.19

14.54

7.8

8.6

125.44

123.02

g/l

7.26

2507

19695

Redundant prepuce, phimosis and paraphimosis

976

7461

1.33

14.53

9.5

10.0

126.04

125.64

g/l

0.22

946

7280

Erectile dysfunction

463

3201

1.53

14.47

14.9

8.4

122.68

121.85

g/l

0.38

442

3114

Other spirochaetal diseases

860

11234

0.75

14.44

7.5

8.1

122.24

121.27

g/l

0.79

854

10906

Lichen simplex chronicus and prurigo

310

1959

1.66

14.42

9.8

7.9

119.69

121.63

g/l

0.89

299

1897

Benign paroxysmal vertigo

1374

11081

1.27

14.39

6.6

7.6

122.52

119.97

g/l

5.16

1334

10761

Cluster headache, wide,, including avohilmo

225

1305

1.81

14.38

7.8

9.6

127.54

124.12

g/l

1.52

219

1270

Cluster headache, strict, including avohilmo

210

1194

1.85

14.37

8.2

10.1

127.77

124.10

g/l

1.57

204

1162

Diabetic neuropathy

676

4977

1.42

14.31

10.0

9.7

115.51

121.70

g/l

11.27

662

4856

Spirochaetal infections, other/unspecified

859

11207

0.75

14.30

7.5

8.1

122.19

121.23

g/l

0.77

853

10880

Malnutrition

123

591

2.28

14.29

12.1

8.4

116.78

120.55

g/l

1.12

116

576

Acute nasopharyngitis (common cold)

517

3601

1.47

14.29

8.0

9.6

126.44

126.23

g/l

0.07

501

3516

Acquired absence of organs, not elsewhere classified

320

2.82

14.29

9.9

8.1

117.79

122.17

g/l

0.99

311

Thyroiditis, ILD-related definition

455

3114

1.51

14.28

8.9

7.9

121.32

120.70

g/l

0.27

445

3020

Behavioural syndromes associated with physiological disturbances and physical factors

4289

26852

1.14

14.27

7.5

8.3

123.44

121.69

g/l

6.48

4205

26078

Squamous cell neoplasms and carcinomas of the skin

414

2793

1.55

14.23

6.6

6.3

115.15

120.86

g/l

6.90

405

2722

Meralgia paraesthetica

173

935

1.98

14.22

7.8

9.7

123.07

120.89

g/l

0.71

168

910

Pure hyperglyceridaemia

125

607

2.24

14.04

12.6

7.9

125.17

122.60

g/l

0.59

125

590

Occupational exposure to risk-factors

192

1081

1.91

14.04

5.5

9.6

129.56

122.73

g/l

4.13

185

1049

Paraplegia, diplegia of upper limbs

127

622

2.23

14.03

10.1

8.6

120.53

121.77

g/l

0.25

120

607

Wet age-related macular degeneration

928

6956

1.33

14.03

6.4

6.5

117.08

118.75

g/l

1.81

911

6738

Other ulcerative colitis

262

1596

1.72

14.02

9.3

8.7

120.77

124.11

g/l

1.77

253

1553

Other spirochaetal diseases

877

11379

0.76

14.00

7.4

8.1

122.30

121.26

g/l

0.88

870

11049

Acute suppurative otitis media

863

6118

1.34

14.00

9.4

9.0

124.63

124.16

g/l

0.25

844

5933

Asthma mixed form (mode)

198

1111

1.85

13.98

5.5

6.3

123.72

121.72

g/l

0.63

193

1081

Hyperfunction of pituitary gland

197

1107

1.86

13.98

9.5

9.0

121.87

121.86

g/l

0.00

189

1077

Fistulae involving female genital tract

440

2.48

13.95

7.8

8.1

111.27

119.28

g/l

3.63

431

Acute and subacute iridocyclitis

852

6501

1.34

13.93

7.6

8.0

120.22

121.97

g/l

1.66

830

6320

Foreign body in alimentary tract

267

1641

1.71

13.93

9.0

8.9

122.14

122.20

g/l

0.01

259

1594

Other abnormal findings in urine

105

481

2.44

13.93

10.5

7.9

117.86

120.06

g/l

0.51

100

473

Thyrotoxicosis

1064

8352

1.30

13.92

9.1

7.5

121.30

120.31

g/l

0.84

1038

8121

Mental retardation, wide definition

177

960

1.93

13.88

9.1

10.3

125.61

122.67

g/l

0.92

172

933

Injury of nerves and spinal cord at neck level

135

681

2.17

13.85

9.8

8.5

120.10

122.20

g/l

0.54

130

663

Actinic keratosis

2002

15581

1.21

13.81

6.6

7.0

118.73

119.69

g/l

1.40

1936

15162

Herpesviral [herpes simplex] infections

495

3472

1.47

13.75

8.5

8.2

119.37

121.87

g/l

2.00

486

3370

Pre-eclampsia or poor fetal growth

912

6983

1.32

13.75

7.7

7.5

119.34

120.52

g/l

1.04

875

6782

Femoral hernia

226

1337

1.79

13.70

9.4

7.9

123.13

120.85

g/l

0.90

221

1296

Other enthesopathy of foot (+metatarsalgia)

422

2875

1.51

13.62

7.5

8.2

120.87

121.32

g/l

0.18

408

2795

Other factor of the environment

328

2.73

13.55

8.4

8.1

117.84

121.88

g/l

0.91

319

Inflammatory bowel disease, strict (require KELA)

948

7358

1.31

13.51

8.7

121.30

123.45

g/l

2.46

922

7157

Divergent concomitant strabismus

321

2070

1.61

13.51

8.4

8.7

123.03

122.76

g/l

0.08

310

2011

Anterior Iridocyclitis

896

6916

1.33

13.47

7.7

8.2

120.26

121.92

g/l

1.59

873

6726

Viral warts

846

6470

1.33

13.47

7.5

8.4

122.40

122.56

g/l

0.08

825

6288

Chronic tubulo-interstitial nephritis

176

971

1.92

13.42

7.5

6.9

113.60

121.42

g/l

5.75

169

946

Necrosis of pulp, including avohilmo

2510

21452

1.18

13.42

8.9

8.6

123.56

122.75

g/l

1.15

2436

20848

Panniculitis affecting regions of neck and back

177

979

1.91

13.41

9.9

8.9

122.67

121.59

g/l

0.29

170

954

Toxic effect of alcohol

120

585

2.23

13.39

11.7

9.9

123.17

122.91

g/l

0.05

120

570

Keratitis

1583

13044

1.23

13.35

8.5

8.2

121.61

122.08

g/l

0.39

1544

12679

Other congenital malformations

473

3300

1.47

13.35

9.8

8.5

120.16

122.85

g/l

2.10

461

3216

Panhypopituitarism

111

529

2.32

13.29

13.0

9.2

123.94

122.26

g/l

0.39

103

517

Superficial injury of forearm

399

2702

1.52

13.28

7.5

8.7

122.64

123.30

g/l

0.25

389

2624

Salpingitis and oophoritis

676

5021

1.38

13.24

8.5

7.3

119.64

118.97

g/l

0.43

658

4869

Congenital malformations of the musculoskeletal system, not elsewhere classified

286

2.74

13.19

8.7

7.5

125.07

121.93

g/l

0.67

281

Thyrotoxicosis, other and/or unspecified

829

6347

1.33

13.16

9.8

7.5

121.16

120.47

g/l

0.43

808

6166

Other and unspecified injuries of lower leg

310

1998

1.61

13.05

6.9

8.6

121.78

122.69

g/l

0.32

302

1951

Myelodysplastic syndrome, including Hilmo

161

877

1.97

13.05

7.0

6.9

103.74

121.06

g/l

17.46

156

856

Other disorders of binocular movement

105

488

2.30

13.04

8.1

8.9

121.98

122.02

g/l

0.01

100

475

Hemiplegia

240

1464

1.72

12.86

10.8

8.6

123.88

121.12

g/l

1.35

235

1421

Hypothyroidism, strict autoimmune, 3 medication purchases required

3918

23388

1.14

12.81

7.6

7.8

120.74

120.87

g/l

0.14

3821

22741

Other disorders of bladder

598

4399

1.41

12.80

8.1

8.2

121.44

121.83

g/l

0.18

585

4266

Other (seronegative) rheumatoid arthritis, wide

874

6780

1.32

12.77

8.3

7.4

116.81

120.35

g/l

5.93

852

6589

Primary biliary cholangitis (PBC)

112

541

2.24

12.75

14.7

6.3

114.45

119.99

g/l

1.69

105

523

Somnolence

294

2.75

12.75

13.3

9.4

118.37

121.65

g/l

0.62

286

Hydrocele

616

4569

1.39

12.48

8.4

9.1

122.03

122.83

g/l

0.39

590

4462

Adenocarcinoma of pancreas

148

797

2.00

12.47

7.6

7.3

113.42

121.42

g/l

5.90

143

781

Burns and corrosions

580

4253

1.40

12.44

9.4

9.2

123.01

123.72

g/l

0.33

568

4133

Mixed connective tissue disease

280

1789

1.63

12.42

9.6

8.4

118.65

120.45

g/l

0.86

271

1743

Other/unspecified synovitis and tenosynovitis

486

3464

1.44

12.36

8.0

8.3

120.39

121.49

g/l

0.57

476

3360

Psoriasis

1283

10453

1.25

12.24

8.8

8.5

122.44

122.10

g/l

0.24

1257

10160

Fissure and fistula of anal and rectal regions

1027

8160

1.28

12.19

8.3

8.0

121.69

122.85

g/l

1.03

1000

7922

Other hearing loss

1399

11262

1.24

12.17

7.2

7.3

119.73

119.76

g/l

0.02

1354

10946

Superficial injury of ankle and foot

441

3096

1.46

12.11

8.6

8.4

123.59

123.70

g/l

0.04

433

3008

Mixed hyperlipidaemia

196

1155

1.79

12.08

12.7

8.2

121.53

123.17

g/l

0.51

196

1116

Other disorders of veins

1781

14903

1.21

12.03

8.0

7.7

120.33

120.68

g/l

0.30

1749

14486

Seropositive rheumatoid arthritis, strict definition

667

5038

1.36

11.90

8.8

7.9

117.90

120.93

g/l

3.50

652

4891

Third [oculomotor] nerve palsy

109

539

2.22

11.89

11.0

8.2

119.08

120.00

g/l

0.18

104

528

Lactose intolerance

125

642

2.05

11.82

12.5

8.4

121.36

121.64

g/l

0.05

118

624

Symptoms and signs involving emotional state

130

678

2.02

11.81

8.1

8.2

124.71

122.32

g/l

0.68

130

662

Other neurotic disorders

237

1477

1.69

11.79

6.3

8.4

123.48

122.12

g/l

0.45

229

1434

Acute generalized exanthematous pustulosis

206

1239

1.75

11.75

9.9

8.4

117.73

120.49

g/l

1.17

200

1209

Persistent delusional disorders

348

2362

1.53

11.69

7.1

8.4

123.90

121.93

g/l

1.02

339

2291

Convalescence

227

1399

1.69

11.67

18.7

7.3

116.33

122.67

g/l

4.76

216

1365

Ventricular septal defect, a heart condition

410

2.32

11.61

17.7

10.7

123.28

121.92

g/l

0.21

402

Acute laryngitis and tracheitis

372

2503

1.49

11.56

11.7

8.5

124.85

124.53

g/l

0.10

363

2431

Bell's palsy

509

3703

1.41

11.56

8.4

8.5

120.92

121.62

g/l

0.33

499

3597

Other and specified injuries of hip and thigh

121

625

2.09

11.55

5.5

8.6

120.67

121.46

g/l

0.17

114

609

Acute pharyngitis

528

3821

1.40

11.49

9.3

9.1

125.20

124.51

g/l

0.32

515

3731

Embedded teeth, including avohilmo

282

1827

1.58

11.45

8.2

8.9

120.19

124.18

g/l

2.58

267

1782

Pain associated with micturition

503

3660

1.41

11.43

7.2

7.9

121.28

121.14

g/l

0.05

482

3544

Benign neoplasm of middle ear and respiratory system

386

2690

1.49

11.42

8.8

8.3

121.78

122.20

g/l

0.14

379

2614

Hypertrophic disorders of skin

222

1366

1.69

11.41

8.5

8.6

121.52

122.38

g/l

0.26

217

1328

Other Crohn's disease

282

1840

1.59

11.33

9.0

8.5

118.71

124.80

g/l

4.90

276

1791

Lactose intolerance, other/unspecified

114

577

2.09

11.29

12.9

8.5

120.55

121.56

g/l

0.20

107

563

Other inflammation of eyelid

592

4430

1.37

11.26

7.2

8.1

121.30

120.97

g/l

0.15

575

4300

L01XE Protein kinase inhibitors

279

1833

1.61

11.24

8.1

8.0

119.20

121.17

g/l

0.76

269

1782

Carcinoma in situ of other and unspecified genital organs

449

2.27

11.11

4.0

7.2

121.41

118.66

g/l

0.74

440

Disorders of vitreous body and globe

2470

20650

1.16

10.98

8.0

7.9

119.89

120.62

g/l

1.04

2407

20107

Fitting and adjustment of other devices

1178

12972

0.81

10.98

6.6

7.0

120.61

121.23

g/l

0.49

1153

12629

Crohn's disease NAS

267

1736

1.60

10.94

7.9

8.5

119.25

124.25

g/l

3.57

260

1689

Generalized skin eruption due to drugs and medicaments

182

1083

1.77

10.86

9.7

8.4

117.15

120.74

g/l

1.58

177

1055

Colitis, primary sclerosing, strict definition

226

2.83

10.85

17.1

11.8

117.74

125.29

g/l

1.64

218

Burns and corrosions of external body surface, specified by site

451

3252

1.43

10.82

9.0

122.27

123.77

g/l

0.74

441

3163

Peritonsillar abscess

818

6417

1.30

10.80

8.2

8.8

123.77

122.76

g/l

0.71

800

6239

Other and unspecified vascular occlusions

480

3514

1.42

10.76

7.1

118.60

120.37

g/l

1.08

469

3416

Nontoxic multinodular goitre

867

6870

1.29

10.75

6.0

6.9

120.41

118.95

g/l

1.43

851

6669

Vascular dementia (mixed)

111

575

2.10

10.66

6.3

6.8

119.37

117.83

g/l

0.33

104

556

Nummular dermatitis

390

2759

1.47

10.65

9.5

7.9

119.75

122.22

g/l

1.50

381

2677

Melanocytic naevi of trunk

503

3705

1.40

10.63

7.7

8.4

119.70

122.62

g/l

2.46

487

3599

Hypertrophic scar

203

1246

1.69

10.58

8.4

8.6

122.04

122.15

g/l

0.03

198

1211

Other diseases of peritoneum

208

1291

1.69

10.57

6.6

7.9

120.84

120.26

g/l

0.16

197

1258

Malignant neoplasm of anus and anal canal, including Hilmo

331

2.48

10.42

12.5

6.4

113.08

122.21

g/l

4.12

326

1091

8372

1.25

10.41

5.5

6.4

118.04

118.89

g/l

0.76

1063

8126

Degenerative diseases of the nervous system

1859

11670

1.19

10.36

5.1

6.8

119.99

119.09

g/l

1.13

1809

11340

Chronic rhinitis, nasopharyngitis and pharyngitis

1327

11030

1.22

10.32

9.0

8.1

124.14

121.07

g/l

6.62

1299

10725

Lateral epicondylitis

531

3959

1.37

10.29

6.6

9.0

125.75

122.14

g/l

3.83

510

3850

Recurrent dislocation of patella

154

881

1.80

10.25

9.4

9.6

126.54

124.31

g/l

0.62

148

861

Sleep disorders

4018

26071

1.12

10.23

7.5

8.3

123.58

121.72

g/l

6.92

3936

25320

Diabetes mellitus in pregnancy

818

4093

1.29

10.23

6.7

8.2

121.37

121.60

g/l

0.12

790

3983

Other noninflammatory disorders of uterus, except cervix

943

5079

1.28

10.23

6.1

7.2

119.70

117.38

g/l

3.28

924

4940

Vascular dementia

456

3211

1.41

10.21

5.9

6.2

118.60

118.09

g/l

0.21

440

3123

Sequelae of injuries of upper limb

419

3019

1.43

10.19

9.2

8.8

121.71

123.50

g/l

0.94

399

2938

Meningitis

220

1397

1.65

10.13

10.3

9.5

120.02

122.75

g/l

1.15

213

1359

Coxibs

1352

5885

1.23

10.11

6.9

8.9

123.14

120.08

g/l

5.77

1318

5720

Psoriasis vulgaris

820

6508

1.29

10.06

8.9

8.8

122.21

122.31

g/l

0.04

801

6334

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

640

4917

1.33

10.05

8.2

9.0

121.58

123.63

g/l

1.69

621

4786

Tuberculosis, IBD comorbidity

343

2397

1.48

10.01

8.2

7.1

119.23

120.41

g/l

0.49

332

2335

Entropion and trichiasis of eyelid

436

3182

1.42

10.01

6.8

7.3

117.93

119.50

g/l

0.96

429

3088

Disorders of vitreous body

2385

20146

1.16

9.98

8.1

7.9

119.83

120.59

g/l

1.07

2323

19616

Other benign neoplasms of skin

1719

14698

1.19

9.81

6.9

7.7

120.81

120.72

g/l

0.06

1665

14284

Benign neoplasm: Bronchus and lung

401

2.29

9.77

10.0

7.3

124.78

120.82

g/l

1.06

393

Pedestrian injured in transport accident

297

2027

1.52

9.77

8.8

8.6

119.87

122.63

g/l

1.52

290

1968

Coeliac disease

476

3522

1.39

9.75

8.0

7.9

119.35

122.52

g/l

2.67

461

3422

Calcific tendinitis of shoulder

245

1607

1.58

9.74

6.4

9.6

122.14

122.04

g/l

0.02

236

1565

Crohn's disease of large intestine

210

1330

1.64

9.73

10.4

8.5

117.52

123.92

g/l

4.77

203

1298

Injury of muscle and tendon at shoulder and upper arm level

1742

14934

1.19

9.72

7.5

8.6

122.99

122.52

g/l

0.42

1688

14532

Lifestyle-related condition

296

2.49

9.70

8.6

7.9

116.68

121.76

g/l

1.18

287

Memory loss

444

3269

1.41

9.67

7.0

7.4

119.95

119.76

g/l

0.07

429

3174

Mouth breathing

1829

15713

1.18

9.66

8.0

9.0

125.31

122.80

g/l

5.54

1772

15282

Contact with heat and hot substances

230

1494

1.60

9.59

8.1

9.6

121.46

123.60

g/l

0.79

224

1453

Other and unspecified urticaria

729

5729

1.30

9.59

8.5

8.0

123.33

121.65

g/l

1.39

705

5563

Other diseases of blood and blood-forming organs

323

2254

1.49

9.58

10.3

8.7

127.85

122.19

g/l

3.24

318

2185

Postmenopausal atrophic vaginitis

739

5181

0.77

9.58

5.3

7.6

120.48

117.70

g/l

3.98

730

5042

Menorrhagia

1300

5978

1.22

9.57

7.3

7.5

120.32

117.90

g/l

4.38

1262

5810

Ovarian dysfunction

194

1203

1.65

9.54

6.6

6.9

125.57

121.20

g/l

2.79

188

1172

Crushed, pushed or stepped on by crowd or human stampede

261

1741

1.54

9.46

8.6

9.5

123.58

125.47

g/l

0.74

254

1694

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

135

3.44

9.46

12.5

9.9

115.90

124.47

g/l

1.45

129

Striking against or struck by other objects

1358

11400

1.21

9.43

9.2

9.0

123.47

123.59

g/l

0.07

1320

11081

Dislocation, sprain and strain of joints and ligaments of thorax

152

896

1.78

9.43

6.7

9.2

125.18

122.64

g/l

0.77

147

875

Malignant neoplasm of breast, ER-negative, including Hilmo

759

5719

1.29

9.40

6.8

6.6

117.51

120.01

g/l

3.41

748

5540

Parkinson's disease, including avohilmo

798

6384

1.28

9.37

5.6

7.5

122.10

120.02

g/l

2.14

771

6211

Tuberculosis, wide

352

2505

1.45

9.33

8.2

7.2

119.21

120.21

g/l

0.39

341

2437

Thyrotoxicosis with toxic multinodular goitre

277

1889

1.53

9.29

6.6

7.5

120.71

119.06

g/l

0.68

272

1837

Ocular pain

322

2254

1.47

9.23

7.7

8.5

123.01

121.78

g/l

0.52

317

2195

Viral infections of the central nervous system

316

2206

1.48

9.22

7.5

8.8

123.39

122.79

g/l

0.20

310

2144

Non-small cell lung cancer, squamous, helper endpoint

245

1635

1.57

9.15

7.8

7.3

120.28

120.48

g/l

0.06

239

1594

Mental and behavioural disorders due to hallucinogens

3.71

9.05

5.0

14.1

132.03

130.55

g/l

0.17

Excessive vomiting in pregnancy

239

1578

1.55

9.04

4.7

7.6

122.57

120.37

g/l

1.11

231

1537

Crohn's disease of small intestine

272

1858

1.51

8.89

8.9

8.6

120.81

124.27

g/l

1.88

267

1809

Malignant melanoma of skin, including Hilmo

604

4693

1.32

8.87

6.9

7.9

120.49

122.92

g/l

2.22

586

4566

Other and unspecified intracranial injuries

142

837

1.79

8.87

9.9

8.9

121.39

122.11

g/l

0.13

137

815

Superficial injury of wrist and hand

748

5954

1.28

8.86

8.4

8.7

124.85

122.42

g/l

2.52

734

5784

Allergic urticaria

302

2104

1.47

8.85

7.1

8.5

121.54

121.83

g/l

0.08

289

2042

Otitis externa

916

7471

1.25

8.80

7.7

8.2

123.31

121.87

g/l

1.37

895

7256

Disorders of refraction and accommodation

982

8024

1.24

8.80

9.3

8.3

123.26

122.25

g/l

0.83

961

7785

Rare circulating lymphoid malignancy, including Hilmo

135

787

1.81

8.78

7.7

8.6

112.38

123.41

g/l

6.05

130

771

Restless leg syndrome

569

4398

1.33

8.75

6.8

8.0

121.46

121.06

g/l

0.19

555

4268

Other benign neoplasms of connective and other soft tissue

418

3092

1.39

8.73

7.7

8.3

122.39

122.07

g/l

0.12

409

3008

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

708

5618

1.28

8.69

8.7

9.0

121.63

123.44

g/l

1.53

688

5471

Infective bursitis

154

937

1.75

8.68

10.3

9.9

120.67

123.25

g/l

0.76

148

912

Acute lymphadenitis

220

1445

1.57

8.68

9.3

9.2

122.92

123.47

g/l

0.14

215

1404

Need for immunization against other single viral diseases

102

551

1.99

8.67

14.9

10.1

109.53

123.57

g/l

10.25

102

541

Psoriatic and enteropathic arthropathies

464

3486

1.36

8.66

7.4

8.8

122.31

122.66

g/l

0.14

452

3392

Other and unspecified mononeuropathies, also in other diseases

142

844

1.78

8.66

7.7

8.9

119.22

120.47

g/l

0.27

137

824

Fourth [trochlear] nerve palsy

119

676

1.89

8.63

7.8

8.4

120.71

120.20

g/l

0.10

119

659

Secondary malignant neoplasm of respiratory and digestive organs

475

2.08

8.62

5.2

6.9

116.20

121.79

g/l

1.84

464

Isolated proteinuria

137

810

1.79

8.54

8.6

9.1

118.45

122.23

g/l

1.15

137

788

Acute bronchiolitis

165

909

1.67

8.52

9.0

122.54

124.06

g/l

0.39

160

891

Viral infections of the central nervous system

294

2058

1.47

8.51

7.7

8.8

123.17

122.68

g/l

0.15

288

2002

Corneal ulcer

752

6028

1.27

8.49

8.1

8.2

122.17

122.55

g/l

0.19

731

5860

Personal history of malignant neoplasm

253

1721

1.52

8.47

8.2

6.9

118.52

120.85

g/l

1.26

248

1667

Retinal detachments and breaks

1729

14980

1.17

8.45

8.0

7.8

119.68

121.34

g/l

2.75

1687

14551

Seronegative rheumatoid arthritis

486

3693

1.35

8.44

8.3

7.9

117.68

120.80

g/l

3.05

477

3588

Disorders of purine and pyrimidine metabolism

161

3.02

8.43

12.2

9.0

116.71

123.50

g/l

1.09

154

Temporomandibular joint disorders, including avohilmo

1558

13171

1.18

8.42

6.5

8.0

123.01

121.33

g/l

2.83

1517

12800

Seborrhoeic dermatitis

427

3190

1.38

8.41

8.7

7.8

123.65

122.71

g/l

0.39

409

3105

Malignant neoplasm of breast, HER-negative

681

5298

1.28

8.39

6.7

6.6

117.80

119.87

g/l

2.26

671

5125

Insomnia

3845

25381

1.11

8.37

7.4

8.3

123.59

121.72

g/l

6.75

3763

24654

Other keratitis

447

3359

1.36

8.36

9.2

8.3

121.20

122.97

g/l

1.03

437

3273

Acne

271

1861

1.48

8.35

11.1

9.3

122.67

125.13

g/l

1.06

266

1807

Intentional self-harm by jumping from a high place

3.49

8.34

21.5

13.6

118.32

125.31

g/l

0.93

Dementia

2221

13443

1.15

8.33

5.4

7.1

120.39

119.53

g/l

1.19

2155

13081

Chondrocostal junction syndrome [Tietze]

159

983

1.69

8.28

7.0

8.4

125.15

120.15

g/l

2.58

154

957

Spondylopathies (FG)

516

3961

1.33

8.23

7.4

8.8

121.25

123.13

g/l

1.28

506

3857

Ulcerative colitis (strict definition, require KELA)

651

5155

1.29

8.17

8.4

8.9

121.52

123.54

g/l

1.68

631

5018

Lesion of sciatic nerve

215

1433

1.57

8.16

6.3

7.0

122.88

119.84

g/l

1.35

209

1390

Nontoxic goitre/thyroid nodule

1251

10607

1.20

8.03

5.9

7.1

120.35

119.21

g/l

1.27

1227

10301

Biological medication for rheuma

612

4819

1.29

8.01

9.2

9.0

120.86

123.64

g/l

2.68

600

4686

Otitis externa, unspecified

435

3281

1.36

7.96

7.4

8.3

124.54

122.73

g/l

1.15

422

3191

Erosion of teeth , including avohilmo

892

7329

1.23

7.94

10.7

8.3

122.31

122.80

g/l

0.28

868

7107

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

292

2066

1.45

7.91

7.1

7.4

119.06

119.93

g/l

0.31

284

2006

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

199

1313

1.58

7.88

6.8

9.5

122.88

121.60

g/l

0.37

194

1282

Background retinopathy and retinal vascular changes

107

605

1.89

7.88

11.0

8.6

114.67

120.82

g/l

1.80

593

Tumor necrosis factor alpha inhibitors

542

4215

1.31

7.85

9.2

8.9

120.52

123.73

g/l

3.00

531

4104

Sicca syndrome [Sjögren]

343

2504

1.41

7.84

8.2

7.7

117.44

119.21

g/l

0.99

333

2433

Hypertension, portal

3.78

7.76

13.9

8.4

105.18

122.35

g/l

2.95

Acne vulgaris

208

1378

1.54

7.75

11.4

9.1

123.51

125.74

g/l

0.77

203

1339

Plantar fascial fibromatosis

377

2799

1.38

7.68

6.9

8.6

121.18

121.21

g/l

0.01

368

2721

Coarctation of the aorta

215

2.52

7.66

24.6

11.8

116.64

125.00

g/l

1.89

208

Disorders of tooth development and eruption

591

3757

1.29

7.65

8.9

8.1

122.06

123.25

g/l

0.69

575

3654

Lichen simplex chronicus

159

1006

1.66

7.64

9.6

8.1

121.09

122.27

g/l

0.29

152

978

conjunctival haemorrhage

352

2601

1.40

7.59

9.5

7.9

119.33

120.83

g/l

0.69

341

2526

Alzheimer disease

1619

10283

1.17

7.52

4.6

6.4

119.85

118.65

g/l

1.61

1574

9984

Spontaneous rupture of synovium and tendon

358

2653

1.39

7.49

7.4

8.5

122.34

121.39

g/l

0.38

350

2574

Tooth eruption problems

379

2745

1.37

7.48

9.3

9.1

120.44

123.84

g/l

2.54

361

2678

Suppurative and unspecified otitis media

1244

9368

1.19

7.48

9.1

8.5

123.76

123.10

g/l

0.50

1212

9099

Parkinson's disease

748

6100

1.26

7.48

5.4

7.6

122.24

120.02

g/l

2.25

722

5940

Malignant melanoma, including Hilmo

711

5755

1.26

7.47

7.0

7.8

120.79

122.73

g/l

1.75

690

5593

Atrophic disorders of skin

560

4413

1.29

7.40

6.4

7.6

120.84

120.61

g/l

0.10

541

4281

Other and unspecified mononeuropathies of upper limb

129

780

1.73

7.39

7.2

10.7

121.81

121.93

g/l

0.02

123

762

Adalimumab

345

2543

1.39

7.36

9.0

121.43

124.11

g/l

1.45

337

2479

Rash and other nonspecific skin eruption

395

2977

1.36

7.36

8.4

8.3

119.59

120.86

g/l

0.61

387

2894

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1084

9142

1.20

7.34

7.9

8.8

125.24

122.83

g/l

3.41

1065

8883

Blepharochalasis

1348

11597

1.18

7.33

6.9

7.6

121.41

119.50

g/l

2.94

1307

11263

Ulcerative colitis (strict) with PSC

166

2.70

7.21

17.5

8.3

118.71

125.92

g/l

1.11

158

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

143

870

1.65

7.18

13.2

10.2

123.78

125.83

g/l

0.48

138

844

Supervision of normal pregnancy

320

2504

0.72

7.18

5.5

9.2

123.21

121.39

g/l

1.06

315

2452

Acetic acid derivatives and related substances

1322

5851

1.19

7.16

7.0

9.0

122.64

120.03

g/l

4.41

1295

5686

Atopic dermatitis, strict definition with reimbursement

967

7804

1.21

7.12

7.5

8.4

122.95

123.11

g/l

0.08

943

7575

Inguinal or femoral hernia, bilateral

526

4150

1.30

7.09

7.8

8.2

123.03

122.96

g/l

0.02

513

4011

Benign neoplasm of ovary

656

5295

1.26

7.09

6.7

6.8

118.10

118.51

g/l

0.24

643

5145

Superficial injury of shoulder and upper arm

459

3550

1.32

7.08

6.0

7.9

122.89

122.61

g/l

0.11

450

3453

Pleural plaque with presence of asbestos

394

3004

1.36

7.05

6.0

7.8

126.23

120.65

g/l

6.22

382

2921

Perforation of tympanic membrane

412

3146

1.34

7.03

9.5

7.8

121.35

121.99

g/l

0.26

396

3055

Giant cell arteritis

206

1409

1.53

7.03

7.4

7.3

118.89

119.31

g/l

0.12

200

1367

Erythema multiforme

106

618

1.81

7.01

7.8

8.6

120.40

121.07

g/l

0.11

605

Inguinal hernia, bilateral

517

4078

1.30

6.99

7.8

8.3

123.04

123.05

g/l

0.00

504

3943

Glucosamine medication

2364

16874

1.13

6.96

6.7

7.4

119.30

119.62

g/l

0.34

2309

16406

Endometriosis

1227

6127

1.19

6.86

6.3

7.4

120.78

118.10

g/l

5.23

1192

5956

Open wound of shoulder and upper arm

518

1.88

6.85

6.9

9.4

118.07

122.31

g/l

1.11

503

Preterm labour and delivery

793

6546

1.23

6.77

6.6

8.0

121.72

119.81

g/l

2.23

772

6348

Sixth [abducent] nerve palsy

161

1054

1.60

6.76

8.7

8.4

119.01

121.34

g/l

0.75

156

1027

Thyroiditis

265

1904

1.43

6.71

8.4

8.3

123.04

120.59

g/l

1.32

257

1858

Orthopaedic devices associated with adverse incidents

609

0.32

6.69

7.2

7.1

117.95

120.18

g/l

0.25

596

Bacterial, viral and other infectious agents

353

2655

1.36

6.69

10.3

9.5

120.98

124.73

g/l

2.69

346

2587

Reactive arthropathies, FINNGEN

272

1964

1.42

6.68

10.5

9.0

119.07

123.41

g/l

2.89

265

1907

Medial epicondylitis

151

975

1.61

6.61

5.9

10.6

127.03

122.97

g/l

1.43

146

946

Autoimmune hyperthyroidism

222

1549

1.47

6.60

7.7

7.5

122.25

121.45

g/l

0.24

215

1499

Achilles tendinitis

413

3183

1.33

6.58

8.6

9.3

125.29

121.38

g/l

3.10

408

3096

Reactive arthropathies

344

2584

1.36

6.58

10.6

8.7

119.28

122.84

g/l

2.52

337

2510

Other and unspecified psoriasis

297

2189

1.40

6.55

11.2

8.9

121.03

122.19

g/l

0.42

291

2124

Other disorders of white blood cells

238

1691

1.46

6.55

10.6

8.5

115.60

121.62

g/l

4.21

227

1648

Other disorders starting during childhood or adolescence

120

722

1.68

6.54

14.2

9.7

122.75

125.61

g/l

0.70

115

700

Scabies

462

3609

1.30

6.53

8.0

8.8

125.69

124.16

g/l

0.82

448

3517

Pedal cyclist injured in transport accident

874

7319

1.21

6.52

7.6

8.5

122.73

122.87

g/l

0.07

843

7125

Bronchitis, not specified as acute or chronic

339

2545

1.36

6.50

8.6

122.22

121.30

g/l

0.35

328

2479

Burn and corrosion of trunk

130

816

1.67

6.50

10.9

9.1

123.26

122.74

g/l

0.10

125

798

Hepatomegaly and splenomegaly, not elsewhere classified

246

2.30

6.49

15.5

8.6

111.88

121.29

g/l

2.26

241

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

391

3006

1.34

6.46

8.7

8.2

120.13

121.71

g/l

0.79

386

2923

Lymphoid leukaemia

257

1858

1.43

6.44

9.8

8.0

113.14

121.62

g/l

8.15

250

1804

Tuberculosis

283

2077

1.40

6.40

8.2

7.3

119.50

120.03

g/l

0.16

276

2018

Degeneration of nervous system due to alcohol

122

763

1.71

6.37

11.5

9.9

117.55

122.94

g/l

1.97

122

741

Postmenopausal bleeding

1146

5215

1.19

6.37

6.7

7.5

119.52

117.53

g/l

3.00

1113

5072

Atypical facial pain

201

1390

1.49

6.35

7.3

8.8

123.59

120.29

g/l

1.63

196

1355

Ulcerative enterocolitis

127

796

1.66

6.35

10.9

8.7

116.48

122.81

g/l

2.60

122

775

Use of ropinirole

182

1244

1.54

6.34

5.5

8.9

124.83

121.31

g/l

1.60

174

1211

Hallux rigidus

586

4739

1.26

6.31

7.5

8.3

120.10

120.16

g/l

0.02

572

4613

Degeneration of the brain due to alcohol

122

765

1.70

6.31

11.5

10.3

117.55

122.62

g/l

1.79

122

741

Hypermetropia

253

1822

1.42

6.29

7.5

8.4

121.89

122.22

g/l

0.09

245

1768

Ganglion

768

6376

1.22

6.26

7.0

8.4

122.63

121.49

g/l

0.80

747

6213

Disease of hard tissues of teeth, NOS

2718

12843

1.12

6.22

7.3

8.0

123.40

121.76

g/l

3.74

2642

12492

Nosocomial condition (hospital)

155

2.67

6.21

8.1

6.5

111.97

120.79

g/l

1.99

150

Benign lipomatous neoplasm

1291

11214

1.17

6.21

7.3

8.2

123.58

121.25

g/l

3.98

1253

10906

Injury of muscle and tendon at wrist and hand level

577

4671

1.26

6.18

8.2

9.2

123.70

123.27

g/l

0.19

565

4547

Use of levodopa decarboxylase inhibitor

664

5465

1.24

6.18

5.4

7.4

122.20

119.85

g/l

2.28

644

5315

Aspergillosis

247

2.28

6.11

12.1

7.3

119.92

122.04

g/l

0.36

241

Dementia, including avohilmo

2340

14484

1.12

6.09

5.5

7.2

120.41

119.50

g/l

1.39

2273

14104

UC patients in KELA-register (code 208), prior to 1994

198

1382

1.49

6.08

11.0

9.0

120.04

122.50

g/l

0.87

192

1345

Visual impairment including blindness (binocular or monocular)

290

2154

1.38

6.08

9.2

7.4

118.65

120.37

g/l

0.83

284

2087

Herpesviral [herpes simplex] infections

872

7349

1.20

6.05

7.9

8.0

120.40

121.84

g/l

1.33

854

7133

Melanocytic naevi, other sites/unspecified

319

2404

1.36

6.05

6.7

8.9

120.36

122.35

g/l

0.92

309

2337

Maternal care for other conditions predominantly related to pregnancy

515

4028

1.27

6.05

8.8

8.0

121.51

120.94

g/l

0.28

497

3921

Alzheimer disease, including avohilmo

1851

11592

1.14

6.02

4.8

6.6

120.06

118.84

g/l

1.87

1800

11268

Impaction of intestines

176

2.50

5.99

14.3

7.5

115.65

120.72

g/l

0.80

169

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

271

1991

1.39

5.97

8.1

9.4

125.30

124.53

g/l

0.24

265

1941

Parkinson's disease, strict definition

684

5667

1.23

5.96

5.5

7.5

122.12

119.92

g/l

2.10

660

5514

Dermatographic urticaria

227

1622

1.43

5.96

5.9

8.6

124.42

121.66

g/l

1.22

217

1578

Bacterial, viral and other infectious agents

330

2504

1.35

5.95

10.1

9.7

121.05

124.76

g/l

2.46

324

2439

Exposure to excessive natural heat

4.06

5.88

7.3

7.5

120.42

123.02

g/l

0.19

Bullous disorders

260

1915

1.40

5.84

6.8

8.0

117.75

120.62

g/l

1.45

255

1858

Isolated proteinuria with specified morphological lesion

314

2.06

5.77

6.9

7.6

113.40

122.05

g/l

2.14

306

Other disorders of penis

433

3431

1.29

5.68

9.1

9.8

125.18

123.99

g/l

0.51

420

3348

Seronegative juvenile rheumatoid arthritis

277

2.06

5.67

10.7

9.4

116.82

123.25

g/l

1.54

268

Personal history of medical treatment

246

2.19

5.66

12.4

7.1

119.14

121.25

g/l

0.27

240

Other and unspecified disorders of white blood cells

176

1219

1.50

5.65

9.7

9.2

115.39

120.90

g/l

2.66

167

1191

Inflammatory disorders of breast

191

1335

1.46

5.65

6.7

7.5

120.04

120.35

g/l

0.08

185

1299

Other specified and unspecified retinal disorders

162

1106

1.53

5.63

7.6

8.5

119.91

121.01

g/l

0.28

157

1078

Pedal cyclist injured in other and unspecified transport accidents

433

3432

1.29

5.60

7.6

8.6

122.63

123.25

g/l

0.23

414

3345

Phantom limb syndrome with pain

3.68

5.57

10.6

7.4

118.70

123.30

g/l

0.39

Otalgia

289

2174

1.36

5.56

7.6

8.4

123.91

121.21

g/l

1.48

282

2117

Other disorders of bone density and structure

606

1.70

5.49

7.0

8.9

127.12

121.28

g/l

2.08

590

Migraine without aura, drug-induced

221

2.21

5.48

4.8

10.1

126.30

121.28

g/l

0.97

216

Hyphaema and other vascular disorders of iris and ciliary body

100

618

1.71

5.47

8.2

7.8

117.13

120.97

g/l

1.08

100

600

Dental pulpitis, including avohilmo

3953

23741

1.09

5.47

8.4

8.7

124.82

122.46

g/l

9.94

3839

23099

Postzoster neuralgia

490

1.81

5.44

7.1

7.5

115.23

120.18

g/l

1.53

477

Polycystic ovarian syndrome, broad definition

234

1701

1.39

5.44

7.5

6.6

127.01

121.05

g/l

5.42

228

1652

Injury of eye and orbit

532

4327

1.25

5.44

9.0

8.8

124.75

124.25

g/l

0.21

518

4203

Acute appendicitis, with complications

828

7030

1.20

5.41

9.5

8.4

122.23

122.09

g/l

0.07

810

6847

Diseases of tongue

251

1860

1.39

5.38

6.7

7.5

120.30

121.07

g/l

0.24

242

1801

Infections of genitourinary tract in pregnancy

273

2044

1.36

5.35

6.6

7.7

121.17

119.74

g/l

0.61

266

1989

Female genital prolapse

1139

5572

1.17

5.32

5.8

7.4

119.31

117.77

g/l

2.03

1099

5421

Colonic or urogenital fistula

1140

9933

1.16

5.32

8.9

8.2

120.99

121.92

g/l

0.81

1111

9655

Nonspecific lymphadenitis

216

1565

1.42

5.30

8.2

8.9

122.52

123.49

g/l

0.30

209

1524

Respiratory tuberculosis, confirmed and not-confirmed

243

1801

1.39

5.26

8.5

7.7

119.92

119.97

g/l

0.01

236

1753

Respiratory tuberculosis

243

1801

1.39

5.26

8.5

7.7

119.92

119.97

g/l

0.01

236

1753

Inflammatory diseases of prostate (prostatitis)

611

5081

1.23

5.17

7.5

9.6

126.07

123.64

g/l

1.96

587

4965

Scar conditions and fibrosis of skin

144

975

1.52

5.14

7.2

8.7

121.84

121.19

g/l

0.14

136

945

Temporal arteritis

174

1230

1.48

5.12

7.6

7.1

119.36

119.31

g/l

0.01

169

1193

Diseases of external ear

1455

12921

1.14

5.08

7.4

8.0

122.48

121.67

g/l

0.82

1420

12557

Atopic dermatitis, strict definition

908

7630

1.18

5.08

7.6

8.7

122.86

123.17

g/l

0.17

886

7423

Lichen planus

536

4408

1.24

5.06

6.9

8.0

121.18

120.65

g/l

0.24

520

4271

Other female pelvic inflammatory diseases

543

4462

1.23

5.06

7.3

6.9

121.75

118.87

g/l

3.09

525

4331

Acute epiglottitis

402

1.84

5.00

10.6

8.4

121.60

124.31

g/l

0.53

392

Malignant neoplasm of other and unspecified parts of mouth

159

2.45

4.98

10.7

6.5

114.00

124.11

g/l

2.25

159

Other menopausal disorders

755

5025

0.84

4.96

6.7

7.8

120.12

118.19

g/l

2.08

737

4891

Epidermolysis bullosa

6.69

4.95

19.9

7.0

116.92

121.41

g/l

0.34

Perineal laceration during delivery

223

2521

0.73

4.93

5.7

7.5

120.82

122.10

g/l

0.45

216

2450

Premature rupture of membranes

339

3103

0.77

4.92

7.9

122.24

121.30

g/l

0.41

326

3022

Effects of other external causes

103

655

1.63

4.90

6.5

10.0

128.89

124.65

g/l

1.25

103

636

Deficiency of other B group vitamins

580

1.68

4.90

10.7

8.2

118.47

120.40

g/l

0.40

568

Benign neoplasm of major salivary glands

423

3408

1.27

4.89

10.1

8.1

120.73

121.35

g/l

0.24

413

3309

Convergent concomitant strabismus

184

1315

1.43

4.89

12.8

9.4

121.14

123.22

g/l

0.65

177

1278

Disorders of conjunctiva

3576

26622

1.08

4.87

8.3

8.1

121.69

121.63

g/l

0.07

3496

25878

Malignant melanoma of skin

432

3487

1.26

4.86

7.5

7.9

120.48

122.85

g/l

1.68

422

3395

Residual foreign body in soft tissue

196

1421

1.42

4.85

8.7

9.7

122.99

124.05

g/l

0.27

191

1384

Medical abortion

2308

11369

1.11

4.83

6.8

7.1

119.49

118.57

g/l

1.48

2258

11048

Polypectomy (DHB20)

296

2290

1.33

4.82

8.3

8.9

123.95

123.06

g/l

0.30

281

2226

Disorders of urea cycle metabolism

10.41

4.79

11.2

8.2

116.11

114.83

g/l

—

Giant cell arteritis with polymyalgia rheumatica

174

1246

1.46

4.79

7.6

7.2

119.36

119.32

g/l

0.01

169

1209

Chromosomal abnormalities, not elsewhere classified

382

1.81

4.77

12.7

11.2

128.85

123.96

g/l

1.07

371

Ankylosing spondylitis

326

2550

1.30

4.76

7.8

9.2

119.90

122.72

g/l

1.76

319

2486

Ulcerative colitis (strict definition, all Crohn cases excluded)

527

4348

1.23

4.76

7.9

8.7

121.83

123.73

g/l

1.28

515

4231

Other and unspecified follicular disorders

158

1109

1.47

4.75

7.4

10.0

124.32

123.78

g/l

0.11

152

1081

Anti-inflammatory and antirheumatic products, non-steroids

1352

5994

1.14

4.74

8.3

9.0

122.31

120.15

g/l

3.09

1312

5827

Benign neoplasm: Parotid gland

338

2665

1.30

4.73

10.9

8.4

120.86

121.69

g/l

0.29

333

2587

Toxic effect of other gases, fumes and vapours

136

2.49

4.72

9.0

11.7

129.97

125.56

g/l

0.47

131

Benign neoplasm: salivary glands, exclude unknown (D119)

374

2986

1.28

4.71

10.6

8.3

121.00

121.70

g/l

0.26

368

2899

Effects of foreign body entering through natural orifice

992

8639

1.16

4.71

8.5

9.1

125.31

123.55

g/l

1.89

958

8414

Malignant melanoma

562

4679

1.22

4.67

7.7

7.8

120.77

122.93

g/l

1.75

548

4549

Hyperkinetic disorders (excl. ADHD)

252

1.99

4.66

6.1

11.7

127.08

126.97

g/l

0.01

243

Other disorders of patella

595

4974

1.21

4.65

7.6

9.2

123.20

122.45

g/l

0.40

583

4846

Malignant neoplasm of palate

3.26

4.64

12.2

8.4

113.00

125.08

g/l

1.55

Benign neoplasm: Skin of eyelid, including canthus

661

5593

1.20

4.63

6.9

7.7

120.08

120.46

g/l

0.18

642

5430

Disorders of optic nerve, not elsewhere classified

638

1.63

4.63

8.2

9.0

117.66

121.11

g/l

0.79

623

Bicipital tendinitis

198

1453

1.40

4.62

7.6

9.3

126.57

122.73

g/l

1.69

192

1412

Myopia

394

3161

1.26

4.61

9.1

8.3

123.49

123.41

g/l

0.02

386

3076

Haemangioma, any site

326

2565

1.30

4.60

6.3

8.5

121.20

121.92

g/l

0.26

319

2491

Other specified/unspecified bacterial intestinal infections

271

2086

1.33

4.57

9.0

8.2

118.38

121.82

g/l

2.01

264

2023

Other specified and unspecified disorders of eye and adnexa

152

1069

1.47

4.55

12.0

8.5

120.24

120.90

g/l

0.15

152

1040

Crohn disease (strict definition, require KELA, min 2 HDR)

215

1598

1.38

4.55

10.8

9.0

120.73

124.02

g/l

1.36

209

1552

Presbycusis

655

5494

1.20

4.55

5.9

6.5

117.75

118.28

g/l

0.28

623

5337

Crohn disease (strict definition, require KELA)

218

1624

1.37

4.55

10.6

9.0

121.07

124.09

g/l

1.20

212

1578

Hordeolum and other deep inflammation of eyelid

218

1627

1.37

4.53

8.0

8.9

124.50

122.32

g/l

0.81

212

1580

Haemangioma and lymphangioma, any site

347

2757

1.28

4.52

6.3

8.6

121.05

121.97

g/l

0.38

340

2679

Caught, crushed, jammed or pinched in or between objects

194

1423

1.40

4.52

9.8

126.13

125.00

g/l

0.29

184

1385

Caries of enamel

3399

26373

0.92

4.48

8.9

8.5

122.06

122.46

g/l

0.53

3333

25628

Deviated nasal septum

1492

13366

1.13

4.47

8.8

8.9

124.88

122.65

g/l

3.95

1441

12992

Retinal breaks without detachment

485

5853

0.82

4.46

8.7

8.3

120.79

121.69

g/l

0.45

468

5695

Certolizumab pegol

333

1.84

4.43

9.5

9.2

115.92

121.90

g/l

1.26

324

Congenital malformations of spine and bony thorax

133

2.42

4.42

11.1

11.5

120.57

123.40

g/l

0.34

128

Postpartum care and examination

303

1484

1.31

4.42

6.1

8.5

120.15

122.62

g/l

1.34

291

1448

Pediculosis, acariasis and other infestations

547

4562

1.21

4.41

8.0

8.7

124.81

123.50

g/l

0.75

532

4437

Other benign neoplasm of uterus: Other parts/unspecified

1345

0.62

4.40

4.6

5.4

117.46

116.94

g/l

0.11

1306

Other abnormal uterine and vaginal bleeding

854

5278

1.17

4.40

7.0

7.1

118.86

117.58

g/l

1.23

829

5132

Burns and corrosions of multiple body regions

221

2.08

4.40

11.9

10.0

124.40

122.11

g/l

0.23

216

Endometriosis diagnosis and infertility diagnosis occurring together

273

2106

1.31

4.39

5.2

7.4

121.73

120.98

g/l

0.28

265

2051

Benign neoplasm of mouth and pharynx

449

3685

1.24

4.39

8.1

8.2

120.94

121.78

g/l

0.37

439

3579

Effects of heat and light

201

2.15

4.39

11.3

9.7

124.15

121.72

g/l

0.28

193

Fall on and from ladder

349

2795

1.28

4.36

7.9

8.8

124.23

123.12

g/l

0.45

341

2719

Myeloproliferative diseases

357

2864

1.28

4.36

8.7

7.7

118.49

121.22

g/l

1.39

347

2781

Rhabdomyosarcoma

8.37

4.33

5.9

19.6

103.67

121.64

g/l

—

Speech therapy

1127

9968

1.14

4.31

9.2

7.9

119.19

120.82

g/l

2.00

1098

9696

Injury of muscle and tendon at hip and thigh level

375

3028

1.26

4.27

9.2

8.9

121.23

123.81

g/l

1.67

366

2944

False labour

736

3912

1.18

4.26

4.9

8.5

124.69

121.31

g/l

5.16

710

3804

Nonadministration of surgical and medical care

3.76

4.25

7.7

7.1

127.47

119.54

g/l

0.74

Prepatellar bursitis

192

1425

1.39

4.22

7.1

9.9

124.13

123.97

g/l

0.04

187

1386

Use of levodopa decarbox-comt-inhibitor

157

1133

1.45

4.21

4.6

8.0

123.19

120.66

g/l

0.86

152

1100

HSIL lesion of the cervix uteri, vagina or vulva

506

4207

1.21

4.19

7.4

7.2

119.69

120.65

g/l

0.55

494

4083

Exposure to other and unspecified man-made environmental factors

401

1.75

4.18

7.9

9.3

123.18

122.44

g/l

0.09

391

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

163

1179

1.42

4.14

6.3

9.7

124.40

123.50

g/l

0.23

158

1148

Psoriatic arthropathies

376

3047

1.25

4.13

7.5

9.0

122.78

122.34

g/l

0.15

367

2959

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

229

1746

1.34

4.12

10.4

8.8

121.05

124.27

g/l

1.38

223

1698

APECED

11.39

4.05

15.3

5.1

116.43

135.38

g/l

—

Amblyopia ex anopsia

135

949

1.46

4.04

9.2

8.8

124.18

121.85

g/l

0.59

129

922

Other and unspecified disorders of psychological development

128

2.30

4.03

6.9

14.9

128.00

126.64

g/l

0.12

123

Outcome of delivery

230

1862

0.76

4.03

6.4

9.0

119.93

122.15

g/l

1.07

224

1818

Other disorders of the genitourinary system

501

4195

1.21

4.01

8.6

7.2

119.56

119.03

g/l

0.26

484

4066

Superficial injury of neck

412

1.71

4.01

6.6

9.8

120.54

124.95

g/l

0.99

402

Bacterial meningitis

139

988

1.45

3.99

10.7

10.0

118.08

122.30

g/l

1.53

133

963

Vasomotor and allergic rhinitis

1367

12042

1.12

3.99

7.9

8.3

124.39

121.54

g/l

5.66

1331

11718

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

460

3815

1.22

3.95

7.1

7.0

121.59

119.36

g/l

1.90

453

3698

Certain zoonotic bacterial diseases

122

849

1.49

3.94

7.5

8.8

122.21

121.68

g/l

0.11

117

826

Propionic acid derivatives

1335

5994

1.13

3.90

8.5

9.0

122.78

120.15

g/l

4.34

1298

5827

Endometriosis of pelvic peritoneum

470

3728

1.21

3.88

5.9

8.2

121.78

118.86

g/l

2.92

457

3621

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

169

1250

1.40

3.86

10.0

9.1

119.71

121.68

g/l

0.54

164

1215

Localized adiposity

116

2.44

3.85

8.5

11.7

121.00

120.62

g/l

0.03

111

Motorcycle rider injured in other and unspecified transport accidents

197

1488

1.35

3.82

12.4

10.1

126.45

126.39

g/l

0.01

188

1454

Macular hole

256

2014

1.31

3.80

5.7

7.3

119.31

120.40

g/l

0.38

251

1950

Palmar fascial fibromatosis [Dupuytren]

705

6104

1.17

3.79

8.7

8.2

120.20

121.39

g/l

0.81

689

5945

Granulomatous disorders of skin and subcutaneous tissue

634

1.55

3.77

8.0

8.7

117.97

120.64

g/l

0.62

617

Disorders of vagus nerve

4.79

3.76

9.0

9.2

122.58

121.47

g/l

0.06

Pedal cyclist injured in noncollision transport accidents

412

3407

1.23

3.75

8.5

8.9

122.73

123.48

g/l

0.33

402

3316

Injury of muscle and tendon at lower leg level

615

5272

1.18

3.75

8.7

9.0

125.06

123.24

g/l

1.35

602

5146

Other and unspecified rosacea

320

2584

1.26

3.70

7.8

8.4

122.16

121.38

g/l

0.27

311

2517

Polyp of the female genital tract

1124

5741

1.13

3.67

6.6

7.4

119.33

117.85

g/l

1.81

1099

5584

Rhabdomyosarcoma, including Hilmo

4.13

3.66

7.9

13.3

112.00

124.43

g/l

1.09

Injury of nerves at wrist and hand level

147

1072

1.41

3.65

11.1

10.2

119.74

124.15

g/l

1.71

141

1042

Polyglandular dysfunction

3.14

3.65

10.1

17.4

115.50

123.03

g/l

0.90

Mixed conductive and sensorineural hearing loss

524

4449

1.20

3.64

7.0

7.6

120.72

120.37

g/l

0.15

508

4319

Beningn neoplasm: Meninges, unspecified

450

1.66

3.63

7.7

6.9

122.28

120.55

g/l

0.32

442

Other and unspecified mental retardation

307

1.78

3.63

7.9

13.5

126.89

123.91

g/l

0.40

295

Use of antiglaucoma preparations and miotics

349

2856

1.25

3.62

7.0

6.5

118.15

119.06

g/l

0.37

337

2781

Unspecific neurodegenerative disorder

2092

13164

1.10

3.61

4.9

7.0

120.29

119.22

g/l

1.64

2029

12812

Other and unspecified haemorrhagic conditions

419

1.67

3.59

11.6

8.1

113.25

121.19

g/l

2.54

411

Disorders of synovium and tendon in diseases classified elsewhere

611

1.55

3.58

6.2

9.5

125.06

123.21

g/l

0.36

591

Hypertrichosis

332

1.73

3.58

8.0

7.5

126.96

121.02

g/l

1.44

326

Other disorders of cornea

379

3129

1.23

3.57

8.4

7.9

120.55

121.87

g/l

0.62

369

3035

Hyposplenism

4.37

3.57

7.7

23.3

106.58

127.45

g/l

1.87

Other facial nerve disorders

107

741

1.49

3.57

6.3

10.1

125.59

120.22

g/l

2.06

100

723

Cardiovascular devices associated with adverse incidents

5.39

3.53

29.4

7.0

121.20

122.79

g/l

—

Other disorders of conjunctiva

601

5174

1.18

3.52

9.3

7.7

120.05

120.75

g/l

0.36

583

5020

Arthropathy in ulcerative colitis

321

1.77

3.52

8.4

10.5

121.37

122.04

g/l

0.10

312

Haemorrhage in early pregnancy

776

6609

1.15

3.48

5.7

7.8

122.24

119.74

g/l

3.24

752

6428

Excessive attrition of teeth

2214

20491

1.09

3.45

7.9

8.5

123.44

122.32

g/l

1.80

2159

19915

Hypersomnia

354

1.72

3.43

9.7

10.6

126.93

121.27

g/l

1.17

347

Conjunctivitis

3078

24052

1.07

3.43

8.2

8.1

121.95

121.57

g/l

0.49

3010

23382

Nonalcoholic steatohepatitis

213

1.95

3.41

7.8

11.2

115.79

123.60

g/l

1.39

206

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

274

2203

1.27

3.39

7.2

8.7

125.18

122.47

g/l

1.34

266

2144

Hypersplenism

117

2.35

3.38

8.0

11.1

111.84

122.56

g/l

1.56

117

Typhoid and paratyphoid fevers

172

2.06

3.34

10.6

6.9

118.36

121.80

g/l

0.42

167

Chronic thyroiditis

2.47

3.33

5.7

5.3

122.73

120.83

g/l

0.21

Other/unspecified reactive arthropathies

240

1902

1.29

3.32

11.1

9.0

119.22

122.88

g/l

2.03

234

1849

Melanocytic naevi of other and unspecified parts of face

208

1621

1.31

3.29

6.0

8.5

123.64

121.64

g/l

0.76

202

1579

Folate deficiency anaemia

276

1.81

3.28

11.4

9.6

107.94

121.38

g/l

3.39

271

Noninflammatory disorders of female genital tract

1416

6434

1.11

3.27

6.6

7.4

119.70

118.15

g/l

2.27

1376

6257

Chondropathies

547

4701

1.18

3.25

7.7

8.7

123.79

122.85

g/l

0.51

528

4568

Diseases of middle ear and mastoid

2184

16548

1.08

3.24

8.5

8.3

123.12

122.49

g/l

0.71

2121

16092

Amputation of ankle

4.00

3.23

10.4

6.6

112.33

120.54

g/l

0.64

Nasal polyp

826

7316

1.14

3.22

7.6

8.5

125.02

121.88

g/l

4.37

799

7113

Prolonged pregnancy

216

2403

0.78

3.21

5.7

8.1

120.32

121.58

g/l

0.43

208

2345

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

519

4453

1.18

3.20

7.1

8.5

124.66

121.95

g/l

2.30

504

4326

Soft tissue disorders in diseases classified elsewhere

6.12

3.20

3.9

12.2

122.75

119.29

g/l

—

Endometriosis ASRM stages 1,2

484

4121

1.19

3.19

6.0

7.4

121.71

120.13

g/l

1.14

470

4002

Macular pucker

706

6204

1.16

3.19

7.6

7.4

118.15

120.52

g/l

2.53

689

6023

Tularaemia

529

1.55

3.19

5.7

9.7

123.88

122.27

g/l

0.30

517

Other osteochondrodysplasias

270

1.79

3.17

8.3

9.8

116.76

120.98

g/l

0.75

264

Malignant neoplasm of testis

385

1.65

3.17

13.0

10.7

120.33

129.16

g/l

2.36

373

Lichen planus, including avohilmo

758

6687

1.15

3.16

7.0

7.9

121.44

120.67

g/l

0.49

735

6501

Ulcerative rectosigmoiditis

295

2408

1.25

3.14

8.8

8.5

122.34

123.93

g/l

0.66

289

2343

Osteitis due to dental implant

213

1.92

3.14

13.4

9.6

113.76

121.13

g/l

1.51

208

Alcohol induced polyneuropathy

319

1.74

3.12

14.7

9.5

119.29

121.02

g/l

0.21

312

Bitten or struck by other mammals

361

3009

1.21

3.09

10.1

8.5

122.90

123.10

g/l

0.07

354

2930

Albinism

8.52

3.07

2.8

6.9

127.50

123.33

g/l

—

Spasmodic torticollis

116

841

1.42

3.05

5.5

7.6

123.93

120.67

g/l

1.06

116

820

Flatulence and related conditions

243

1.81

3.05

7.9

116.83

119.59

g/l

0.34

237

Nonsuppurative otitis media

702

5329

1.15

3.05

10.1

8.2

123.16

122.89

g/l

0.13

684

5167

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

6.56

3.04

3.5

10.3

137.25

115.55

g/l

—

Cysts of oral region, not elsewhere classified

228

1819

1.28

3.04

8.0

9.3

122.82

123.16

g/l

0.08

217

1771

Benign neoplasm of eye and adnexa

411

3481

1.20

3.02

7.8

7.7

118.53

121.03

g/l

1.75

395

3381

Acute mastoiditis

192

1.92

3.02

11.8

9.2

119.06

122.13

g/l

0.40

186

Complications of labour and delivery

1777

10723

0.92

2.99

7.2

7.7

120.15

119.42

g/l

0.89

1732

10424

Muscular dystrophy

201

1.90

2.98

3.8

10.7

125.47

122.61

g/l

0.34

195

Supervision of high-risk pregnancy

482

2470

1.18

2.96

6.2

9.2

122.81

121.34

g/l

0.91

465

2418

Impacted cerumen

298

3601

0.81

2.95

7.0

7.6

120.90

120.83

g/l

0.02

290

3489

Unspecified renal colic

166

2.01

2.94

8.7

6.9

123.65

122.23

g/l

0.15

160

Lichen sclerosus et atrophicus

367

3083

1.21

2.94

6.0

7.5

120.62

119.77

g/l

0.39

356

2983

186

1.91

2.94

7.3

11.3

125.71

121.90

g/l

0.46

179

Retinal detachment with retinal break

563

4903

1.16

2.91

8.4

8.0

120.01

121.82

g/l

1.19

551

4772

Other contact dermatitis

279

2284

1.24

2.91

8.8

8.1

122.40

122.00

g/l

0.12

267

2215

Asphyxiation

4.64

2.91

5.8

4.8

136.56

125.17

g/l

—

Myeloproliferative diseases (CML excluded)

314

2608

1.23

2.90

8.2

7.8

119.79

121.18

g/l

0.47

305

2531

Intercostal neuropathy

203

1.88

2.90

7.3

11.4

123.22

120.73

g/l

0.32

197

Foreign body or object entering through skin

228

1831

1.27

2.87

9.5

9.2

122.67

124.80

g/l

0.83

221

1786

Contact with other sharp object(s)

216

1722

1.27

2.87

10.8

9.7

124.62

125.06

g/l

0.10

210

1678

Conductive hearing loss, unspecified

314

2608

1.22

2.86

8.4

8.2

121.28

122.00

g/l

0.27

304

2530

Other and unspecified bullous disorders

287

1.73

2.86

6.9

7.4

120.85

120.13

g/l

0.09

280

Malignant neoplasm of parotid gland, including Hilmo

264

1.76

2.86

6.1

6.4

118.59

123.72

g/l

0.99

258

Carcinoma in situ of stomach

4.63

2.85

5.1

8.5

119.67

122.64

g/l

—

Guillain-Barre syndrome

470

1.55

2.84

14.4

8.5

119.73

121.50

g/l

0.28

460

Lesion of plantar nerve

219

1754

1.27

2.84

5.2

7.9

122.94

119.43

g/l

1.91

214

1706

Traumatic amputation of part of head

3.24

2.84

8.9

10.6

127.58

120.56

g/l

0.56

L01XX Other antineoplastic agents

247

2010

1.26

2.83

8.3

8.0

114.81

120.52

g/l

3.59

240

1958

Disorders of orbit

158

1216

1.33

2.82

8.1

8.9

122.06

121.07

g/l

0.25

152

1182

Torsion of testis

388

1.59

2.81

11.6

132.69

130.52

g/l

0.32

378

All dysplastic lesions of the cervix uteri, vagina or vulva

764

6683

1.13

2.81

7.5

7.4

118.93

120.56

g/l

1.65

743

6483

Autoimmune polyglandular failure

3.87

2.78

13.7

25.3

118.10

129.77

g/l

—

Thyrotoxicosis with diffuse goitre

468

4029

1.17

2.78

7.9

7.7

121.37

120.59

g/l

0.35

451

3903

Hereditary angioödema type 1

4.80

2.75

5.0

4.3

128.50

123.55

g/l

—

Other and unspecified acne

258

1.72

2.73

10.1

9.1

118.53

124.40

g/l

0.88

249

Spinal instabilities

705

1.43

2.73

8.2

10.7

121.46

121.05

g/l

0.07

686

Malignant neoplasm of other and unspecified male genital organs, including Hilmo

3.13

2.72

24.8

23.1

112.83

123.59

g/l

1.11

Medicines for HER+ breast cancer

1365

11870

1.10

2.72

5.6

7.1

118.24

118.66

g/l

0.39

1328

11555

Rosacea

402

3430

1.19

2.71

8.4

8.2

121.45

121.52

g/l

0.02

391

3332

Congenital absence, atresia and stenosis of large intestine

5.19

2.69

8.7

9.4

119.71

124.47

g/l

—

Unspecified visual impairment (binocular)

386

1.59

2.69

11.6

9.6

117.71

121.36

g/l

0.70

377

Glaucoma, exfoliation

476

4124

1.17

2.68

5.1

6.4

120.45

118.73

g/l

1.22

460

4009

Otitis media in diseases classified elsewhere

5.28

2.64

7.3

13.0

126.43

120.62

g/l

—

Ectopic pregnancy

497

4316

1.16

2.63

6.5

7.4

121.01

119.33

g/l

1.17

483

4189

178

1400

1.28

2.61

9.6

7.1

119.43

121.95

g/l

1.11

178

1357

Spermatocele

350

2969

1.20

2.61

7.3

9.5

124.11

122.65

g/l

0.59

342

2895

Erythema nodosum

105

771

1.40

2.61

6.5

7.9

117.08

120.51

g/l

1.04

105

751

Profound mental retardation

4.41

2.61

12.6

7.8

115.13

129.81

g/l

—

Special screening examination for other diseases and disorders

368

3124

1.19

2.60

10.8

7.4

117.93

122.10

g/l

3.67

353

3030

Varus deformity, not elsewhere classified

263

1.71

2.60

11.8

7.1

123.21

121.39

g/l

0.31

255

2.57

2.58

16.7

17.0

110.07

127.54

g/l

1.63

Other/unspecified enthesopathies, not elsewhere classified

318

2674

1.21

2.57

7.6

8.3

122.83

121.24

g/l

0.71

309

2596

Use of rivastigmine

673

5969

1.14

2.57

4.0

6.3

119.60

118.59

g/l

0.69

646

5795

Single spontaneous delivery

1252

7248

0.91

2.57

5.9

7.2

119.54

118.16

g/l

1.89

1221

7067

Lichen ruber planus, wide definition including periferal and oral lichen planus

871

7855

1.12

2.57

7.1

8.0

121.93

120.63

g/l

1.15

846

7634

Injury of blood vessels at ankle and foot level

3.60

2.55

5.8

4.1

120.40

125.27

g/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

177

1410

1.29

2.50

10.1

7.8

110.94

121.28

g/l

8.86

168

1367

Juvenile osteochondrosis

691

1.40

2.48

8.9

10.8

123.62

124.72

g/l

0.19

672

Tinnitus

952

8642

1.11

2.48

8.4

122.40

121.39

g/l

0.87

935

8391

Carcinoma in situ of breast, intraductal

286

2392

1.21

2.48

6.1

7.3

117.97

118.72

g/l

0.30

278

2322

Hypogonadotropic hypogonadism

105

779

1.38

2.47

6.4

11.3

137.11

128.08

g/l

3.22

105

757

Fracture of spine, level unspecified

2.68

2.46

9.1

4.6

118.07

124.98

g/l

0.54

Benign neoplasm: Skin of other and unspecified parts of face

423

3662

1.17

2.43

6.0

7.7

122.66

120.72

g/l

1.20

405

3557

Malignant neoplasm of testis, including Hilmo

444

1.51

2.43

12.4

10.2

119.29

128.36

g/l

2.65

431

Periodic paralysis

5.64

2.42

1.3

10.5

121.83

122.38

g/l

—

Disorders of puberty, all

205

1.74

2.42

11.8

10.6

123.94

125.25

g/l

0.12

195

Other lesions of median nerve

110

828

1.37

2.38

6.3

7.8

119.90

119.44

g/l

0.07

104

804

Other and unspecified trigeminal disorders

390

1.54

2.37

8.1

122.16

119.22

g/l

0.52

383

Malignant neoplasm of uterus, part unspecified

4.06

2.36

4.8

2.8

112.63

123.21

g/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

531

4288

1.15

2.36

7.0

8.0

122.44

119.00

g/l

4.17

517

4170

Aortic hypoplasia

4.40

2.36

61.9

55.3

113.29

122.61

g/l

—

Digestive system disorders of fetus and newborn

5.16

2.35

21.5

9.1

117.17

112.08

g/l

—

Poor fetal growth

246

2034

1.22

2.34

11.4

7.2

118.71

121.74

g/l

1.59

235

1971

Mental and behavioural disorders associated with the puerperium

156

1.85

2.31

6.6

9.4

119.43

120.70

g/l

0.16

151

Drug phototoxic response

4.44

2.31

8.4

13.4

119.57

115.53

g/l

—

HSIL lesion of the cervix uteri

421

3654

1.16

2.27

7.9

7.2

119.90

121.03

g/l

0.61

410

3545

Polyclonal hypergammaglobulinaemia

3.48

2.25

17.4

9.9

119.11

121.84

g/l

—

Scleritis and episcleritis

206

1687

1.24

2.25

7.8

8.7

121.37

122.43

g/l

0.32

201

1633

Additional codes for the location of defect, injury or illness

209

1716

1.24

2.24

7.9

8.8

123.54

121.63

g/l

0.64

203

1662

Other specified transport accidents

137

1.93

2.24

10.8

12.0

122.40

124.42

g/l

0.19

130

Contact with machinery

458

4018

1.16

2.23

8.4

9.3

125.27

123.84

g/l

0.69

444

3908

Malignant neoplasm of other and unspecified male genital organs

4.34

2.23

32.3

12.8

108.71

121.90

g/l

—

Vascular dementia (undefined)

158

1245

1.28

2.23

4.3

6.1

119.42

117.16

g/l

0.72

149

1212

Infections with a predominantly sexual mode of transmission

891

8092

1.11

2.21

9.8

8.2

120.83

122.85

g/l

2.34

866

7853

Medullary carcinoma of thyroid gland, including Hilmo

2.82

2.19

4.9

6.0

125.36

127.51

g/l

0.13

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1048

6719

0.91

2.19

6.5

8.3

122.56

120.32

g/l

3.42

1016

6533

Osteomalacia

191

1.75

2.16

6.3

10.6

127.87

121.33

g/l

0.71

186

Other congenital malformations of limb(s)

109

1.99

2.16

31.9

7.6

121.95

123.71

g/l

0.13

103

Benign neoplasm: Skin of scalp and neck

704

1.37

2.14

6.9

9.7

119.66

120.63

g/l

0.16

689

Urethritis and urethral syndrome

575

1.41

2.13

7.9

9.8

120.51

121.14

g/l

0.11

560

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

3.21

2.13

12.9

9.2

114.56

127.00

g/l

—

Open wound of wrist and hand

1823

16712

1.07

2.12

9.4

8.8

123.92

123.49

g/l

0.38

1780

16237

Superficial frostbite

178

1.77

2.10

10.2

12.1

125.77

122.90

g/l

0.34

172

Use of memantine

1285

9873

1.09

2.10

4.1

6.4

120.31

118.46

g/l

2.71

1242

9590

Use of other anti-dementia drugs

1285

9873

1.09

2.10

4.1

6.4

120.31

118.46

g/l

2.71

1242

9590

Urethral stricture

249

2097

1.21

2.10

6.7

8.4

122.04

123.06

g/l

0.33

239

2039

Carcinoma in situ of skin of eyelid, including canthus

2.45

2.09

3.0

6.7

115.36

122.44

g/l

0.59

Sequelae of tuberculosis

544

1.42

2.09

5.7

6.7

120.65

118.80

g/l

0.35

530

Primary angle-closure glaucoma

180

1470

1.25

2.09

5.6

7.9

120.20

118.92

g/l

0.35

173

1420

Chronic suppurative otitis media

235

1966

1.21

2.08

9.0

8.5

121.54

121.70

g/l

0.04

226

1903

Traumatic amputation of forearm

4.54

2.07

37.2

10.8

100.83

119.88

g/l

—

Severe visual impairment, monocular

257

1.63

2.06

4.9

6.8

121.53

121.33

g/l

0.02

251

372

3240

1.17

2.05

13.5

8.6

113.37

122.57

g/l

11.27

366

3153

Long labour

467

4530

0.88

2.05

7.6

8.1

120.25

121.18

g/l

0.48

456

4392

Foreign body in respiratory tract

176

1436

1.25

2.03

9.4

9.2

125.03

121.53

g/l

1.65

170

1399

Fibrosis and sclerosis of liver

4.29

2.03

15.3

9.1

111.33

120.00

g/l

—

Chronic laryngitis and laryngotracheitis

540

4820

1.13

2.01

9.2

7.9

123.05

120.36

g/l

2.33

529

4684

Tetraplegia

212

1.69

2.01

21.6

10.0

116.59

123.87

g/l

1.45

206

Excessive earwax

2498

23131

1.06

2.00

6.9

8.1

122.67

121.15

g/l

3.36

2435

22506

Neurological devices associated with adverse incidents

5.65

2.00

4.0

6.3

126.80

118.50

g/l

—

Stenosis and insufficiency of lacrimal passages

352

3061

1.16

1.97

5.8

7.8

120.27

119.77

g/l

0.19

338

2966

Fat embolism (traumatic)

2.66

1.96

5.4

7.6

115.55

120.78

g/l

0.35

Struck by thrown, projected or falling objec

180

1482

1.23

1.92

7.2

9.2

127.40

125.04

g/l

0.79

171

1445

Other maternal disorders predominantly related to pregnancy

1716

10088

1.07

1.92

6.9

7.9

121.81

119.64

g/l

4.89

1657

9827

108

1.97

1.92

8.3

9.1

125.10

124.73

g/l

0.03

102

Cellulitis of external ear

294

1.55

1.91

8.1

8.6

123.23

119.64

g/l

0.61

285

Tongue abnormality

227

1915

1.21

1.90

6.4

8.3

120.56

120.28

g/l

0.07

218

1863

Alcohol abuse counselling and surveillance

461

1.43

1.89

10.1

10.4

120.67

124.38

g/l

0.63

450

Demyelinating diseases of the central nervous system

253

2151

1.19

1.88

9.5

9.0

123.26

123.07

g/l

0.06

245

2092

Hereditary retinal dystrophy

386

1.47

1.88

4.9

8.2

121.20

122.22

g/l

0.14

376

Motor- or nonmotor-vehicle accident in traffic area

153

1.77

1.87

9.4

13.2

127.23

123.88

g/l

0.35

148

Use of donepezil

784

8198

0.91

1.87

4.2

6.4

121.54

118.40

g/l

4.87

758

7959

Failed attempted abortion

160

1.73

1.86

3.7

10.0

125.19

120.62

g/l

0.47

154

Carcinoma in situ of lip

3.11

1.85

3.6

6.8

114.75

124.60

g/l

—

Allergic rhinitis

951

8660

1.09

1.85

8.0

8.7

124.82

122.64

g/l

2.65

923

8412

Unequal limb length (acquired)

123

1.84

5.9

10.6

124.32

127.24

g/l

0.22

118

Congenital malformations of eye, ear, face and neck

181

1496

1.22

1.84

9.8

9.1

123.33

123.39

g/l

0.01

172

1455

Acute poliomyelitis

380

1.47

1.84

4.8

6.9

124.41

121.34

g/l

0.55

371

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

205

1720

1.21

1.83

6.7

7.2

119.92

119.06

g/l

0.26

200

1677

Use of apomorphine

3.52

1.81

16.1

8.6

106.00

128.00

g/l

—

Diving or jumping into water causing injury other than drowning or submersion

125

1.86

1.81

16.2

13.6

130.86

126.52

g/l

0.40

120

Crushing injury of ankle and foot

2.01

1.81

8.2

6.8

126.39

122.48

g/l

0.35

Disorders of optic chiasm

4.41

1.79

9.4

7.0

129.80

126.38

g/l

—

Other infestations

504

0.64

1.78

6.0

9.6

119.76

121.10

g/l

0.14

492

Hypertrophy of tongue papillae

349

1.48

1.78

8.1

9.2

116.52

122.17

g/l

0.98

342

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

276

1.55

1.77

9.3

10.1

116.68

120.04

g/l

0.49

270

Benign neoplasm: Choroid

240

2050

1.19

1.77

7.3

7.9

118.35

120.73

g/l

1.07

231

1991

Other demyelinating diseases of the central nervous system

103

804

1.30

1.76

15.2

10.0

122.43

123.30

g/l

0.18

786

Carcinoma in situ of skin

361

3179

1.15

1.76

6.7

6.9

117.33

119.76

g/l

1.51

350

3090

Endometriosis of ovary

516

4517

1.12

1.76

7.0

7.7

119.26

118.03

g/l

0.79

492

4386

Other disorders of Eustachian tube

771

1.31

1.75

9.4

8.3

122.32

121.12

g/l

0.24

754

Malignant neoplasm, without specification of site

115

913

1.28

1.75

6.0

6.3

116.07

120.85

g/l

1.72

115

890

Injury of muscle and tendon at ankle and foot level

632

1.34

1.73

6.3

10.0

124.39

123.38

g/l

0.16

613

Q fever

4.44

1.73

22.8

7.4

120.20

124.64

g/l

—

Disorders of puberty

179

1.65

1.72

9.7

11.4

123.48

125.90

g/l

0.23

171

Otitis media, unspecified

300

2398

1.16

1.70

10.6

8.8

124.93

123.15

g/l

0.76

289

2337

Shoulder region

403

1.44

1.70

8.1

9.0

119.98

122.31

g/l

0.36

395

Vasomotor rhinitis (mode)

255

2194

1.18

1.70

5.9

8.8

126.47

121.47

g/l

3.54

248

2130

Interstitial emphysema and related conditions originating in the perinatal period

3.39

1.70

14.8

18.8

106.67

123.79

g/l

—

Benign neoplasm: Connective and other soft tissue of abdomen

2.16

1.68

12.7

8.2

123.64

121.29

g/l

0.12

Rat-bite fevers

3.52

1.68

15.3

7.5

112.50

121.95

g/l

—

Inhalation and ingestion of food causing obstruction of respiratory tract

279

1.53

1.68

15.2

9.4

124.27

120.44

g/l

0.60

272

Ankylosing spondylitis, ICD10

307

2680

1.16

1.68

7.9

9.1

119.91

123.89

g/l

2.96

300

2611

Melanocytic naevi of lower limb, including hip

145

1188

1.24

1.67

6.8

9.7

118.73

121.76

g/l

0.92

139

1157

Congenital malformations of genital organs

223

1886

1.18

1.67

10.8

8.2

121.83

122.17

g/l

0.09

217

1830

Other and unspecified disorders of sclera

2.98

1.65

4.6

6.8

113.14

117.62

g/l

—

Disorders of amino-acid transport

2.50

1.65

11.5

5.0

120.30

126.57

g/l

—

Pregnancy examination and test

316

1708

1.15

1.64

7.5

8.7

122.34

122.35

g/l

0.00

305

1670

L02BA Anti-estrogens

555

5026

1.11

1.64

5.4

7.2

118.01

119.25

g/l

0.97

542

4885

Underdevelopment of the second kidney

3.27

1.63

3.0

34.1

102.50

127.35

g/l

—

Fenamates

608

3745

1.11

1.63

7.1

8.8

120.40

119.19

g/l

0.78

591

3638

Endometriosis ASRM stages 3,4

691

6325

1.10

1.62

6.7

6.8

119.44

119.28

g/l

0.08

664

6143

Hypertrophy of breast in women and men

611

5566

1.10

1.59

7.8

8.1

121.62

120.80

g/l

0.47

595

5406

Failed induction of labour

107

850

1.27

1.59

5.1

7.5

120.19

121.75

g/l

0.38

102

821

Chronic suppurative otitis media, including avohilmo

270

2350

1.16

1.56

8.9

8.7

121.89

121.88

g/l

0.00

259

2275

Other zoonotic bacterial diseases, not elsewhere classified

125

1.79

1.53

13.2

7.5

115.62

120.15

g/l

0.45

120

Benign neoplasm: Conjunctiva

118

958

1.26

1.53

8.1

8.9

118.26

120.61

g/l

0.60

113

935

Squamous cell neoplasms and carcinoma of rectum

2.80

1.53

7.3

9.9

110.43

122.18

g/l

—

Colorectal squamous cell carcinoma

2.79

1.53

7.3

9.9

110.43

122.18

g/l

—

Severe mental retardation

2.37

1.52

3.2

7.3

128.40

126.40

g/l

—

Other and unspecified injuries of forearm

155

1.67

1.52

15.9

12.8

118.44

123.01

g/l

0.55

149

Carcinoma in situ of bronchus and lung

2.57

1.51

8.4

11.9

114.67

118.58

g/l

—

Routine general health check-up of defined subpopulation

317

1.44

1.51

6.0

6.8

119.73

122.60

g/l

0.43

309

Other specified/unspecified nutritional deficiencies

164

1.65

1.50

8.0

7.1

117.23

123.04

g/l

0.76

159

Primary open-angle glaucoma

1441

13156

1.06

1.49

6.2

7.1

119.80

119.48

g/l

0.25

1399

12795

Infliximab

329

0.60

1.49

2.6

10.8

120.55

126.00

g/l

1.01

318

Iridocyclitis in diseases classified elsewhere

527

1.34

1.47

6.5

8.3

121.30

121.04

g/l

0.04

512

Other hypersecretion of intestinal hormones

3.60

1.46

26.6

13.1

101.00

124.18

g/l

—

Aphakia

397

1.39

1.46

9.9

8.7

118.46

120.28

g/l

0.22

381

Other nonthrombocytopenic purpura

272

1.49

1.45

3.2

9.2

120.90

121.41

g/l

0.06

264

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

141

1.67

1.45

5.3

11.7

118.48

127.13

g/l

1.47

134

Pregnancy with abortive outcome

2306

11483

1.05

1.44

6.7

7.0

119.79

118.58

g/l

2.33

2251

11159

Ovarian hyperstimulation (induction)

221

1.52

1.43

4.5

8.5

121.82

122.77

g/l

0.10

216

Polyglandular dysfunction, other/unspecified

2.92

1.43

9.8

7.5

115.00

119.22

g/l

—

Thyroiditis, unspecified

356

1.41

1.43

7.4

7.1

120.37

119.74

g/l

0.08

347

Antenatal screening

416

2604

0.89

1.42

5.8

9.2

122.27

121.22

g/l

0.55

410

2551

Raynaud syndrome

277

2434

1.15

1.42

6.0

8.5

121.92

121.79

g/l

0.04

266

2372

Familial chondrocalcinosis

0.00

1.42

0.0

6.7

—

118.55

—

Benign neoplasm: Other parts of oropharynx

257

1.49

1.41

8.6

10.6

119.76

120.88

g/l

0.13

251

Other and unspecified hypertrophic disorders of skin

151

1.65

1.41

10.8

117.42

121.84

g/l

0.49

145

Injury of blood vessels at wrist and hand level

200

1.57

1.40

10.6

11.4

116.90

123.45

g/l

0.86

193

Delivery

1296

7262

0.94

1.40

6.4

7.2

119.29

118.17

g/l

1.40

1265

7081

Sexual dysfunction

401

1.38

1.39

10.4

11.5

123.59

123.51

g/l

0.01

390

Vestibular neuronitis

333

2968

1.13

1.39

6.7

8.3

123.11

121.67

g/l

0.67

322

2880

Bilateral cryptorchidism (undescended testicles)

0.00

1.38

0.0

8.0

—

133.16

—

Erythema annulare centrifugum

2.27

1.37

4.6

7.6

119.11

123.49

g/l

—

Chronic diseases of tonsils and adenoids

3058

20073

0.96

1.36

7.9

8.6

124.88

121.74

g/l

13.48

2962

19528

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

3.20

1.35

7.6

9.6

128.80

121.89

g/l

—

Contact with other specified venomous animals

153

1.63

1.34

11.5

11.6

124.67

123.01

g/l

0.14

148

Benign neoplasm: other/unspecified salivary gland

103

839

1.25

1.34

6.9

7.8

119.18

120.39

g/l

0.25

819

Dementia in Alzheimer disease

773

6063

1.08

1.34

3.9

6.4

119.67

118.19

g/l

1.27

756

5894

Disturbances of smell and taste

146

1230

1.21

1.33

6.9

9.1

120.70

120.65

g/l

0.01

141

1191

Other appendicitis

294

2608

1.14

1.33

9.5

8.4

122.68

122.92

g/l

0.06

285

2542

Labour and delivery complicated by fetal stress [distress]

396

2882

0.90

1.33

5.4

7.8

121.24

122.56

g/l

0.70

388

2798

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

293

2603

1.14

1.31

6.7

8.7

124.10

121.69

g/l

1.21

282

2529

Dacryoadenitis

203

1.53

1.31

5.5

9.8

121.43

120.11

g/l

0.14

195

Other peripheral vertigo

341

3058

1.13

1.30

6.2

8.0

123.68

120.56

g/l

2.29

329

2972

Female infertility

825

4655

1.08

1.30

7.1

8.2

120.48

118.84

g/l

1.60

799

4529

Complications associated with artificial fertilization

235

1.47

1.29

4.4

9.5

122.29

121.28

g/l

0.11

229

Subacute thyroiditis

114

942

1.23

1.28

7.2

7.4

123.99

119.75

g/l

1.58

109

918

Vitiligo

262

1.45

1.28

6.8

9.7

123.70

123.08

g/l

0.07

255

Iliac crest spur

2.99

1.27

11.0

9.6

132.20

115.16

g/l

—

Endometriosis of intestine

236

1.46

1.27

6.7

8.7

123.26

119.86

g/l

0.48

231

Drug-induced aplastic anaemia

2.34

1.27

6.5

3.2

108.25

124.51

g/l

—

Carcinoma in situ of cervix uteri

206

1791

1.16

1.25

7.2

7.1

119.50

120.67

g/l

0.40

201

1739

Atypical virus infections of central nervous system

256

1.45

1.24

5.0

8.1

124.00

123.24

g/l

0.07

249

Other histiocytosis syndromes

2.49

1.23

4.7

30.2

122.17

127.12

g/l

—

Unspecified dementia

444

3640

1.10

1.22

4.4

6.2

120.21

118.46

g/l

1.06

429

3532

Arthropathic psoriasis

396

3594

1.11

1.22

7.6

8.8

122.84

122.56

g/l

0.10

388

3490

Scissor bite

388

1.34

1.21

11.1

11.8

121.21

123.77

g/l

0.36

378

Use of benzatropine

2.83

1.20

5.0

6.5

131.80

125.40

g/l

—

Other prurigo

300

1.41

1.20

9.4

6.7

121.68

121.81

g/l

0.02

293

Colorectal neuroendocrine tumor and carcinoma

334

1.38

1.20

5.8

7.5

116.84

123.44

g/l

1.37

329

Unspecified drowning and submersion

2.64

1.20

2.4

27.5

136.57

124.20

g/l

—

Chronic iridocyclitis

163

1402

1.18

1.19

7.1

8.4

120.94

121.56

g/l

0.14

156

1358

Benign leiomyoma with endometriosis

448

4896

0.91

1.19

6.7

118.69

118.41

g/l

0.12

433

4755

Carcinoma in situ of skin of other and unspecified parts of face

361

3271

1.12

1.19

6.8

6.4

115.55

118.84

g/l

2.93

351

3179

Infections with a predominantly sexual mode of transmission

1142

10050

1.06

1.18

9.0

8.4

122.04

123.08

g/l

0.99

1111

9759

Medical treatment for female infertility

427

3866

1.10

1.18

6.0

7.5

120.90

121.76

g/l

0.43

413

3747

Persons encountering health services in circumstances related to reproduction

2127

13738

1.05

1.18

9.7

9.5

123.96

123.90

g/l

0.04

2055

13386

Contact with and exposure to communicable diseases

741

7903

0.93

1.16

8.1

8.6

124.64

123.49

g/l

0.81

713

7677

Occupant of streetcar injured in transport accident

2.48

1.16

3.6

8.2

114.29

122.03

g/l

—

Certain conditions originating in the perinatal period

168

1283

1.17

1.16

12.7

10.1

121.79

124.03

g/l

0.70

163

1248

All dysplastic lesions of the cervix uteri

605

5555

1.08

1.16

7.6

7.4

118.98

120.85

g/l

1.65

589

5390

Family history of mental and behavioural disorders

2.46

1.15

7.4

7.3

121.71

121.53

g/l

—

Disorders of breast

1631

14135

1.05

1.15

7.4

7.0

119.62

119.01

g/l

0.69

1587

13737

Biliary cirrhosis, secondary

2.68

1.14

44.2

6.9

106.00

123.71

g/l

—

Female infertility, cervical, vaginal, other or unspecified origin

749

4541

1.08

1.14

6.9

8.2

119.64

118.86

g/l

0.51

726

4418

Benign neoplasm of bone and articular cartilage

274

2449

1.13

1.14

8.1

9.0

122.15

123.18

g/l

0.37

265

2382

Rheumatic fever without mention of heart involvement

1.78

1.14

9.0

8.3

122.87

119.87

g/l

0.25

Chronic myeloproliferative disease

453

1.32

1.13

9.7

9.2

107.02

120.28

g/l

4.67

442

Benign neoplasm: Liver/bile ducts (ICD-9)

2.62

1.13

5.8

10.4

121.20

121.76

g/l

—

Type 1 diabetes, wide definition, subgroup 2

397

0.69

1.11

9.1

7.0

120.14

120.89

g/l

0.06

385

Postpartum haemorrhage

498

4551

0.92

1.10

6.9

8.3

115.90

121.23

g/l

7.68

483

4413

Use of selegiline

180

1574

1.16

1.09

4.9

7.6

122.13

121.04

g/l

0.32

174

1531

Degenerative macular diseases

497

4589

1.09

6.8

7.0

118.16

119.97

g/l

1.24

486

4459

Other bursitis, not elsewhere classified

263

1.41

1.08

3.8

8.3

123.78

121.04

g/l

0.32

257

Delivery, wide proxy

1098

6162

0.94

1.08

6.4

6.9

118.74

117.96

g/l

0.73

1071

5994

Tic and related disorders

161

1.51

1.08

9.6

7.6

121.38

123.69

g/l

0.24

155

Allergic colitis

304

1.36

1.08

22.0

8.4

123.93

124.33

g/l

0.04

295

Triptan medication for migraine, single purchase ok

2705

18953

0.96

1.06

7.8

8.7

124.34

122.10

g/l

6.98

2645

18423

Migraine, single triptan purchase ok & required. ICD-code if available is included

2705

18953

0.96

1.06

7.8

8.7

124.34

122.10

g/l

6.98

2645

18423

Symptoms and signs involving appearance and behaviour

188

1.47

1.05

4.9

7.3

121.52

120.97

g/l

0.06

181

Use of teriflunomide

177

0.55

1.04

3.8

8.1

133.50

125.67

g/l

—

170

Other disorders of amniotic fluid and membranes

217

2384

0.88

1.02

6.7

8.1

121.89

121.41

g/l

0.14

212

2326

Ankle and foot

215

1.44

1.02

8.4

6.4

122.27

121.41

g/l

0.09

210

Chalazion

383

3508

1.10

1.02

7.2

8.6

123.41

122.34

g/l

0.46

370

3406

Tuberculosis of nervous system

2.09

1.01

17.4

10.9

117.57

117.67

g/l

—

Other congenital malformations of skull and face bones

1.90

1.01

3.7

26.3

128.78

127.00

g/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

579

1.25

0.98

8.6

8.5

115.00

119.87

g/l

1.39

565

Noise effects on inner ear

165

1448

1.16

0.98

8.2

9.7

127.19

124.59

g/l

0.85

157

1405

Alzheimer’s disease (Late onset)

1036

8276

1.06

0.98

4.2

6.3

119.94

118.15

g/l

2.18

1011

8039

Maternal care for known or suspected fetal abnormality and damage

254

2430

0.90

0.97

7.5

8.3

119.96

121.44

g/l

0.66

248

2371

Other and unspecified disease of Bartholin gland

744

1.21

0.96

7.5

7.7

122.33

118.07

g/l

1.38

723

Psoriatic arthropathies, ICD10

362

3321

1.10

0.95

7.5

8.9

122.95

122.74

g/l

0.07

355

3230

Embedded and impacted teeth

647

4998

1.07

0.95

7.3

8.7

123.35

124.45

g/l

0.68

625

4861

Lipodystrophy, not elsewhere classified

2.28

0.95

13.7

5.3

119.00

121.46

g/l

—

Normotensive glaucoma

347

3184

1.10

0.93

6.5

7.2

119.05

119.03

g/l

0.01

337

3095

Other osteochondropathies

227

2037

1.12

0.93

8.4

9.3

122.28

123.93

g/l

0.57

220

1986

Varicose veins of other sites

227

2039

1.12

0.92

7.4

9.1

125.52

123.92

g/l

0.53

219

1989

Congenital malformations of uterus and cervix

314

1.32

0.92

18.7

9.2

123.63

121.11

g/l

0.41

307

Shigellosis

152

1.49

0.91

9.1

7.6

119.91

122.02

g/l

0.19

146

Other otitis externa (chronic)

221

1985

1.12

0.91

8.6

9.0

122.65

122.07

g/l

0.16

213

1924

Benign neoplasm: Skin of trunk

138

1204

1.16

0.90

7.5

9.4

123.33

121.45

g/l

0.47

132

1178

Multiple system atrophy (rare forms of Parkinsonism)

1.72

0.89

14.3

6.6

114.77

120.90

g/l

0.50

Other psoriatic arthropathies

350

3218

1.10

0.89

7.1

9.0

123.19

122.68

g/l

0.18

343

3129

Benign neoplasm: Trachea

2.10

0.89

10.0

4.4

124.17

122.29

g/l

—

Ankyloglossia

211

1.39

0.88

11.2

11.6

126.41

126.01

g/l

0.03

202

Hypertrophy of breast

477

4440

1.08

0.88

7.7

121.99

119.81

g/l

1.77

462

4318

Severe bullous disorders, KELA reimbursement

1.82

0.88

4.8

5.5

113.00

119.74

g/l

0.54

Pedal cyclist injured in collision with motor vehicle

789

1.19

0.87

7.4

8.9

122.89

122.51

g/l

0.06

771

Other congenital malformations of face and neck

651

1.21

0.87

6.9

9.8

125.32

122.53

g/l

0.57

636

Kaposi sarcoma, including Hilmo

1.97

0.84

1.8

6.7

108.00

124.75

g/l

—

Effects of air pressure and water pressure

106

1.56

0.82

13.4

14.3

123.63

125.02

g/l

0.10

101

Postpartum hemorraghe, parous women as controls

498

4533

0.93

0.82

6.9

7.1

115.90

121.80

g/l

9.21

483

4398

Clubfoot

190

1.40

0.81

10.2

10.3

117.12

124.89

g/l

0.90

183

Lymphocyte function antigen-1 [LFA-1] defect

0.00

0.81

0.0

7.3

—

122.04

—

Acquired atrophy of ovary and fallopian tube

1.77

0.79

10.6

6.8

119.20

119.44

g/l

—

Malignant neoplasm of placenta, including Hilmo

2.31

0.79

7.4

3.5

120.80

119.61

g/l

—

Disorders of glossopharyngeal nerve

1.77

0.78

29.1

10.4

111.56

122.56

g/l

—

Other or unspecified paralytic strabismus

175

1.41

0.78

10.5

8.5

116.79

121.22

g/l

0.37

167

Benign neoplasm: Skin of lip

397

1.26

0.77

5.7

7.3

121.41

119.94

g/l

0.19

387

Subclinical iodine-deficiency hypothyroidism

1.92

0.76

6.0

7.9

129.43

118.64

g/l

—

Primary open-angle glaucoma, strict

1140

10916

1.05

0.76

6.4

7.1

119.67

119.42

g/l

0.16

1108

10608

Open bite that required surgery (Lefort1 or BSSO)

141

1.44

0.76

3.1

11.7

124.20

122.54

g/l

0.15

136

Cleft lip and cleft lip and palate

150

1.43

0.76

13.2

11.3

121.43

128.16

g/l

0.70

144

MS-disease / Multiple Sclerosis

192

1733

1.11

0.75

6.6

8.8

125.31

123.11

g/l

0.93

187

1687

Vascular dementia (other)

203

1.37

0.74

11.7

6.8

117.07

117.30

g/l

0.02

198

Crowding of teeth, including avohilmo

177

1313

1.12

0.74

10.9

9.1

120.95

123.96

g/l

1.12

172

1284

Unspecified transport accident

109

1.52

0.74

9.0

9.6

120.62

123.11

g/l

0.17

101

Lichen striatus

2.03

0.73

2.2

8.3

122.20

123.65

g/l

—

Organ-limited amyloidosis

144

1.44

0.72

14.6

7.4

121.70

122.00

g/l

0.02

139

Other noninflammatory disorders of vagina

229

2092

1.10

0.72

6.6

7.0

118.37

g/l

0.00

221

2038

Other congenital malformations of peripheral vascular system

283

1.29

0.72

19.2

10.5

121.75

121.97

g/l

0.02

276

Other inflammation of vagina/vulva

656

1.18

0.71

8.2

8.0

118.27

120.38

g/l

0.54

638

L02BG Aromatase inhibitors

1069

10251

1.04

0.70

5.7

7.1

118.29

118.43

g/l

0.10

1040

9970

Carcinoma in situ of prostate

225

0.69

0.70

7.9

10.0

123.94

122.77

g/l

0.11

219

Diaper [napkin] dermatitis

1.93

0.70

9.0

8.1

106.00

127.59

g/l

—

Pectus carinatum

1.93

0.70

2.4

26.9

132.20

137.89

g/l

—

Febrile neutrophilic dermatosis [Sweet]

1.68

0.68

20.6

5.6

103.71

122.30

g/l

—

Sweet's syndrome

1.68

0.68

20.6

5.8

103.71

122.23

g/l

—

Contact with blunt object, undetermined intent

128

1.44

0.68

3.8

13.6

128.61

123.87

g/l

0.41

123

Palindromic rheumatism

282

0.73

0.68

13.0

9.1

124.33

121.89

g/l

0.19

277

Xanthelasma of eyelid

224

1.32

0.67

8.9

7.3

117.31

119.93

g/l

0.26

218

Whooping cough

1.54

0.67

18.5

6.5

110.31

126.01

g/l

1.52

Obstructed labour due to malposition and malpresentation of fetus

445

4412

0.94

0.66

6.6

8.6

121.89

121.41

g/l

0.21

436

4275

Disorder of the sleep-wake schedule

395

1.23

0.66

4.4

10.6

125.77

122.34

g/l

0.49

384

Bus occupant injured in other and unspecified transport accidents

155

1.39

0.65

7.2

7.4

116.48

122.11

g/l

0.60

149

Granuloma annulare

351

1.24

0.65

9.0

7.3

115.49

120.08

g/l

0.78

343

Other mosquito-borne viral fevers

164

1.37

0.65

5.0

8.1

125.91

123.39

g/l

0.25

159

Melanoma in situ of other and unspecified parts of face

412

0.78

0.64

10.0

7.6

118.09

119.63

g/l

0.16

407

FESS (DNB20)

366

3906

0.93

0.64

6.7

9.0

126.88

122.87

g/l

3.06

347

3802

Viral conjunctivitis

100

879

1.15

0.64

7.9

9.1

121.67

122.15

g/l

0.09

859

Neuromyelitis optica

1.69

0.64

4.3

8.3

116.50

123.27

g/l

—

Foreign body entering into or through eye or natural orifice

267

2476

1.08

0.62

8.3

9.2

126.24

124.11

g/l

0.92

260

2410

Pemphigus erythematosus

0.00

0.62

0.0

5.8

—

122.52

—

Other assisted single delivery

256

0.73

0.62

8.3

9.7

123.11

121.50

g/l

0.12

249

Other protozoal intestinal diseases

345

0.77

0.62

5.7

9.9

123.85

120.62

g/l

0.30

337

Unspecified hairloss

1.88

0.61

2.7

11.1

129.50

122.59

g/l

—

Antepartum haemorrhage, not elsewhere classified

164

1488

1.11

0.61

10.1

8.0

120.69

121.51

g/l

0.20

159

1450

Miliary tuberculosis

1.58

0.61

10.1

5.8

93.62

118.92

g/l

—

Benign neoplasm: Connective and other soft tissue of thorax

123

1.43

0.61

5.8

7.4

123.18

120.75

g/l

0.19

118

Respiratory tuberculosis, clinically confirmed

373

1.23

0.60

11.4

8.6

115.89

120.04

g/l

0.83

367

Other predominantly sexually transmitted diseases, not elsewhere classified

504

4783

1.06

0.58

9.1

8.1

122.83

123.51

g/l

0.32

487

4647

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

159

1.36

0.58

6.9

13.5

129.14

126.14

g/l

0.21

154

Blepharospasm

275

1.26

0.58

6.4

9.7

124.94

121.17

g/l

0.54

269

Colour vision deficiencies

0.56

0.58

7.8

13.7

113.20

128.41

g/l

—

Disorders of male genital organs in diseases classified elsewhere

177

1.33

0.57

11.9

14.2

129.57

124.95

g/l

0.40

169

Intentional self-harm by hanging, strangulation and suffocation

168

1.34

0.57

4.7

10.9

130.23

125.56

g/l

0.48

162

Nontoxic single thyroid nodule

194

2105

0.92

0.56

5.2

7.7

121.26

120.00

g/l

0.36

188

2039

Other superficial injuries of ankle and foot

125

1.39

0.55

11.5

6.6

127.00

122.66

g/l

0.37

119

Graves disease, strict definition

282

2638

1.07

0.54

6.4

8.2

122.33

121.27

g/l

0.37

272

2569

Foreign body on external eye

482

5066

0.95

0.54

7.7

9.8

127.68

125.01

g/l

1.96

465

4933

Crossbite

156

1316

1.10

0.54

9.4

9.6

125.07

122.85

g/l

0.69

148

1287

Puerperal sepsis

359

3389

1.06

0.53

8.2

7.7

121.41

119.53

g/l

1.11

353

3293

Traumatic amputation of hip and thigh

1.64

0.52

9.4

6.4

121.00

121.44

g/l

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

1.54

0.51

14.1

6.8

115.50

123.88

g/l

—

Transient global amnesia

350

3308

1.06

0.51

5.6

7.6

121.94

119.90

g/l

1.15

341

3215

Benign neoplasm: Scapula and long bones of upper limb

243

1.25

0.51

4.8

10.0

127.30

122.50

g/l

0.71

235

Uterine polyps

294

2763

1.07

0.51

6.9

7.5

120.01

118.05

g/l

1.14

284

2690

Ethmoidectomy

387

4082

0.94

0.51

7.0

9.0

126.88

122.76

g/l

3.35

368

3972

Peroneal tendinitis

353

1.20

0.50

5.2

10.1

128.52

120.26

g/l

1.55

348

Exposure to ignition of highly flammable material

119

1.38

0.50

8.3

13.5

121.31

126.90

g/l

0.42

114

Dyshidrosis [pompholyx]

334

0.80

0.50

5.7

7.0

129.78

122.66

g/l

1.27

325

Tonsillectomy and adenotomy

1706

12176

0.97

0.50

7.4

9.0

126.06

123.67

g/l

4.68

1647

11845

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

159

1727

0.92

0.49

11.0

7.6

119.01

120.97

g/l

0.68

152

1682

Adenomyosis (Endometriosis of uterus)

424

4035

1.05

0.48

6.5

7.3

119.83

117.59

g/l

1.70

417

3927

Complications predominantly related to the puerperium

647

6225

1.04

0.46

8.3

7.4

120.34

119.97

g/l

0.19

638

6036

Atopic dermatitis

1921

16090

0.98

0.46

8.1

8.4

122.62

122.46

g/l

0.13

1882

15648

Gender identity disorders

164

0.73

0.45

9.1

11.8

123.17

126.26

g/l

0.23

156

Interstitial myositis

1.71

0.45

2.0

7.0

126.40

121.42

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

159

1719

0.92

0.45

11.0

7.1

119.01

121.16

g/l

0.77

152

1672

Abnormal findings on diagnostic imaging of breast

349

1.19

0.45

7.7

6.9

118.39

118.58

g/l

0.02

343

Benign neoplasm: Parathyroid gland

322

1.20

0.44

3.5

7.1

124.55

120.00

g/l

0.76

316

Anogenital herpesviral [herpes simplex] infection

141

1300

1.09

0.43

11.5

9.1

121.04

123.63

g/l

0.86

136

1261

Plasmodium vivax malaria

0.00

0.42

0.0

10.4

—

114.29

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.42

0.0

11.4

—

121.59

—

Ascariasis

0.00

0.42

0.0

7.9

—

119.25

—

Dysplasia of cervi uteri

645

4499

1.04

0.42

7.4

8.0

118.44

118.88

g/l

0.23

629

4368

Cholera

1.53

0.42

10.8

10.7

126.60

120.53

g/l

—

Meningococcal infection

159

1.28

0.41

8.9

8.0

129.55

125.39

g/l

0.40

153

Unattended death

280

0.81

0.40

4.6

7.0

122.04

120.66

g/l

0.13

273

Abrasion of teeth

1167

11970

0.97

0.40

7.3

8.2

121.54

121.40

g/l

0.09

1129

11647

Cleft lip and palate

115

1.33

0.40

7.7

12.4

120.40

127.09

g/l

0.57

110

Benign neoplasm: Vagina

307

1.19

0.40

6.0

6.1

115.44

118.05

g/l

0.37

300

Benign mammary dysplasia

455

4368

1.05

0.39

7.2

6.9

117.99

118.14

g/l

0.06

443

4250

Pervasive developmental disorders excl. Autism + Asperger

167

1.25

0.39

4.8

14.7

121.95

124.51

g/l

0.24

158

Postpartum hemorraghe, all women as controls

498

5097

0.96

0.39

6.9

7.6

115.90

121.67

g/l

8.90

483

4944

Oral lichen planus, including avohilmo , including avohilmo

209

1969

1.07

0.38

7.2

8.2

124.00

120.89

g/l

1.52

203

1922

Benign lipomatous neoplasm of other sites/unspecified

314

2994

1.05

0.38

7.7

7.8

122.21

120.91

g/l

0.59

308

2905

Acrodermatitis chronica atrophicans

1.52

0.37

9.3

7.6

112.00

121.93

g/l

—

Otosclerosis

231

2441

0.94

0.37

8.3

120.41

120.86

g/l

0.13

225

2375

Other congenital malformations of skin

225

2126

1.06

0.37

8.7

120.80

122.38

g/l

0.55

220

2071

Neuroendocrine tumor and carcinoma of rectum

1.37

0.37

5.5

7.1

113.00

123.26

g/l

1.18

Gestational diabetes (for exclusion)

792

5343

1.03

0.37

6.9

8.0

121.84

121.36

g/l

0.29

770

5188

Calcaneal spur

319

1.17

0.37

11.8

7.7

120.08

121.22

g/l

0.14

313

Alzheimer’s disease, strict definition

1097

8816

1.03

0.36

4.5

6.4

119.89

118.36

g/l

1.80

1072

8560

Pediculosis and phthiriasis

117

1.30

0.36

6.2

8.0

121.80

124.01

g/l

0.15

112

Other porphyria

1.40

0.35

6.3

6.1

135.83

125.16

g/l

—

Crystalline deposits in vitreous body

293

1.18

0.35

5.5

7.2

116.65

120.53

g/l

0.59

288

Undescended testicle

199

1.22

0.35

14.3

12.1

125.00

129.32

g/l

0.41

192

Spontaneous abortion

1284

8849

0.98

0.34

6.4

7.6

120.98

119.17

g/l

2.85

1243

8609

Presence of other devices

913

9323

0.97

0.33

7.3

6.7

121.10

120.86

g/l

0.13

882

9048

Tic and related disorders

201

1.20

0.33

9.6

10.3

121.38

125.53

g/l

0.50

193

Carcinoma in situ of penis

1.39

0.32

7.4

23.0

121.57

123.58

g/l

—

Enterobiasis

305

0.85

0.32

9.8

10.2

121.81

123.72

g/l

0.18

296

Undefined dementia

446

3970

1.04

0.31

4.4

5.7

120.23

118.38

g/l

1.16

431

3859

Rheumatic heart disease, other

1.28

0.30

4.6

6.3

124.43

120.78

g/l

—

Other abnormal products of conception

726

4678

1.03

0.30

6.3

8.0

121.99

120.81

g/l

0.85

698

4536

Allergic conjunctivitis

1997

19156

1.02

0.29

8.4

7.9

121.69

121.23

g/l

0.49

1953

18632

Obstructed labour due to maternal pelvic abnormality

422

4081

1.04

0.29

7.8

7.7

119.69

119.35

g/l

0.14

410

3966

Other specified disorders of external ear

123

1308

0.93

0.28

6.9

9.0

121.82

122.22

g/l

0.08

117

1270

Other disorders of breast

322

3341

0.96

0.27

6.8

7.3

118.47

118.96

g/l

0.20

317

3242

Tic disorders

196

1.18

0.27

10.0

10.8

122.83

125.07

g/l

0.24

188

Urticaria due to cold and heat

159

1.21

0.27

7.7

7.6

121.11

122.79

g/l

0.20

154

Other obstructed labour

179

1703

1.05

0.27

6.8

7.5

120.69

120.59

g/l

0.02

172

1652

Chorioretinal inflammation

809

1.08

0.27

12.8

8.6

120.54

121.29

g/l

0.13

788

Other protozoal intestinal diseases

478

0.89

0.26

7.0

9.4

124.53

121.82

g/l

0.35

466

Eccrine sweat disorders

1.26

0.26

1.8

7.6

132.44

124.95

g/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

160

1.20

0.26

16.3

7.6

118.37

120.95

g/l

0.22

154

LSIL lesion of the cervix uteri, vagina or vulva

315

3038

1.04

0.26

7.6

7.3

117.49

120.86

g/l

2.78

307

2951

Benign neoplasm: Skin, unspecified

125

1180

1.06

0.25

7.4

8.5

120.62

121.48

g/l

0.17

120

1154

Presbyopia

199

1903

1.05

0.25

8.5

8.9

124.85

123.01

g/l

0.69

194

1851

Other and unspecified cicatricial alopecia

0.73

0.25

7.0

7.9

134.83

119.35

g/l

—

Familial erythrocytosis

133

1.22

0.25

15.4

7.4

131.44

121.71

g/l

1.10

128

Anomalies of dental arch relationship, including avohilmo

542

4758

1.03

0.25

7.7

8.7

124.93

123.10

g/l

1.29

526

4630

Merkel cell carcinoma of skin

1.40

0.24

5.4

5.8

120.00

123.49

g/l

—

Maternal care for other known or suspected fetal problems

430

2805

0.97

0.24

6.7

8.2

120.30

121.99

g/l

1.08

412

2733

Anogenital herpesviral [herpes simplex] infection

240

2307

1.04

0.24

10.3

8.6

122.16

123.11

g/l

0.33

232

2245

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1409

10477

1.02

0.24

7.3

7.5

120.13

119.96

g/l

0.12

1364

10183

Cholesteatoma of middle ear

180

1721

1.05

0.24

8.3

8.2

121.16

121.06

g/l

0.02

175

1679

Mandibular retrognathia

149

1413

1.05

0.24

6.5

10.0

124.71

123.54

g/l

0.34

140

1377

Other fusion of spine

1.31

0.23

7.8

7.1

117.80

121.13

g/l

—

Ménière disease

332

3218

1.03

0.23

5.4

7.8

123.75

120.41

g/l

2.59

321

3129

Yellow nail syndrome

0.00

0.22

0.0

12.4

—

125.09

—

Other fluke infections

0.00

0.22

0.0

13.4

—

122.17

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.22

0.0

7.8

—

115.55

—

Enophthalmos

0.00

0.22

0.0

9.6

—

122.33

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

0.00

0.22

0.0

8.8

—

118.92

—

Sudden idiopathic hearing loss

365

3551

1.03

0.21

9.1

8.1

122.21

121.17

g/l

0.41

358

3443

Thyrotoxicosis with toxic single thyroid nodule

202

1.15

0.20

3.6

7.0

123.96

120.64

g/l

0.35

197

Multiple gestation

165

1720

0.96

0.20

8.1

7.9

119.10

121.06

g/l

0.69

159

1678

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1897

18229

1.01

0.19

8.5

7.9

121.55

121.21

g/l

0.33

1856

17728

Allergic contact dermatitis

367

3767

0.97

0.19

7.6

7.8

121.70

121.58

g/l

0.04

361

3652

Corneal degeneration

453

1.09

0.19

9.3

7.5

118.55

119.67

g/l

0.16

441

Other specified and unspecified disorders of choroid

109

1.21

0.19

11.0

7.6

119.77

121.41

g/l

0.12

103

Asymptomatic human immunodeficiency virus [HIV] infection status

153

0.84

0.18

10.5

16.4

118.69

125.97

g/l

0.55

148

Twin gestation

159

1650

0.96

0.17

8.4

7.9

118.90

121.14

g/l

0.82

153

1610

Leiomyoma of uterus

2182

12246

1.01

0.17

6.8

7.1

119.38

118.88

g/l

0.60

2113

11910

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

1.17

0.17

10.0

16.7

137.00

131.50

g/l

—

Benign neoplasm of other and unspecified female genital organs

118

1131

1.05

0.16

6.0

6.7

117.80

118.95

g/l

0.26

118

1106

Use of galantamine

291

2985

0.97

0.16

3.6

6.2

121.46

118.57

g/l

1.64

283

2896

Benign neoplasm: Vulva

535

0.93

0.16

4.6

7.0

115.92

118.48

g/l

0.38

521

Dentofacial anomalies [including malocclusion]

2473

20022

0.99

0.16

7.0

8.6

123.50

122.10

g/l

2.94

2402

19474

Other and unspecified disorders of vitreous body

1728

16872

1.01

0.16

7.3

8.0

121.63

120.35

g/l

1.98

1683

16412

Maternal care for known or suspected malpresentation of fetus

340

2405

1.03

0.16

6.6

8.1

121.30

121.95

g/l

0.24

325

2341

N06DA Anticholinesterases

1536

12233

0.99

0.15

4.2

6.7

120.67

118.92

g/l

3.02

1483

11896

Use of anticholinesterases

1536

12233

0.99

0.15

4.2

6.7

120.67

118.92

g/l

3.02

1483

11896

Pregnancy, childbirth and the puerperium

1014

5362

0.99

0.14

5.8

6.6

118.40

117.87

g/l

0.40

998

5202

Intrahepatic Cholestasis of Pregnancy (ICP)

116

1206

0.96

0.14

11.5

7.7

121.99

121.84

g/l

0.03

110

1175

Testicular dysfunction, other/unspecified

122

1.16

0.14

7.5

15.9

136.93

125.90

g/l

1.05

117

Pollen allergy

423

4254

0.98

0.14

7.8

8.9

125.42

123.92

g/l

0.77

412

4143

Whooping cough

218

1.11

0.14

11.5

6.8

115.38

124.67

g/l

1.35

209

Other puerperal infections

119

1234

0.96

0.13

8.3

7.8

121.18

121.37

g/l

0.04

119

1197

Villonodular synovitis (pigmented)

190

1.11

0.13

6.2

12.4

122.81

120.95

g/l

0.16

185

Neonatal jaundice from other and unspecified causes

175

1.11

0.12

24.3

14.7

116.45

123.61

g/l

0.78

170

Use of dimethyl fumarate

133

1.13

0.12

10.8

7.7

124.47

122.45

g/l

0.15

128

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

116

1199

0.97

0.12

11.5

7.2

121.99

121.89

g/l

0.02

110

1164

Maternal care for known or suspected abnormality of pelvic organs

549

3684

1.01

0.11

6.6

8.1

120.90

121.13

g/l

0.10

538

3585

Retained placenta and membranes, without haemorrhage

293

2986

0.98

0.11

6.0

7.4

118.14

120.02

g/l

0.98

288

2902

Benign neoplasm: Eye, unspecified

115

0.86

0.11

6.7

4.8

112.70

119.48

g/l

—

115

Haemorrhagic and haematological disorders of fetus and newborn

211

1.09

0.11

22.6

14.5

113.83

122.90

g/l

1.19

206

Bullous keratopathy

241

1.09

0.10

5.7

5.9

115.85

121.44

g/l

0.78

235

Photocontact dermatitis [berloque dermatitis]

1.18

0.10

2.0

9.8

123.20

121.26

g/l

—

Mesial bite

156

0.89

0.10

12.4

12.0

124.21

123.11

g/l

0.06

151

Contact with nonpowered hand tool

131

1345

0.97

0.10

10.2

9.7

124.90

125.02

g/l

0.02

126

1311

Contraceptive management

1333

9277

1.01

0.09

8.5

9.7

123.55

123.95

g/l

0.29

1287

9056

Idiopathic hypercalciuria

155

1.11

0.09

10.6

9.0

127.88

123.78

g/l

0.37

149

Early syphilis

370

1.06

0.09

9.2

10.8

126.21

124.80

g/l

0.17

358

Other disorders of breast and lactation associated with childbirth

227

0.92

0.09

6.9

7.4

120.52

121.64

g/l

0.09

222

Single delivery by caesarean section

394

2229

1.01

0.09

7.3

9.4

117.98

120.67

g/l

1.94

384

2179

Other congenital malformations of male genital organs

126

1.12

0.09

9.4

14.5

133.07

130.06

g/l

0.18

121

Overjet

377

0.95

0.08

11.4

11.0

118.31

122.90

g/l

0.85

367

Enterobiasis

0.84

0.08

5.7

8.2

120.83

123.62

g/l

—

Lichenoid drug reaction

1.14

0.07

11.6

5.7

122.80

116.43

g/l

—

Injury of nerves at ankle and foot level

168

1.08

0.06

12.1

8.1

126.72

122.54

g/l

0.29

162

Premenstrual syndrome

188

1.07

0.05

9.4

10.4

119.15

120.48

g/l

0.11

183

Other predominantly sexually transmitted diseases, not elsewhere classified

409

4058

1.01

0.05

10.2

8.1

121.05

123.36

g/l

1.58

394

3942

Postpartum haemorrhage due to retained placenta

226

2284

0.99

0.04

7.4

7.1

114.74

122.08

g/l

6.19

220

2210

Other deformity of hallux (acquired)

209

1.06

0.04

3.7

7.2

121.77

119.59

g/l

0.15

204

L02BB Anti-androgens

378

3805

0.99

0.04

6.0

7.8

114.95

121.16

g/l

7.06

365

3705

Deep bite

283

2468

1.01

0.02

8.3

9.5

125.25

123.39

g/l

0.81

276

2404

Vascular dementia (sudden onset)

1.08

0.02

2.7

5.5

113.00

114.78

g/l

—

Unspecified lump in breast

457

4557

1.00

0.01

8.1

7.0

119.48

118.82

g/l

0.34

445

4432

Impacted teeth

395

3502

1.00

0.01

6.8

8.9

124.51

124.61

g/l

0.03

387

3406

Triptan medication for migraine, min. 3 purchases

1718

13121

1.00

0.01

7.5

8.4

123.92

121.78

g/l

4.62

1675

12750

Defect, injury or illness of neck

126

0.95

0.00

14.3

7.8

133.50

123.20

g/l

0.86

121

Heberden's nodes [with arthropathy]

244

1.03

0.00

7.4

7.2

123.04

119.20

g/l

0.40

238

Hereditary motor and sensory neuropathy

228

1.01

0.00

9.2

7.7

120.91

123.60

g/l

0.19

222

Contact with lifting and transmission devices, not elsewhere classified

528

1.00

0.00

9.7

11.3

124.40

124.16

g/l

0.02

512

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

197

1.02

0.00

2.3

11.4

128.50

124.27

g/l

0.51

191

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

196

1.02

0.00

4.3

8.6

125.50

120.11

g/l

0.78

191

Contact with venomous snakes and lizards

264

0.98

0.00

2.8

10.5

128.19

121.99

g/l

0.68

258

Hypertrophy of (infrapatellar) fat pad

226

1.02

0.00

3.7

11.2

125.09

121.57

g/l

0.34

220

Disorders of parathyroid gland, other and/or unspecified

195

1.03

0.00

9.0

7.3

116.60

119.67

g/l

0.23

189

Congenital retinoschisis

0.98

0.00

4.3

9.4

118.17

121.26

g/l

—

Toxic effect of noxious substances eaten as seafood

0.00

0.0

3.4

—

123.60

—

Toxic liver disease with acute hepatitis, drug-induced

0.00

0.0

17.0

—

127.33

—

Deficiency of vitamin E

0.00

0.0

9.6

—

118.40

—

Plasmodium malariae malaria

0.00

0.0

2.7

—

119.17

—

Chlamydia psittaci infection

0.00

0.0

2.6

—

118.60

—

Pustulosis subcornealis

0.00

0.0

12.8

—

117.50

—

Early syphilis

350

1.00

-0.00

9.4

11.0

126.34

124.87

g/l

0.16

338

Other protozoal diseases, not elsewhere classified/unspecified

0.00

-0.00

0.0

20.7

—

117.33

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

9.6

—

106.80

—

Anthrax

0.00

-0.00

0.0

8.0

—

119.78

—

Fetal blood loss

0.00

-0.00

0.0

10.7

—

123.57

—

Blastomycosis

0.00

-0.00

0.0

3.0

—

140.29

—

Other specified disorders of eye and adnexa in diseases classified elsewhere

0.00

-0.00

0.0

2.4

—

124.86

—

Accident to nonpowered aircraft causing injury to occupant

0.00

-0.00

0.0

10.2

—

129.67

—

Neuropathic heredofamilial amyloidosis

0.00

-0.00

0.0

6.3

—

126.67

—

Visual disturbances in diseases classified elsewhere

0.00

-0.00

0.0

8.0

—

131.88

—

Beau lines

0.00

-0.00

0.0

19.7

—

113.50

—

Reduction defects of lower limb

1.01

-0.00

21.5

5.9

117.88

124.58

g/l

—

Histoplasmosis

0.00

-0.00

0.0

18.4

—

105.60

—

Dietary selenium deficiency

0.00

-0.00

0.0

14.7

—

117.50

—

Ascariasis

0.00

-0.00

0.0

9.0

—

115.83

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

2.6

—

122.00

—

Reduction defects of lower limb

0.90

-0.00

32.6

5.9

131.80

127.51

g/l

—

Androgen resistance syndrome

0.00

-0.00

0.0

11.6

—

112.00

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

3.2

—

132.50

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

2.5

—

122.50

—

Granuloma inguinale

0.00

-0.00

0.0

4.0

—

107.20

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Hemoglobin [Mass/volume] in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS